细胞株Cell Lines 90及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net
- 价 格：¥19200
- 货 号：NTCC-CV90
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID ND37306
AC CVCL_FT84
DR Coriell; ND37306
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37321
AC CVCL_FT85
DR Coriell; ND37321
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37346
AC CVCL_FT86
DR Coriell; ND37346
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37356
AC CVCL_FT87
DR Coriell; ND37356
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37357
AC CVCL_FT88
DR Coriell; ND37357
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37377
AC CVCL_FT89
DR Coriell; ND37377
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37378
AC CVCL_FT90
DR Coriell; ND37378
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37428
AC CVCL_FT91
DR Coriell; ND37428
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37503
AC CVCL_FT92
DR Coriell; ND37503
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37517
AC CVCL_EZ19
DR Coriell; ND37517
DR NHCDR; ND37517
CC Discontinued: Coriell; ND37517; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND37601
AC CVCL_FT93
DR Coriell; ND37601
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37609
AC CVCL_EZ20
DR Coriell; ND37609
DR NHCDR; ND37609
CC Discontinued: Coriell; ND37609; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND37624
AC CVCL_EE19
DR Coriell; ND37624
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND37710
AC CVCL_HS09
DR Coriell; ND37710
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND37731
AC CVCL_EZ21
DR Coriell; ND37731
DR NHCDR; ND37731
CC Discontinued: Coriell; ND37731; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND37732
AC CVCL_EZ22
DR Coriell; ND37732
DR NHCDR; ND37732
CC Discontinued: Coriell; ND37732; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND37757
AC CVCL_EZ23
DR Coriell; ND37757
DR NHCDR; ND37757
CC Discontinued: Coriell; ND37757; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND37766
AC CVCL_FT94
DR Coriell; ND37766
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38020
AC CVCL_EZ24
DR Coriell; ND38020
DR NHCDR; ND38020
CC Discontinued: Coriell; ND38020; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND38136
AC CVCL_EZ25
DR Coriell; ND38136
DR NHCDR; ND38136
CC Discontinued: Coriell; ND38136; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND38155
AC CVCL_HS10
DR Coriell; ND38155
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38170
AC CVCL_HS11
DR Coriell; ND38170
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2882; Arteriovenous hemangioma/malformation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38181
AC CVCL_HS12
DR Coriell; ND38181
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38208
AC CVCL_IH83
DR Coriell; ND38208
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C50485; Cerebral hemorrhage
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38209
AC CVCL_FT95
DR Coriell; ND38209
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38258
AC CVCL_FT96
DR Coriell; ND38258
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38262
AC CVCL_EZ26
DR Coriell; ND38262
DR NHCDR; ND38262
CC Discontinued: Coriell; ND38262; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND38409
AC CVCL_FT97
DR Coriell; ND38409
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38473
AC CVCL_IG62
DR Coriell; ND38473
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38477
AC CVCL_Y812
DR Coriell; ND38477
DR NHCDR; ND38477
WW http://shared.eagle-i.net/i/00000144-7f70-38a8-5797-c9ee80000000
CC Discontinued: Coriell; ND38477; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y811 ! ND29543
SX Male
CA Induced pluripotent stem cell
//
ID ND38528
AC CVCL_EZ27
DR Coriell; ND38528
DR NHCDR; ND38528
CC Discontinued: Coriell; ND38528; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND38530
AC CVCL_EZ28
DR Coriell; ND38530
DR NHCDR; ND38530
CC Discontinued: Coriell; ND38530; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND38534
AC CVCL_FT98
DR Coriell; ND38534
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38545
AC CVCL_Y814
DR Coriell; ND38545
DR NHCDR; ND38545
WW http://shared.eagle-i.net/i/00000144-7e91-07f1-5797-c9ee80000000
CC Discontinued: Coriell; ND38545; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_M952 ! GM04689
SX Female
CA Induced pluripotent stem cell
//
ID ND38546
AC CVCL_Y815
DR Coriell; ND38546
DR NHCDR; ND38546
WW http://shared.eagle-i.net/i/00000144-7e97-1585-5797-c9ee80000000
CC Discontinued: Coriell; ND38546; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V574 ! GM04887
SX Female
CA Induced pluripotent stem cell
//
ID ND38547
AC CVCL_Y816
DR Coriell; ND38547
DR NHCDR; ND38547
WW http://shared.eagle-i.net/i/00000144-7e9b-b6d6-5797-c9ee80000000
CC Discontinued: Coriell; ND38547; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y854 ! GM04777
SX Male
CA Induced pluripotent stem cell
//
ID ND38548
AC CVCL_Y817
DR Coriell; ND38548
DR NHCDR; ND38548
WW http://shared.eagle-i.net/i/00000144-7ea8-2088-5797-c9ee80000000
CC Discontinued: Coriell; ND38548; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_V568 ! GM04717
SX Female
CA Induced pluripotent stem cell
//
ID ND38549
AC CVCL_Y818
DR Coriell; ND38549
DR NHCDR; ND38549
WW http://shared.eagle-i.net/i/00000144-7eb0-1cdb-5797-c9ee80000000
CC Discontinued: Coriell; ND38549; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y964 ! GM04805
SX Female
CA Induced pluripotent stem cell
//
ID ND38551
AC CVCL_Y819
DR Coriell; ND38551
DR NHCDR; ND38551
WW http://shared.eagle-i.net/i/00000144-7eb7-c27a-5797-c9ee80000000
CC Discontinued: Coriell; ND38551; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y859 ! GM04287
SX Male
CA Induced pluripotent stem cell
//
ID ND38552
AC CVCL_Y820
DR Coriell; ND38552
DR NHCDR; ND38552
WW http://shared.eagle-i.net/i/00000144-7ebd-2803-5797-c9ee80000000
CC Discontinued: Coriell; ND38552; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y861 ! GM04687
SX Female
CA Induced pluripotent stem cell
//
ID ND38554
AC CVCL_Y821
DR Coriell; ND38554
DR NHCDR; ND38554
WW http://shared.eagle-i.net/i/00000144-7ec0-a8b8-5797-c9ee80000000
CC Discontinued: Coriell; ND38554; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y882 ! GM04729
SX Female
CA Induced pluripotent stem cell
//
ID ND38555
AC CVCL_Y822
DR Coriell; ND38555
DR NHCDR; ND38555
WW http://shared.eagle-i.net/i/00000144-7ec4-d5f1-5797-c9ee80000000
CC Discontinued: Coriell; ND38555; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y885 ! GM04797
SX Female
CA Induced pluripotent stem cell
//
ID ND38558
AC CVCL_FT99
DR Coriell; ND38558
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38582
AC CVCL_FU00
DR Coriell; ND38582
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38594
AC CVCL_IG92
DR Coriell; ND38594
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84626; Cerebral cavernous malformation
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38630
AC CVCL_FU01
DR Coriell; ND38630
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38689
AC CVCL_HS13
DR Coriell; ND38689
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38724
AC CVCL_FV33
DR Coriell; ND38724
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38771
AC CVCL_FU02
DR Coriell; ND38771
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38782
AC CVCL_GP56
DR Coriell; ND38782
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38791
AC CVCL_EZ29
DR Coriell; ND38791
DR NHCDR; ND38791
CC Discontinued: Coriell; ND38791; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND38836
AC CVCL_FU03
DR Coriell; ND38836
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38865
AC CVCL_EZ30
DR Coriell; ND38865
DR NHCDR; ND38865
CC Discontinued: Coriell; ND38865; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND38912
AC CVCL_FU04
DR Coriell; ND38912
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38947
AC CVCL_FU05
DR Coriell; ND38947
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND38960
AC CVCL_FV34
DR Coriell; ND38960
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND38965
AC CVCL_FU06
DR Coriell; ND38965
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39021
AC CVCL_EZ31
DR Coriell; ND39021
DR NHCDR; ND39021
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ile112Thr).
CC Discontinued: Coriell; ND39021; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39022
AC CVCL_EZ32
DR Coriell; ND39022
DR NHCDR; ND39022
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).
CC Discontinued: Coriell; ND39022; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39023
AC CVCL_Y806
DR Coriell; ND39023
DR NHCDR; ND39023
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Ala4Val).
CC Discontinued: Coriell; ND39023; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39025
AC CVCL_T864
DR Coriell; ND39025
DR NHCDR; ND39025
RX PubMed=25760436;
CC Discontinued: Coriell; ND39025; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39026
AC CVCL_T862
DR Coriell; ND39026
DR NHCDR; ND39026
RX PubMed=25760436;
CC Discontinued: Coriell; ND39026; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39027
AC CVCL_T855
DR Coriell; ND39027
DR NHCDR; ND39027
RX PubMed=25760436;
WW http://shared.eagle-i.net/i/00000144-7a25-3bf7-5797-c9ee80000000
CC Discontinued: Coriell; ND39027; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_U113 ! ND10734
SX Female
CA Finite cell line
//
ID ND39030
AC CVCL_Y823
DR Coriell; ND39030
DR NHCDR; ND39030
RX PubMed=25760436;
CC Discontinued: Coriell; ND39030; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T849 ! ND29149
SX Female
CA Induced pluripotent stem cell
//
ID ND39032
AC CVCL_Y824
DR Coriell; ND39032
DR NHCDR; ND39032
RX PubMed=25760436;
WW http://shared.eagle-i.net/i/00000144-7a3d-fbd0-5797-c9ee80000000
CC Discontinued: Coriell; ND39032; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY26 ! ND29415
SX Male
CA Induced pluripotent stem cell
//
ID ND39034
AC CVCL_Y825
DR Coriell; ND39034
DR NHCDR; ND39034
RX PubMed=25760436;
WW http://shared.eagle-i.net/i/00000144-7a2d-e548-5797-c9ee80000000
CC Discontinued: Coriell; ND39034; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y894 ! ND29563
SX Male
CA Induced pluripotent stem cell
//
ID ND39036
AC CVCL_Y826
DR Coriell; ND39036
DR NHCDR; ND39036
WW http://shared.eagle-i.net/i/00000144-7b3d-14ab-5797-c9ee80000000
CC Miscellaneous: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (SOD1-Gly86Arg).
CC Discontinued: Coriell; ND39036; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND39037
AC CVCL_Y827
DR Coriell; ND39037
DR NHCDR; ND39037
RX PubMed=25760436;
WW http://shared.eagle-i.net/i/00000144-7b44-8ef4-5797-c9ee80000000
CC Discontinued: Coriell; ND39037; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND39064
AC CVCL_FV35
DR Coriell; ND39064
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39131
AC CVCL_FU07
DR Coriell; ND39131
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39132
AC CVCL_FU08
DR Coriell; ND39132
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39183
AC CVCL_EZ33
DR Coriell; ND39183
DR NHCDR; ND39183
CC Discontinued: Coriell; ND39183; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND39276
AC CVCL_FV36
DR Coriell; ND39276
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39277
AC CVCL_EE20
DR Coriell; ND39277
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39326
AC CVCL_FV37
DR Coriell; ND39326
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39450
AC CVCL_EZ34
DR Coriell; ND39450
DR NHCDR; ND39450
CC Discontinued: Coriell; ND39450; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39472
AC CVCL_FU09
DR Coriell; ND39472
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39508
AC CVCL_EE21
DR Coriell; ND39508
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39510
AC CVCL_EZ35
DR Coriell; ND39510
DR NHCDR; ND39510
CC Discontinued: Coriell; ND39510; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND39515
AC CVCL_FU10
DR Coriell; ND39515
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39518
AC CVCL_FU11
DR Coriell; ND39518
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39528
AC CVCL_EZ36
DR Coriell; ND39528
DR NHCDR; ND39528
CC Discontinued: Coriell; ND39528; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39538
AC CVCL_EZ37
DR Coriell; ND39538
DR NHCDR; ND39538
CC Discontinued: Coriell; ND39538; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39701
AC CVCL_EE22
DR Coriell; ND39701
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39708
AC CVCL_FU12
DR Coriell; ND39708
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39757
AC CVCL_FU13
DR Coriell; ND39757
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39793
AC CVCL_FU14
DR Coriell; ND39793
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39826
AC CVCL_EH99
DR Coriell; ND39826
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85028; Progressive supranuclear palsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39876
AC CVCL_IG63
DR Coriell; ND39876
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND39896
AC CVCL_Y828
DR Coriell; ND39896
DR NHCDR; ND39896
WW http://shared.eagle-i.net/i/00000144-7f77-6a7f-5797-c9ee80000000
CC Discontinued: Coriell; ND39896; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND39955
AC CVCL_EZ38
DR Coriell; ND39955
DR NHCDR; ND39955
CC Discontinued: Coriell; ND39955; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND39957
AC CVCL_EZ39
DR Coriell; ND39957
DR NHCDR; ND39957
CC Discontinued: Coriell; ND39957; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND39985
AC CVCL_FU15
DR Coriell; ND39985
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39997
AC CVCL_FV38
DR Coriell; ND39997
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND39999
AC CVCL_EZ40
DR Coriell; ND39999
DR NHCDR; ND39999
CC Discontinued: Coriell; ND39999; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40018
AC CVCL_Y829
DR Coriell; ND40018
WW http://shared.eagle-i.net/i/00000144-7f5f-52f0-5797-c9ee80000000
CC Discontinued: Coriell; ND40018; probable.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID ND40019
AC CVCL_Y830
DR Coriell; ND40019
DR NHCDR; ND40019
WW http://shared.eagle-i.net/i/00000144-7f66-8a66-5797-c9ee80000000
CC Discontinued: Coriell; ND40019; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y831 ! ND40020
SX Male
CA Induced pluripotent stem cell
//
ID ND40020
AC CVCL_Y831
DR Coriell; ND40020
DR NHCDR; ND40020
WW http://shared.eagle-i.net/i/00000144-7f6b-64ac-5797-c9ee80000000
CC Discontinued: Coriell; ND40020; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y830 ! ND40019
SX Male
CA Induced pluripotent stem cell
//
ID ND40021
AC CVCL_FU16
DR Coriell; ND40021
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40026
AC CVCL_FU17
DR Coriell; ND40026
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40061
AC CVCL_EZ41
DR Coriell; ND40061
DR NHCDR; ND40061
CC Discontinued: Coriell; ND40061; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40064
AC CVCL_EZ42
DR Coriell; ND40064
DR NHCDR; ND40064
CC Discontinued: Coriell; ND40064; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40065
AC CVCL_EZ43
DR Coriell; ND40065
DR NHCDR; ND40065
CC Discontinued: Coriell; ND40065; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40066
AC CVCL_EZ44
DR Coriell; ND40066
DR NHCDR; ND40066
CC Discontinued: Coriell; ND40066; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40067
AC CVCL_EZ45
DR Coriell; ND40067
DR NHCDR; ND40067
CC Discontinued: Coriell; ND40067; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40068
AC CVCL_EY29
DR Coriell; ND40068
DR NHCDR; ND40068
CC Discontinued: Coriell; ND40068; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40069
AC CVCL_EZ46
DR Coriell; ND40069
DR NHCDR; ND40069
CC Discontinued: Coriell; ND40069; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40070
AC CVCL_EZ47
DR Coriell; ND40070
DR NHCDR; ND40070
CC Discontinued: Coriell; ND40070; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40071
AC CVCL_EZ48
DR Coriell; ND40071
DR NHCDR; ND40071
CC Discontinued: Coriell; ND40071; true.
DI NCIt; C84719; Frontotemporal dementia
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40072
AC CVCL_EZ49
DR Coriell; ND40072
DR NHCDR; ND40072
CC Discontinued: Coriell; ND40072; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40074
AC CVCL_EZ50
DR Coriell; ND40074
DR NHCDR; ND40074
CC Discontinued: Coriell; ND40074; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40075
AC CVCL_EZ51
DR Coriell; ND40075
DR NHCDR; ND40075
CC Discontinued: Coriell; ND40075; true.
DI NCIt; C35527; Familial dystonia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40076
AC CVCL_EZ52
DR Coriell; ND40076
DR NHCDR; ND40076
CC Discontinued: Coriell; ND40076; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40077
AC CVCL_EZ53
DR Coriell; ND40077
DR NHCDR; ND40077
CC Discontinued: Coriell; ND40077; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40078
AC CVCL_EZ54
DR Coriell; ND40078
DR NHCDR; ND40078
CC Discontinued: Coriell; ND40078; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40079
AC CVCL_EZ55
DR Coriell; ND40079
DR NHCDR; ND40079
CC Discontinued: Coriell; ND40079; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40080
AC CVCL_EZ56
DR Coriell; ND40080
DR NHCDR; ND40080
CC Discontinued: Coriell; ND40080; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40081
AC CVCL_EZ57
DR Coriell; ND40081
DR NHCDR; ND40081
CC Discontinued: Coriell; ND40081; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40082
AC CVCL_EZ58
DR Coriell; ND40082
DR NHCDR; ND40082
CC Discontinued: Coriell; ND40082; true.
DI NCIt; C84719; Frontotemporal dementia
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40260
AC CVCL_EZ59
DR Coriell; ND40260
DR NHCDR; ND40260
CC Discontinued: Coriell; ND40260; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40268
AC CVCL_GP57
DR Coriell; ND40268
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40346
AC CVCL_FV39
DR Coriell; ND40346
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40365
AC CVCL_IG64
DR Coriell; ND40365
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND40459
AC CVCL_FU18
DR Coriell; ND40459
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40534
AC CVCL_EZ60
DR NHCDR; ND40534
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND40536
AC CVCL_EZ61
DR NHCDR; ND40536
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND40608
AC CVCL_EI00
DR Coriell; ND40608
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85028; Progressive supranuclear palsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40629
AC CVCL_FU19
DR Coriell; ND40629
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND40636
AC CVCL_EE23
DR Coriell; ND40636
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40653
AC CVCL_FU20
DR Coriell; ND40653
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND40809
AC CVCL_EI01
DR Coriell; ND40809
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C85028; Progressive supranuclear palsy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND40874
AC CVCL_FU21
DR Coriell; ND40874
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND40877
AC CVCL_FU22
DR Coriell; ND40877
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C3020; Seizure disorder
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40985
AC CVCL_HS14
DR Coriell; ND40985
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND40992
AC CVCL_EZ62
DR NHCDR; ND40992
DI NCIt; C84719; Frontotemporal dementia
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41001
AC CVCL_EZ63
DR NHCDR; ND41001
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND41003
AC CVCL_EZ64
DR Coriell; ND41003
DR NHCDR; ND41003
CC Discontinued: Coriell; ND41003; true.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND41004
AC CVCL_EZ65
DR NHCDR; ND41004
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND41006
AC CVCL_EZ66
DR NHCDR; ND41006
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41007
AC CVCL_EZ67
DR NHCDR; ND41007
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND41010
AC CVCL_EZ68
DR Coriell; ND41010
DR NHCDR; ND41010
CC Discontinued: Coriell; ND41010; true.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41014
AC CVCL_EZ69
DR NHCDR; ND41014
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41015
AC CVCL_EZ70
DR NHCDR; ND41015
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41016
AC CVCL_EZ71
DR NHCDR; ND41016
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41113
AC CVCL_Y809
DR Coriell; ND41113
DR NHCDR; ND41113
WW http://shared.eagle-i.net/i/00000144-7ec9-6442-5797-c9ee80000000
CC Discontinued: Coriell; ND41113; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W557 ! GM02183
SX Female
CA Induced pluripotent stem cell
//
ID ND41114
AC CVCL_Y832
DR Coriell; ND41114
DR NHCDR; ND41114
WW http://shared.eagle-i.net/i/00000144-7ecd-9a6f-5797-c9ee80000000
CC Discontinued: Coriell; ND41114; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F173 ! GM03814
SX Female
CA Induced pluripotent stem cell
//
ID ND41125
AC CVCL_EZ72
DR NHCDR; ND41125
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND41375
AC CVCL_HS15
DR Coriell; ND41375
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35064; Hereditary hemorrhagic telangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID ND41654
AC CVCL_Y833
DR Coriell; ND41654
DR NHCDR; ND41654
CC Discontinued: Coriell; ND41654; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y895 ! ND30625
SX Male
CA Induced pluripotent stem cell
//
ID ND41656
AC CVCL_Y834
DR Coriell; ND41656
DR NHCDR; ND41656
WW http://shared.eagle-i.net/i/00000144-7ee8-93f9-5797-c9ee80000000
CC Discontinued: Coriell; ND41656; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y897 ! ND33392
SX Female
CA Induced pluripotent stem cell
//
ID ND41657
AC CVCL_Y835
DR Coriell; ND41657
DR NHCDR; ND41657
WW http://shared.eagle-i.net/i/00000144-7eed-289b-5797-c9ee80000000
CC Discontinued: Coriell; ND41657; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y897 ! ND33392
SX Female
CA Induced pluripotent stem cell
//
ID ND41658
AC CVCL_Y836
DR Coriell; ND41658
DR NHCDR; ND41658
CC Discontinued: Coriell; ND41658; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y895 ! ND30625
SX Male
CA Induced pluripotent stem cell
//
ID ND41864
AC CVCL_1N97
DR Coriell; ND41864
DR NHCDR; ND41864
CC Discontinued: Coriell; ND41864; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y837 ! ND41865
OI CVCL_Y838 ! ND41866
SX Male
CA Induced pluripotent stem cell
//
ID ND41865
AC CVCL_Y837
DR Coriell; ND41865
DR NHCDR; ND41865
WW http://shared.eagle-i.net/i/00000144-7b68-c50f-5797-c9ee80000000
CC Discontinued: Coriell; ND41865; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N97 ! ND41864
OI CVCL_Y838 ! ND41866
SX Male
CA Induced pluripotent stem cell
//
ID ND41866
AC CVCL_Y838
DR Coriell; ND41866
DR NHCDR; ND41866
WW http://shared.eagle-i.net/i/00000144-7b6c-c519-5797-c9ee80000000
CC Discontinued: Coriell; ND41866; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N97 ! ND41864
OI CVCL_Y837 ! ND41865
SX Male
CA Induced pluripotent stem cell
//
ID ND41867
AC CVCL_Y839
DR Coriell; ND41867
DR NHCDR; ND41867
CC Discontinued: Coriell; ND41867; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y840 ! ND41869
SX Male
CA Induced pluripotent stem cell
//
ID ND41869
AC CVCL_Y840
DR Coriell; ND41869
DR NHCDR; ND41869
WW http://shared.eagle-i.net/i/00000144-7b53-63e4-5797-c9ee80000000
CC Discontinued: Coriell; ND41869; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y839 ! ND41867
SX Male
CA Induced pluripotent stem cell
//
ID ND41870
AC CVCL_Y841
DR Coriell; ND41870
DR NHCDR; ND41870
WW http://shared.eagle-i.net/i/00000144-7b59-c1fd-5797-c9ee80000000
CC Discontinued: Coriell; ND41870; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y842 ! ND41871
OI CVCL_Y843 ! ND41872
SX Male
CA Induced pluripotent stem cell
//
ID ND41871
AC CVCL_Y842
DR Coriell; ND41871
DR NHCDR; ND41871
CC Discontinued: Coriell; ND41871; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y841 ! ND41870
OI CVCL_Y843 ! ND41872
SX Male
CA Induced pluripotent stem cell
//
ID ND41872
AC CVCL_Y843
DR Coriell; ND41872
DR NHCDR; ND41872
WW http://shared.eagle-i.net/i/00000144-7b61-d831-5797-c9ee80000000
CC Discontinued: Coriell; ND41872; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y841 ! ND41870
OI CVCL_Y842 ! ND41871
SX Male
CA Induced pluripotent stem cell
//
ID ND42222
AC CVCL_Y844
DR Coriell; ND42222
DR NHCDR; ND42222
CC Discontinued: Coriell; ND42222; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N95 ! ND42223
OI CVCL_Y845 ! ND42224
OI CVCL_GP60 ! ND50034
SX Female
CA Induced pluripotent stem cell
//
ID ND42223
AC CVCL_1N95
DR Coriell; ND42223
CC Discontinued: Coriell; ND42223; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y844 ! ND42222
OI CVCL_Y845 ! ND42224
OI CVCL_GP60 ! ND50034
SX Female
CA Induced pluripotent stem cell
//
ID ND42224
AC CVCL_Y845
DR Coriell; ND42224
DR NHCDR; ND42224
CC Discontinued: Coriell; ND42224; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y844 ! ND42222
OI CVCL_1N95 ! ND42223
OI CVCL_GP60 ! ND50034
SX Female
CA Induced pluripotent stem cell
//
ID ND42228
AC CVCL_1N96
DR Coriell; ND42228
CC Discontinued: Coriell; ND42228; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID ND42229
AC CVCL_Y846
DR Coriell; ND42229
CC Discontinued: Coriell; ND42229; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID ND42230
AC CVCL_Y847
DR Coriell; ND42230
DR NHCDR; ND42230
CC Discontinued: Coriell; ND42230; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID ND42235
AC CVCL_Y848
DR Coriell; ND42235
DR NHCDR; ND42235
CC Discontinued: Coriell; ND42235; true.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y861 ! GM04687
SX Female
CA Induced pluripotent stem cell
//
ID ND42240
AC CVCL_Y849
DR Coriell; ND42240
DR NHCDR; ND42240
CC Discontinued: Coriell; ND42240; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F173 ! GM03814
SX Female
CA Induced pluripotent stem cell
//
ID ND42241
AC CVCL_Y850
DR Coriell; ND42241
DR NHCDR; ND42241
CC Discontinued: Coriell; ND42241; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_F173 ! GM03814
SX Female
CA Induced pluripotent stem cell
//
ID ND42242
AC CVCL_Y851
DR Coriell; ND42242
DR NHCDR; ND42242
CC Discontinued: Coriell; ND42242; true.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y898 ! ND30014
SX Female
CA Induced pluripotent stem cell
//
ID ND42245
AC CVCL_Y852
DR Coriell; ND42245
DR NHCDR; ND42245
CC Discontinued: Coriell; ND42245; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND42485
AC CVCL_EZ73
DR NHCDR; ND42485
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (MAPT-Pro301Leu).
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42487
AC CVCL_EZ74
DR NHCDR; ND42487
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42490
AC CVCL_EZ75
DR NHCDR; ND42490
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42491
AC CVCL_EZ76
DR NHCDR; ND42491
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42492
AC CVCL_EZ77
DR NHCDR; ND42492
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42493
AC CVCL_EY30
DR NHCDR; ND42493
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42494
AC CVCL_EZ78
DR NHCDR; ND42494
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42496
AC CVCL_EZ79
DR NHCDR; ND42496
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42497
AC CVCL_EZ80
DR NHCDR; ND42497
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (MAPT IVS10+16).
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42498
AC CVCL_EZ81
DR NHCDR; ND42498
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42503
AC CVCL_EZ82
DR NHCDR; ND42503
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42504
AC CVCL_EZ83
DR NHCDR; ND42504
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42506
AC CVCL_EZ84
DR NHCDR; ND42506
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (C9orf72 (GGGGCC)n expansion).
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42619
AC CVCL_EE24
DR Coriell; ND42619
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C95802; Ischemic cerebrovascular accident
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ND42716
AC CVCL_EZ85
DR NHCDR; ND42716
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ND42717
AC CVCL_EZ86
DR NHCDR; ND42717
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID ND42765
AC CVCL_1N98
DR Coriell; ND42765
CC Discontinued: Coriell; ND42765; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N99 ! ND43208
OI CVCL_GP61 ! ND50035
SX Female
CA Induced pluripotent stem cell
//
ID ND42767
AC CVCL_EZ87
DR Coriell; ND42767
DR NHCDR; ND42767
CC Discontinued: Coriell; ND42767; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND43208
AC CVCL_1N99
DR Coriell; ND43208
CC Discontinued: Coriell; ND43208; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N98 ! ND42765
OI CVCL_GP61 ! ND50035
SX Female
CA Induced pluripotent stem cell
//
ID ND43209
AC CVCL_EZ88
DR Coriell; ND43209
DR NHCDR; ND43209
CC Miscellaneous: At sampling donor was not affected with frontotemporal dementia but at risk for disease (mutation in GRN).
CC Discontinued: Coriell; ND43209; true.
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID ND50012
AC CVCL_EZ89
DR NHCDR; ND50012
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY29 ! ND40068
SX Female
CA Induced pluripotent stem cell
//
ID ND50013
AC CVCL_EZ90
DR NHCDR; ND50013
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY29 ! ND40068
SX Female
CA Induced pluripotent stem cell
//
ID ND50014
AC CVCL_EZ91
DR NHCDR; ND50014
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY29 ! ND40068
SX Female
CA Induced pluripotent stem cell
//
ID ND50015
AC CVCL_EZ92
DR NHCDR; ND50015
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY30 ! ND42493
SX Female
CA Induced pluripotent stem cell
//
ID ND50016
AC CVCL_EZ93
DR NHCDR; ND50016
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY30 ! ND42493
SX Female
CA Induced pluripotent stem cell
//
ID ND50017
AC CVCL_EZ94
DR NHCDR; ND50017
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_EY30 ! ND42493
SX Female
CA Induced pluripotent stem cell
//
ID ND50032
AC CVCL_GP58
DR NHCDR; ND50032
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID ND50033
AC CVCL_GP59
DR NHCDR; ND50033
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8519 ! GM04281
SX Female
CA Induced pluripotent stem cell
//
ID ND50034
AC CVCL_GP60
DR NHCDR; ND50034
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y844 ! ND42222
OI CVCL_1N95 ! ND42223
OI CVCL_Y845 ! ND42224
SX Female
CA Induced pluripotent stem cell
//
ID ND50035
AC CVCL_GP61
DR NHCDR; ND50035
DI NCIt; C84719; Frontotemporal dementia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1N98 ! ND42765
OI CVCL_1N99 ! ND43208
SX Female
CA Induced pluripotent stem cell
//
ID ND7/23
AC CVCL_4259
DR CLO; CLO_0008144
DR CLDB; cl3680
DR ECACC; 92090903
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID ND8
AC CVCL_G216
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_2132 ! N18TG2
CA Hybrid cell line
//
ID ND8/34
AC CVCL_4260
DR CLO; CLO_0008145
DR ECACC; 92090904
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_G216 ! ND8
CA Hybrid cell line
//
ID NDCS-1
AC CVCL_EJ23
SY NDCS1
DR Cosmic; 1602482
RX PubMed=17653762;
RX PubMed=22057234;
CC Doubling time: 30 hours (PubMed=17653762).
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C6476; Dedifferentiated chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NDDLS-1
AC CVCL_M831
RX PubMed=21790860;
DI NCIt; C3704; Dedifferentiated liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NDS-758
AC CVCL_F569
SY 758; TER125; TER214
DR IMGT/HLA; 12014
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-AN
AC CVCL_F570
DR IMGT/HLA; 11787
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-DG
AC CVCL_F571
SY TER93
DR IMGT/HLA; 11131
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-HM
AC CVCL_F572
SY TER153; TER223
DR IMGT/HLA; 12739
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-IH
AC CVCL_F573
DR IMGT/HLA; 12173
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-JD
AC CVCL_F574
SY TER86; TER177; TER218; TER242; TER266
DR IMGT/HLA; 11132
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-MA
AC CVCL_F575
DR IMGT/HLA; 11133
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NDS-NH
AC CVCL_F576
SY TER122; TER254; TER256; TER334
DR IMGT/HLA; 11134
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NE
AC CVCL_3554
DR CLO; CLO_0008149
DR ATCC; CRL-2070
RX PubMed=2098280;
CC Breed/subspecies: C3H/J.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5T97 ! ME [Mouse teratocarcinoma]
CA Cancer cell line
//
ID Ne Col
AC CVCL_U789
DR ATCC; CRL-1345
CC Discontinued: ATCC; CRL-1345; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Ne Loc
AC CVCL_3555
DR CLO; CLO_0008150
DR ATCC; CRL-1205
CC Discontinued: ATCC; CRL-1205; true.
DI NCIt; C118636; Stiff skin syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NE-1
AC CVCL_E306
SY NE1; NE1-E6E7
RX PubMed=15489894;
WW http://www.addexbio.com/productdetail?pid=75
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NE-18
AC CVCL_7083
SY NE18
DR BTO; BTO:0003018
DR Cosmic; 844590
DR Cosmic; 877396
DR Cosmic; 1028951
DR Cosmic; 1152491
RX PubMed=3422461;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7114 ! RH-SLC-L11
SX Female
CA Cancer cell line
//
ID NE-4C
AC CVCL_B063
DR BTO; BTO:0005624
DR ATCC; CRL-2925
RX PubMed=9057134;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID NE-GFP-4C
AC CVCL_L103
DR BTO; BTO:0005625
DR ATCC; CRL-2926
RX PubMed=15246825;
CC Transfected with: UniProtKB; P42212; GFP.
CC Discontinued: ATCC; CRL-2926; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_B063 ! NE-4C
CA Transformed cell line
//
ID NE-MD
AC CVCL_6C06
SY nNOS-EGFP Expressing Macula Densa
RX PubMed=16412259;
RX PubMed=17233813;
RX PubMed=19340543;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID Ne2/1b4.14
AC CVCL_0E04
SY NE2/1B4-14; NE2-1B4.14
DR ATCC; CRL-2356
CC Discontinued: ATCC; CRL-2356; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID Ne8/4c6.3
AC CVCL_0E05
SY NE8/4C6.3; NE8-4C6.3; NE8 4C6.3
DR ATCC; CRL-2355
CC Discontinued: ATCC; CRL-2355; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID NEAmp-48.2
AC CVCL_L101
SY NEAMP 48.2
DR ATCC; PTA-5295
RX Patent=US7101980;
CC Monoclonal antibody target: ChEBI; CHEBI:132237; rac-3,4-methylenedioxy-N-ethylamphetamine.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID NEAmp-62.1
AC CVCL_L102
SY NEAMP 62.1
DR ATCC; PTA-5294
RX Patent=US7101980;
CC Monoclonal antibody target: ChEBI; CHEBI:132237; rac-3,4-methylenedioxy-N-ethylamphetamine.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6972 ! FO [Mouse myeloma]
CA Hybridoma
//
ID NEAU-Ms-941015
AC CVCL_IM40
RX DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC Group: Insect cell line.
OX NCBI_TaxID=271217; ! Mythimna separata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NEAU-Ms-947311
AC CVCL_IM41
RX DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC Group: Insect cell line.
OX NCBI_TaxID=271217; ! Mythimna separata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NEAU-Ms-980312
AC CVCL_AV36
SY NEAU-MS-980312
RX CelloPub=CLPUB00314;
CC Group: Insect cell line.
CC Doubling time: 47.82 hours (CelloPub=CLPUB00314).
OX NCBI_TaxID=271217; ! Mythimna separata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NEAU-Xc-730E
AC CVCL_0A25
SY Xc730E
RX CelloPub=CLPUB00221;
RX DOI=10.3969/j.issn.1005-9369.2000.04.006;
CC Group: Insect cell line.
OX NCBI_TaxID=987431; ! Xestia c-nigrum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NEAU-Xc-960716H
AC CVCL_0A13
RX CelloPub=CLPUB00221;
CC Group: Insect cell line.
CC Doubling time: ~63 hours (CelloPub=CLPUB00221).
OX NCBI_TaxID=987431; ! Xestia c-nigrum
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NEC-DUE1
AC CVCL_AS96
RX PubMed=24551139;
CC Derived from metastatic site: Liver.
ST Source(s): PubMed=24551139
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D10S1248: 16,17
ST D12S391: 18
ST D13S317: 12
ST D16S539: 10
ST D18S51: 13,20
ST D19S433: 13,16
ST D1S1656: 14,15
ST D21S11: 32.2
ST D22S1045: 15,16
ST D2S1338: 19,20
ST D2S441: 11
ST D3S1358: 16,17
ST D5S818: 13
ST D7S820: 10,11
ST D8S1179: 12,13
ST FGA: 20,25
ST SE33: 25.2
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C126323; Gastroesophageal junction large cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEC-DUE2
AC CVCL_AS97
RX PubMed=24551139;
CC Derived from metastatic site: Lymph node.
ST Source(s): PubMed=24551139
ST Amelogenin: X
ST CSF1PO: 13
ST D10S1248: 14
ST D12S391: 17,23
ST D13S317: 8,12
ST D16S539: 10,11
ST D18S51: 12,15
ST D19S433: 15,16
ST D1S1656: 12,14
ST D21S11: 29
ST D22S1045: 11,16
ST D2S1338: 17
ST D2S441: 11
ST D3S1358: 15
ST D5S818: 12
ST D7S820: 8,11
ST D8S1179: 12,13
ST FGA: 21
ST SE33: 22.2,24.2
ST TH01: 8
ST TPOX: 8
ST vWA: 14
DI NCIt; C96157; Colorectal large cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEC14
AC CVCL_3070
DR CLO; CLO_0051392
DR BioSample; SAMN03470816
DR BioSample; SAMN03472271
DR JCRB; JCRB0162
DR RCB; RCB0490
RX PubMed=2445169;
RX PubMed=3618218;
ST Source(s): JCRB; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9,11
ST D5S818: 13 (JCRB)
ST D5S818: 12,13 (RCB)
ST D7S820: 10,12
ST TH01: 8
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEC15
AC CVCL_3929
DR CLO; CLO_0051393
DR BioSample; SAMN03472273
DR RCB; RCB0494
RX PubMed=2445169;
RX PubMed=3618218;
RX PubMed=24812411;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 16
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEC8
AC CVCL_1604
SY NEC-8
DR CLO; CLO_0051391
DR BioSample; SAMN03471665
DR ChEMBL-Cells; CHEMBL3308176
DR ChEMBL-Targets; CHEMBL2366340
DR Cosmic; 910942
DR Cosmic-CLP; 910942
DR GDSC; 910942
DR GEO; GSM827251
DR GEO; GSM1670276
DR JCRB; JCRB0250
DR RCB; RCB0489
RX PubMed=520758;
RX PubMed=2445169;
RX PubMed=3618218;
RX PubMed=9290701;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB
ST Amelogenin: X
ST CSF1PO: 13,15
ST D13S317: 12
ST D16S539: 9,10
ST D5S818: 10,14
ST D7S820: 8
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 14,15
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEC8 cl-1
AC CVCL_IW43
SY NEC8 clone-1
RX PubMed=2445169;
DI NCIt; C6341; Testicular embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1604 ! NEC8
SX Male
CA Cancer cell line
//
ID NECS-L
AC CVCL_L212
RX PubMed=11070410;
DI NCIt; C60639; Rectal small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L213 ! NECS-P
SX Male
CA Cancer cell line
//
ID NECS-P
AC CVCL_L213
RX PubMed=11070410;
DI NCIt; C60639; Rectal small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L212 ! NECS-L
SX Male
CA Cancer cell line
//
ID NEF
AC CVCL_D900
DR BTO; BTO:0005262
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID Nef-ER 31
AC CVCL_1H35
SY Nef-ER #31; Nef-ER #31 Clone
DR NIH-ARP; 6453-91
RX PubMed=11134296;
DI NCIt; C7210; Childhood T lymphoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1714 ! SUP-T1
SX Male
CA Cancer cell line
//
ID NEF26.Ov
AC CVCL_6422
SY NFF26.Ov
DR CLO; CLO_0008151
DR ATCC; CRL-6175
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6175; true.
OX NCBI_TaxID=9685; ! Felis catus
SX Female
CA Undefined cell line type
//
ID NEF36.Sg
AC CVCL_6423
SY NFF36.Sg
DR CLO; CLO_0008152
DR ATCC; CRL-6176
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6176; true.
OX NCBI_TaxID=9685; ! Felis catus
SX Female
CA Undefined cell line type
//
ID NeHepBaHT
AC CVCL_0F42
DR ATCC; CRL-4022
RX Patent=US20090155232;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-4022; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C465 ! NeHepLxHT
OI CVCL_0F41 ! NeHepMsHT
SX Male
CA Telomerase immortalized cell line
//
ID NeHepLxHT
AC CVCL_C465
DR ATCC; CRL-4020
DR BioSample; SAMN03471727
RX Patent=US20090155232;
RX PubMed=19565302;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-4020; probable.
ST Source(s): ATCC; PubMed=19565302
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0F42 ! NeHepBaHT
OI CVCL_0F41 ! NeHepMsHT
SX Male
CA Telomerase immortalized cell line
//
ID NeHepMsHT
AC CVCL_0F41
DR ATCC; CRL-4021
RX Patent=US20090155232;
CC Transfected with: HGNC; 11730; TERT.
CC Discontinued: ATCC; CRL-4021; true.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8,13
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0F42 ! NeHepBaHT
OI CVCL_C465 ! NeHepLxHT
SX Male
CA Telomerase immortalized cell line
//
ID NEM157
AC CVCL_IT35
RX PubMed=25534822;
RX PubMed=25939062;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Doubling time: 30 hours (PubMed=25534822).
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 12
ST D21S11: 30
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,16
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NEM163
AC CVCL_IT36
RX PubMed=25534822;
RX PubMed=25939062;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Doubling time: 36 hours (PubMed=25534822).
ST Source(s): PubMed=25939062
ST Amelogenin: X,Y
ST CSF1PO: 8,10
ST D13S317: 10,11
ST D16S539: 11
ST D21S11: 28,30
ST D5S818: 12,13
ST D7S820: 9
ST TH01: 7,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NEM165
AC CVCL_IT37
RX PubMed=25534822;
RX PubMed=25939062;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Doubling time: 32 hours (PubMed=25534822).
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9
ST D16S539: 11
ST D21S11: 29,33.2
ST D5S818: 12,13
ST D7S820: 12
ST TH01: 8,9.3
ST TPOX: 10,11
ST vWA: 15
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NEM168
AC CVCL_IT38
RX PubMed=25534822;
RX PubMed=25939062;
CC Characteristics: Has a H3F3A p.Lys28Met mutation (H3.3K27M).
CC Doubling time: 34 hours (PubMed=25534822).
ST Source(s): PubMed=25939062
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 10,13
ST D16S539: 11
ST D21S11: 29,29.2
ST D5S818: 11,13
ST D7S820: 8,9
ST TH01: 6,9.3
ST TPOX: 10,11
ST vWA: 18,19
DI NCIt; C94764; Diffuse intrinsic pontine glioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Nemo-1
AC CVCL_1E49
RX PubMed=833871;
DI NCIt; C3269; Schwannoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Neo Jurkat
AC CVCL_U621
DR ATCC; CRL-2898
RX PubMed=10567572;
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 9
ST D7S820: 8,12
ST TH01: 6,9.3
ST TPOX: 8,10
ST vWA: 18
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0065 ! Jurkat
SX Male
CA Cancer cell line
//
ID neo6/C8161.1
AC CVCL_6815
RX PubMed=8302587;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6813 ! C8161
HI CVCL_6C50 ! MCH262A1.D6
CA Hybrid cell line
//
ID neo6/C8161.2
AC CVCL_6816
RX PubMed=8302587;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6813 ! C8161
HI CVCL_6C50 ! MCH262A1.D6
CA Hybrid cell line
//
ID neo6/C8161.3
AC CVCL_6817
RX PubMed=8302587;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6813 ! C8161
HI CVCL_6C50 ! MCH262A1.D6
CA Hybrid cell line
//
ID Neopu
AC CVCL_Z995
DR CLO; CLO_0008153
DR CLDB; cl3681
DR ECACC; 90070561
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID nEPN1
AC CVCL_IR49
RX PubMed=20978004;
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID nEPN2
AC CVCL_IR50
RX PubMed=20978004;
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NEPS
AC CVCL_IS66
RX PubMed=19756736;
DI NCIt; C3714; Epithelioid sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Neu7
AC CVCL_AZ70
SY Neu-7; Neu 7
DR BTO; BTO:0005800
RX PubMed=7583324;
RX PubMed=10516297;
CC Transformant: Activated Erbb2/neu.
CC Caution: Erroneously indicated as originating from mouse in BTO BTO:0005800.
CC Breed/subspecies: CFHB Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NeuCHO
AC CVCL_IR07
SY NeuCho
RX Patent=US20160017277;
WW http://www.neuclone.com/technology/
CC Registration: International Depositary Authority, Cell Bank Australia; CBA20130024.
CC Transfected with: HGNC; 4261; GH1.
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_7180 ! CHO-DG44
SX Female
CA Spontaneously immortalized cell line
//
ID Neuro-2a
AC CVCL_0470
SY NEURO-2A; Neuro 2a; Neuro2a; Neuro2A; N-2a; N2a; N2A; Nb2a; NB2a
DR BTO; BTO:0001976
DR CLO; CLO_0008154
DR CLO; CLO_0050180
DR MCCL; MCC:0000368
DR CLDB; cl3682
DR CLDB; cl3683
DR CLDB; cl3684
DR CLDB; cl3685
DR CLDB; cl4956
DR CLDB; cl5236
DR ATCC; CCL-131
DR BCRC; 60026
DR BCRJ; 0189
DR CCLV; CCLV-RIE 0132
DR CCLV; CCLV-RIE 0229
DR CCRID; 3111C0001CCC000291
DR CCRID; 3131C0001000800029
DR ChEMBL-Cells; CHEMBL3307521
DR ChEMBL-Targets; CHEMBL614062
DR CLS; 400394/p451_Neuro-2A
DR DSMZ; ACC-148
DR ECACC; 89121404
DR ICLC; ATL99007
DR IFO; IFO50081
DR IZSLER; BS TCL 128
DR KCB; KCB 2014025YJ
DR PRIDE; PXD002290
DR RCB; RCB2639
DR TKG; TKG 0509
DR TOKU-E; 2746
DR TOKU-E; 3552
DR TOKU-E; 3563
DR Wikidata; Q18391478
RX PubMed=19903493;
RX PubMed=25193168;
WW https://en.wikipedia.org/wiki/N2a_cell
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-213.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-384.html
WW https://www.researchgate.net/post/What_are_the_details_of_N2A_cell_differentiation_methods
CC Characteristics: Capable of differentiating into various types of neurons.
CC Doubling time: ~70 hours (DSMZ).
CC Omics: Deep proteome analysis.
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID Neuro-2a NucLight Green
AC CVCL_DF49
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/neuro-2a-nuclight-green-cells/
CC Characteristics: Stably expresses a non-perturbing nuclear restricted green fluorescent label.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID Neuro-2a NucLight Red
AC CVCL_DF50
WW http://www.essenbioscience.com/essen-products/reagents-and-consumables/neuro-2a-nuclight-red-cells/
CC Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC Transfected with: mKate2; a bright red fluorescent protein derived from eqFP578.
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID Neuro-2a-Luc
AC CVCL_K046
SY Neuro2A-Luc
DR BTO; BTO:0003958
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID Neuro-2aTG
AC CVCL_F275
DR IFO; IFO50495
RX PubMed=7763725;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0470 ! Neuro-2a
SX Male
CA Cancer cell line
//
ID Newton
AC CVCL_U800
DR Cosmic; 928703
RX PubMed=9354451;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NEYS
AC CVCL_M893
RX PubMed=19624308;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NF
AC CVCL_W770
RX PubMed=2156601;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NF-1
AC CVCL_3556
DR CLO; CLO_0008155
DR ATCC; CRL-2075
RX PubMed=6137898;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID NF2C
AC CVCL_HE74
RX Patent=US6825394;
RX PubMed=10417352;
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 96092754.
CC Characteristics: Proliferates at the permissive temperature (33 Celsius). Dies at the restrictive temperature (39 Celsius).
CC Breed/subspecies: Sprague-Dawley SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Conditionally immortalized cell line
//
ID NF2S-1
AC CVCL_7691
SY Nf2S-1
RX PubMed=17304235;
DI NCIt; C21997; Mouse schwannoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFkappaB-TIME
AC CVCL_Z064
DR ATCC; CRL-4049
CC Transfected with: HGNC; 11730; TERT.
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,11
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 8,9
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0047 ! TIME
SX Male
CA Telomerase immortalized cell line
//
ID NFL/T
AC CVCL_D888
SY Normal Fetal Liver/Transformed
RX PubMed=7777587;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NFPE
AC CVCL_3557
DR CLO; CLO_0008158
DR ATCC; CRL-2069
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3556 ! NF-1
SX Male
CA Cancer cell line
//
ID NFS-1
AC CVCL_1Y69
DR Cosmic; 1132065
DR Cosmic; 1801807
RX PubMed=18650488;
RX PubMed=23437333;
CC Misspelling: 'NSF-1' in Cosmic 1801807.
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
DI NCIt; C3273; Neurofibromatosis type 1
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NFS-1.0 C-1
AC CVCL_0E46
SY NFS-1.0 C1
DR ATCC; CRL-1705
RX PubMed=6330201;
CC Breed/subspecies: NFS.C58v1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-107
AC CVCL_5230
SY NFS107
RX PubMed=3014527;
CC Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC Breed/subspecies: NFS.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-124
AC CVCL_5231
SY NFS124
RX PubMed=3014527;
CC Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC Breed/subspecies: NFS.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-2
AC CVCL_W494
RX PubMed=12237927;
CC Derived from metastatic site: Retroperitoneal space.
DI NCIt; C3043; Fibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NFS-22
AC CVCL_5211
SY NFS22
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-25 C-3
AC CVCL_3558
SY NFS-25 C3
DR CLO; CLO_0008159
DR CLDB; cl3688
DR ATCC; CRL-1695
DR ECACC; 93090713
RX PubMed=6330201;
CC Breed/subspecies: NFS.C58v1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-5 C-1
AC CVCL_3559
SY NFS-5 C1
DR CLO; CLO_0008160
DR CLDB; cl3689
DR ATCC; CRL-1693
DR ECACC; 88041904
RX PubMed=6330201;
CC Breed/subspecies: NFS/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-58
AC CVCL_5232
SY NFS 58; NFS58
RX PubMed=2656885;
RX PubMed=3014527;
CC Breed/subspecies: NFS x DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-60
AC CVCL_3543
SY M-NFS-60; NFS 60; NFS60
DR CLO; CLO_0007812
DR ATCC; CRL-1838
DR BCRJ; 0175
DR ChEMBL-Cells; CHEMBL3307327
DR ChEMBL-Targets; CHEMBL614199
DR CLS; 400301/p2732_NFS-60
DR CLS; 400301-SF/p12832_NFS-60
DR NCBI_Iran; C482
DR NCBI_Iran; C603
RX PubMed=2497280;
RX PubMed=2656885;
RX PubMed=3014527;
WW http://www.atcc.org/support/faqs/d0d1f/MNFS60%20ATCC%20CRL1338-1076.aspx
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NFS-60
CC Characteristics: IL3 dependent.
CC Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC Breed/subspecies: NFS x DBA/2.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-61
AC CVCL_5233
SY NFS61
RX PubMed=3014527;
CC Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC Breed/subspecies: NFS.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-70 C-10
AC CVCL_3560
SY NFS-70 C10
DR CLO; CLO_0008161
DR CLDB; cl3690
DR ATCC; CRL-1694
DR ECACC; 88041905
RX PubMed=6330201;
CC Breed/subspecies: NFS/N.
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFS-78
AC CVCL_5234
SY NFS78
RX PubMed=3014527;
CC Transformant: NCBI_TaxID; 11792; Cas-Br-E murine leukemia virus.
CC Breed/subspecies: NFS.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFSa Y83
AC CVCL_H735
SY NFSaY83
DR CLO; CLO_0050201
DR RCB; RCB0282
CC Breed/subspecies: C3Hf/Bu.
DI NCIt; C24017; Mouse fibrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NFSC
AC CVCL_M103
SY Normal Fat Storing Cells
DR BTO; BTO:0003521
RX PubMed=1753710;
RX PubMed=17760834;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Spontaneously immortalized cell line
//
ID NG-3Y1-D303
AC CVCL_H236
DR RCB; RCB0359
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID NG-3Y1-T15L
AC CVCL_H227
DR JCRB; JCRB0739
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID NG-3Y1-T18D
AC CVCL_H237
DR RCB; RCB0371
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID NG-3Y1-T308
AC CVCL_H228
DR JCRB; JCRB0740
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID NG-3Y1-T6R
AC CVCL_H229
DR JCRB; JCRB0741
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID NG115-401L
AC CVCL_3938
DR CLO; CLO_0008163
DR CLDB; cl3692
DR ECACC; 87032003
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Hybrid cell line
//
ID NG125
AC CVCL_U379
SY NG 125; NG-125
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-451.html
DI NCIt; C85184; Tay-Sachs disease
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NG2-2.16
AC CVCL_4Y73
RX PubMed=3428508;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: SIM.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_7221 ! PSA1-NG2
CA Cancer cell line
//
ID NG97
AC CVCL_A660
RX PubMed=11775071;
RX PubMed=15885136;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NG97ht
AC CVCL_A661
RX PubMed=19009596;
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_A660 ! NG97
SX Male
CA Cancer cell line
//
ID NGC-0295
AC CVCL_DF66
SY NGC0295
RX PubMed=20664524;
RX PubMed=22113314;
RX PubMed=22655593;
CC Biotechnology: Used in NsG0202, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.
CC Transfected with: HGNC; 7808; NGF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID NGC-0301
AC CVCL_DF67
SY C101
RX Patent=US20080286250;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2732.
CC Biotechnology: Used in NsG0301, an encapsulated cell biodelivery device capable of local delivery of GDNF to the brain so at to treat Parkinson disease patients.
CC Transfected with: HGNC; 4232; GDNF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID NGC-0363
AC CVCL_DF68
SY C63
RX Patent=US20080286250;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2733.
CC Transfected with: HGNC; 4232; GDNF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID NGC-407
AC CVCL_DF59
RX Patent=US8088567;
RX PubMed=17555745;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2718.
CC Characteristics: Neural progenitor cell line that can differentiate into neurons, astrocytes and dopaminergic neurons depending on the differentiation conditions.
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transformant: v-Myc.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NGC0211
AC CVCL_DF65
RX DOI=10.2174/1875043501205010035;
RX PubMed=22113314;
CC Biotechnology: Used in NsG0202.1, an encapsulated cell biodelivery device capable of local delivery of NGF to the brain so at to treat the cognitive decline in Alzheimer disease patients.
CC Characteristics: Contains 4 integrated copies of the NGF gene.
CC Transfected with: HGNC; 7808; NGF.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0145 ! ARPE-19
SX Male
CA Spontaneously immortalized cell line
//
ID NGF-2
AC CVCL_W098
RX PubMed=18034678;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NGF-3
AC CVCL_W099
RX PubMed=18034678;
CC Group: Fish cell line.
OX NCBI_TaxID=7962; ! Cyprinus carpio
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NGM
AC CVCL_0R16
DR BCRJ; 0190
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NGP
AC CVCL_2141
DR BioSample; SAMN03473431
DR Cosmic; 717421
DR Cosmic; 923823
DR Cosmic; 930071
DR Cosmic; 1019937
DR Cosmic; 1109120
DR Cosmic; 1161999
DR Cosmic; 1167422
DR Cosmic; 1167988
DR Cosmic; 1526637
DR Cosmic; 2058106
DR Cosmic; 2393638
DR DSMZ; ACC-676
DR GEO; GSM453633
DR GEO; GSM692865
DR LINCS; 51099
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=922665;
RX PubMed=6888561;
RX PubMed=11550280;
RX PubMed=15150091;
RX PubMed=22213050;
RX PubMed=23202128;
CC Doubling time: ~50-70 hours (DSMZ).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Lung.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,12
ST D16S539: 8,11
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9
ST TPOX: 6,9
ST vWA: 16,21
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NGP-C4
AC CVCL_0B58
SY NGP-c4
DR Cosmic; 1518071
DR Cosmic; 2239464
CC Derived from metastatic site: Lung.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2141 ! NGP
SX Male
CA Cancer cell line
//
ID NGP.1A.TR1
AC CVCL_AX38
RX PubMed=1679663;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Derived from metastatic site: Lung.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2141 ! NGP
SX Male
CA Cancer cell line
//
ID NGR50
AC CVCL_J705
DR CLO; CLO_0050340
DR RCB; RCB2040
RX PubMed=8794950;
CC Monoclonal antibody target: Sulfoglucuronosyl paragloboside.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID NGR53
AC CVCL_U838
RX PubMed=7734848;
CC Monoclonal antibody target: IV6-NeuAcalpha-nLc4Cer gangliosides.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID NGR54
AC CVCL_J706
DR CLO; CLO_0050338
DR RCB; RCB2037
RX PubMed=7734848;
CC Monoclonal antibody target: IV3-NeuAcalpha-nLc4Cer gangliosides.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID NGUK-1
AC CVCL_7692
DR CLO; CLO_0008168
DR CLDB; cl3697
RX PubMed=2718262;
RX PubMed=21116501;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/anguk.htm
DI NCIt; C60465; Rat malignant schwannoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID NH-12
AC CVCL_1605
SY NH12
DR CLO; CLO_0050267
DR BioSample; SAMN01821709
DR BioSample; SAMN03472526
DR ChEMBL-Cells; CHEMBL3308211
DR ChEMBL-Targets; CHEMBL2366263
DR Cosmic; 801745
DR Cosmic; 908447
DR Cosmic; 947719
DR Cosmic; 1037350
DR Cosmic; 1099147
DR Cosmic; 1153788
DR Cosmic; 2131593
DR Cosmic-CLP; 908447
DR GDSC; 908447
DR GEO; GSM313808
DR GEO; GSM333802
DR GEO; GSM1670277
DR JCRB; JCRB0833
DR RCB; RCB2108
DR TKG; TKG 0448
RX PubMed=9290701;
RX PubMed=18923524;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
ST Source(s): Cosmic-CLP; JCRB; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8,9
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 11,13
ST TH01: 9,10
ST TPOX: 8
ST vWA: 17,18
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NH-6
AC CVCL_1606
SY NH6
DR CLO; CLO_0050089
DR BioSample; SAMN01821710
DR BioSample; SAMN03472525
DR CCLE; NH6_AUTONOMIC_GANGLIA
DR ChEMBL-Cells; CHEMBL3308801
DR ChEMBL-Targets; CHEMBL1075551
DR Cosmic; 925344
DR GEO; GSM887455
DR GEO; GSM888535
DR JCRB; JCRB0832
DR RCB; RCB2109
DR TKG; TKG 0468
RX PubMed=9290701;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): JCRB; RCB; TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4827; Adrenal gland neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NH-GEN1
AC CVCL_W169
RX PubMed=7933662;
RX PubMed=8007420;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9913; ! Bos taurus
CA Transformed cell line
//
ID NH15-CA2
AC CVCL_4545
DR ECACC; 08062525
RX PubMed=41246;
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0464 ! 108CC15
HI CVCL_4253 ! N115-BU-8
CA Hybrid cell line
//
ID NH17
AC CVCL_2657
DR CLO; CLO_0008169
DR CLDB; cl3698
DR ECACC; 92111101
RX PubMed=11892817;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0013 ! MOLT-4
SX Male
CA Cancer cell line
//
ID NHBE-T
AC CVCL_S124
RX PubMed=19608870;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0112 ! 16HBE14o-
SX Male
CA Transformed cell line
//
ID NHEK/SV3
AC CVCL_9Q50
WW http://www.evercyte.com/nhek-sv3.html
CC Characteristics: SV40-transformed but with a finite life span (max PDL is 30).
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NHEK/SVTERT3-5
AC CVCL_9Q51
WW http://www.evercyte.com/nhek-svtert3-5.html
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NHEM2493
AC CVCL_B447
SY NHEM 2493
DR BTO; BTO:0004821
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NHEM693
AC CVCL_B448
SY NHEM 693
DR BTO; BTO:0004820
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NHI-5B
AC CVCL_M461
RX PubMed=2842785;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M446 ! MSL-G2
CA Cancer cell line
//
ID NHI-6F
AC CVCL_M462
SY NHI-6F-INS; NHI-Ins; NHI-ins
RX PubMed=2842785;
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M446 ! MSL-G2
CA Cancer cell line
//
ID NHI-6F-28
AC CVCL_M463
SY NHI-6F-Tu28; NHI 6F Tu28; NHI-Glu; NHI-glu
CC Transfected with: HGNC; 6081; INS.
CC Breed/subspecies: NEDH.
DI NCIt; C121566; Rat insulinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_M462 ! NHI-6F
CA Cancer cell line
//
ID NHIK 3016
AC CVCL_Z877
SY Norsk Hydro's Institute for Kreftforskning 3016
RX CelloPub=CLPUB00088;
RX CelloPub=CLPUB00205;
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NHIK 3017
AC CVCL_Z878
SY Norsk Hydro's Institute for Kreftforskning 3017
RX CelloPub=CLPUB00088;
RX CelloPub=CLPUB00205;
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NHIK 3025
AC CVCL_U089
SY NHIK-3025; NHIK3025; Norsk Hydro's Institute for Kreftforskning 3025
DR ChEMBL-Cells; CHEMBL3307328
DR ChEMBL-Targets; CHEMBL614201
RX CelloPub=CLPUB00088;
RX CelloPub=CLPUB00205;
RX PubMed=369700;
RX PubMed=4066771;
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NHIK 3043
AC CVCL_Z879
SY Norsk Hydro's Institute for Kreftforskning 3043
RX CelloPub=CLPUB00088;
RX CelloPub=CLPUB00205;
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NHOS
AC CVCL_6688
SY Nishi-Hirosaki osteosarcoma
DR CLO; CLO_0050198
DR RCB; RCB1741
RX PubMed=11429054;
RX PubMed=18630519;
CC Breed/subspecies: BALB/c.
DI NCIt; C24021; Mouse osteosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID NHSF46
AC CVCL_G283
DR CLO; CLO_0050707
DR BioSample; SAMN03472341
DR RCB; RCB0162
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,10
ST D16S539: 10,14
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID NI 1 alpha 364/3B3-14
AC CVCL_K161
DR ECACC; 92030611
CC Monoclonal antibody target: UniProtKB; P01583; Human IL1A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 1 alpha 364/8C4-8
AC CVCL_K162
DR ECACC; 92030612
CC Monoclonal antibody target: UniProtKB; P01583; Human IL1A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 3 416/6C6-6
AC CVCL_J845
DR ECACC; 92030615
RX PubMed=1790303;
CC Monoclonal antibody target: UniProtKB; P08700; Human IL3.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 3 416/7B5-5
AC CVCL_J846
DR ECACC; 92030616
RX PubMed=1790303;
CC Monoclonal antibody target: UniProtKB; P08700; Human IL3.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 4 426/1A6-10
AC CVCL_J847
DR ECACC; 92030617
RX PubMed=1790303;
CC Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 4 426/7A3-3
AC CVCL_J848
DR ECACC; 92030618
DR NCBI_Iran; H123
RX PubMed=1790303;
CC Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI 4 426/8B1-7
AC CVCL_J849
DR ECACC; 92030619
RX PubMed=1790303;
CC Monoclonal antibody target: UniProtKB; P05112; Human IL4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI G 386/3B6-12
AC CVCL_J850
DR ECACC; 92030614
CC Monoclonal antibody target: UniProtKB; P09919; Human CSF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI G 386/3D1-16
AC CVCL_J851
DR ECACC; 92030613
CC Monoclonal antibody target: UniProtKB; P09919; Human CSF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI GM 465/7A6-37
AC CVCL_J852
SY NI GM465/7A6-37
DR ECACC; 92030620
DR NCBI_Iran; H124
CC Monoclonal antibody target: UniProtKB; P04141; Human CSF2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NI-1
AC CVCL_GT45
RX PubMed=22583069;
CC Miscellaneous: Gender from personal communication of Willmann M.
CC Breed/subspecies: Mixed breed.
DI NCIt; C129077; Canine mastocytoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID NIAS-AeAl-2
AC CVCL_Z549
SY NIAS-AeAl 2; AeAl2
DR NISES; SK0013
DR RCB; RCB0277
RX CelloPub=CLPUB00194;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275011
CC Group: Insect cell line.
CC Doubling time: ~30 hours (CelloPub=CLPUB00194).
CC Misspelling: Occasionally 'NIAS-AeA-2'.
CC Discontinued: RCB; RCB0277; true.
OX NCBI_TaxID=7160; ! Aedes albopictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-aff3
AC CVCL_Z559
RX PubMed=15827172;
RX PubMed=19734648;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-ao1
AC CVCL_Z560
RX PubMed=15827172;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-Ke1
AC CVCL_Z561
SY Ke1
RX DOI=10.11416/konchubiotec.75.45;
RX PubMed=22302376;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-Ke17
AC CVCL_Z562
RX PubMed=22302376;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
HI CVCL_Z561 ! NIAS-Bm-Ke1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-Oyanagi 1
AC CVCL_Z563
SY NIAS-Bm-oyanagi1; NBO1
RX DOI=10.11416/jibs.74.117;
RX PubMed=15827172;
CC Group: Insect cell line.
CC Breed/subspecies: N137 x C146.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-Oyanagi 2
AC CVCL_Z564
SY NIAS-Bm-oyanagi2; NBO2
RX DOI=10.11416/jibs.74.117;
RX PubMed=19734648;
CC Group: Insect cell line.
CC Breed/subspecies: N137 x C146.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-SLBEM-1228
AC CVCL_Z565
SY NBS1228
RX DOI=10.11416/jibs.74.117;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Bm-SLBEM-1230
AC CVCL_Z566
SY NBS1230
RX DOI=10.11416/jibs.74.117;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Boma-529b
AC CVCL_Z092
RX PubMed=19460387;
CC Group: Insect cell line.
OX NCBI_TaxID=7092; ! Bombyx mandarina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-LeSe-11
AC CVCL_Z368
SY LeSe-11
DR CLO; CLO_0050505
DR NISES; SK0008
DR RCB; RCB0405
RX DOI=10.1303/aez.18.533;
RX PubMed=10358729;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275012
CC Group: Insect cell line.
OX NCBI_TaxID=271217; ! Mythimna separata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-MaBr-85
AC CVCL_Z126
RX DOI=10.1111/j.1440-169X.1981.00063.x;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275010
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-MaBr-92
AC CVCL_Z124
DR CLO; CLO_0050228
DR NISES; SK0006
DR RCB; RCB0279
RX DOI=10.1111/j.1440-169X.1985.00599.x;
RX PubMed=1367489;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275019
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-MaBr-93
AC CVCL_Z125
DR CLO; CLO_0050229
DR NISES; SK0009
DR RCB; RCB0414
RX DOI=10.1111/j.1440-169X.1985.00599.x;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275020
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-Mb-19
AC CVCL_Z121
SY NIAS-MB-19
RX DOI=10.1111/j.1440-169X.1977.00337.x;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275006
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-Mb-25
AC CVCL_Z122
SY NIAS-MB-25
DR CLO; CLO_0050504
DR NISES; SK0005
DR RCB; RCB0278
RX DOI=10.1111/j.1440-169X.1977.00337.x;
RX PubMed=1367489;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275007
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-Mb-32
AC CVCL_Z123
SY NIAS-MB-32
DR CLO; CLO_0050503
DR NISES; SK0001
DR RCB; RCB0413
RX DOI=10.1111/j.1440-169X.1977.00337.x;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275008
CC Group: Insect cell line.
OX NCBI_TaxID=55057; ! Mamestra brassicae
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-PRC-819A
AC CVCL_Z118
SY NIAS-PRC819A
RX PubMed=14505438;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275054
CC Group: Insect cell line.
OX NCBI_TaxID=64459; ! Pieris rapae
OI CVCL_Z119 ! NIAS-PRC-819B
OI CVCL_Z120 ! NIAS-PRC-819C
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-PRC-819B
AC CVCL_Z119
SY NIAS-PRC819B
RX PubMed=14505438;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275055
CC Group: Insect cell line.
OX NCBI_TaxID=64459; ! Pieris rapae
OI CVCL_Z118 ! NIAS-PRC-819A
OI CVCL_Z120 ! NIAS-PRC-819C
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-PRC-819C
AC CVCL_Z120
SY NIAS-PRC819C
RX PubMed=14505438;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275056
CC Group: Insect cell line.
OX NCBI_TaxID=64459; ! Pieris rapae
OI CVCL_Z118 ! NIAS-PRC-819A
OI CVCL_Z119 ! NIAS-PRC-819B
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-Px-58
AC CVCL_Z132
SY NIAS-PX-58; NIAS-Px 58; PX-58; Px 58
DR CLO; CLO_0050002
DR NISES; SK0012
DR RCB; RCB0556
RX DOI=10.1303/aez.8.64;
RX DOI=10.1016/B978-0-12-470270-7.50007-0;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275004
CC Group: Insect cell line.
OX NCBI_TaxID=66420; ! Papilio xuthus
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-Px-64
AC CVCL_Z134
SY NIAS-PX-64; PX-64; Px 64
DR CLO; CLO_0050001
DR NISES; SK0017
DR RCB; RCB0412
RX DOI=10.1303/aez.8.64;
RX DOI=10.1016/B978-0-12-470270-7.50007-0;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275005
CC Group: Insect cell line.
OX NCBI_TaxID=66420; ! Papilio xuthus
SX Female
CA Spontaneously immortalized cell line
//
ID NIAS-SL64
AC CVCL_HF61
RX PubMed=25172011;
CC Group: Insect cell line.
CC Doubling time: 24 hours (PubMed=25172011).
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIAS-SpSe-1
AC CVCL_Z545
RX CelloPub=CLPUB00195;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275013
CC Group: Insect cell line.
CC Doubling time: ~3 days (CelloPub=CLPUB00195).
OX NCBI_TaxID=1426856; ! Spilarctia seriatopunctata
SX Male
CA Spontaneously immortalized cell line
//
ID NIC
AC CVCL_F577
SY TER73; TER160
DR IMGT/HLA; 11140
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NIE
AC CVCL_F578
SY TER146; TER265; TER348
DR IMGT/HLA; 11141
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NIH 2/4
AC CVCL_5I45
SY NIH2/4
RX PubMed=17486118;
RX PubMed=18483401;
WW https://www.kerafast.com/product/2292/nih-24-cell-line
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3
AC CVCL_0594
SY NIH/3T3; NIH-3T3; NIH3T3; 3T3; 3T3NIH; 3T3-Swiss; Swiss-3T3; Swiss/3T3; Swiss 3T3; Swiss3T3
DR BTO; BTO:0000944
DR BTO; BTO:0005065
DR CLO; CLO_0008172
DR CLO; CLO_0009227
DR CLO; CLO_0050548
DR EFO; EFO_0001222
DR MCCL; MCC:0000362
DR CLDB; cl3702
DR CLDB; cl3704
DR CLDB; cl3705
DR CLDB; cl3706
DR CLDB; cl3707
DR CLDB; cl3708
DR CLDB; cl3709
DR CLDB; cl3710
DR CLDB; cl3711
DR CLDB; cl4451
DR CLDB; cl7203
DR ATCC; CRL-1658
DR ATCC; CRL-6442
DR BCRC; 60008
DR BCRJ; 0191
DR CCRID; 3111C0001CCC000018
DR CCRID; 3111C0002000000034
DR CCRID; 3131C0001000300006
DR CCRID; 3142C0001000000030
DR ChEMBL-Cells; CHEMBL3307716
DR ChEMBL-Targets; CHEMBL614822
DR CLS; 400101/p677_NIH-3T3
DR DSMZ; ACC-59
DR ECACC; 93061524
DR ENCODE; ENCBS117ENC
DR ENCODE; ENCBS990YBC
DR GEO; GSM1014177
DR ICLC; AL07001
DR IZSLER; BS CL 165
DR KCB; KCB 200645YJ
DR KCLB; 21658
DR MeSH; D041681
DR NCBI_Iran; C156
DR NIH-ARP; 9946-386
DR PRIDE; PXD001241
DR PRIDE; PXD004929
DR RCB; RCB2767
DR TKG; TKG 0299
DR TOKU-E; 2753
DR TOKU-E; 3547
DR Wikidata; Q4636420
RX PubMed=2463382;
RX PubMed=9753870;
RX PubMed=23321776;
WW https://en.wikipedia.org/wiki/3T3_cells
WW http://nih3t3.com/
WW http://www.cells-talk.com/index.php/page/copelibrary?key=3T3
WW http://www.atcc.org/support/faqs/89140/ATCC%20CCL92%20vs%20ATCC%20CRL1658-453.aspx
WW http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/NIH-3T3_Stam_protocol.pdf
WW http://www.proteinatlas.org/learn/cellines
CC Part of: ENCODE project mouse cell lines.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: ~20 hours (DSMZ).
CC Discontinued: ATCC; CRL-6442; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3 Duo
AC CVCL_HC51
SY NIH3T3duo
RX PubMed=23929981;
RX PubMed=25255091;
WW https://www.kerafast.com/product/2293/nih-3t3-duo-cell-line
CC Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transfected with: UniProtKB; P03023; E.coli lacI.
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HC50 ! NIH 3T3 Duo Parental
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3 Duo-BFP53BP1
AC CVCL_HC52
RX PubMed=23929981;
WW https://www.kerafast.com/product/2295/nih-3t3-duo-bfp53bp1-cell-line
CC Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO), two copies of a TetO-ISceI-TetO construct (96 copies of TetO) as well as a LacR-GFP and a TetR-mCherry constructs.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.
CC Transfected with: UniProtKB; Q8ISF8; Entacmaea quadricolor eqFP611 (modified to produce the BFP mTagBFP).
CC Transfected with: UniProtKB; P03023; E.coli lacI.
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Transfected with: MGI; MGI:1351320; Trp53bp1.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HC51 ! NIH 3T3 Duo
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3 Duo Parental
AC CVCL_HC50
RX PubMed=23929981;
RX PubMed=25255091;
WW https://www.kerafast.com/product/2294/nih-3t3-duo-parental-cell-line
CC Characteristics: Cell developed for the induction and visualization of double-strand breaks chromosomal damage at specific sites of the mammalian genome. Sytem based on the stable integration of endonuclease ISceI recognition sites flanked by LacO/TetO operator arrays, coupled with retroviral-mediated integration of their fluorescent repressors (LacR/TetR) to visualize the LacO/TetO sites.
CC Characteristics: Integrates one copy of a LacO-ISceI construct (256 copies of LacO) and two copies of a TetO-ISceI-TetO construct (96 copies of TetO).
CC Transfected with: UniProtKB; P03023; E.coli lacI.
CC Transfected with: UniProtKB; P04483; E.coli Tn10 tetR.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3 p-7 cl-3
AC CVCL_L994
DR IFO; IFO50019
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3-IL-7
AC CVCL_D675
SY 3T3 IL-7
DR BCRJ; 0018
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3-ras
AC CVCL_5845
SY NIH-3T3-ras; NIH3T3-ras; A51; GhrasT-NIH/Swiss
DR BTO; BTO:0005549
DR CLS; 400100/p2750_NIH-3T3-RAS
RX PubMed=3858844;
RX PubMed=26254261;
CC Transfected with: HGNC; 5173; HRAS (with V-12).
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3-TK-
AC CVCL_9116
SY NIH 3T3 TK-; 3T3 NIH TK-; TK- NIH/3T3
DR CLO; CLO_0001349
DR CLDB; cl68
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3/DC-SIGN
AC CVCL_0R23
SY NIH 3T3/MX-DC-SIGN
DR NIH-ARP; 9947-49
RX PubMed=12021323;
CC Transfected with: HGNC; 1641; CD209.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH 3T3/L-SIGN
AC CVCL_0R24
SY NIH 3T3/MX-L-SIGN (L6)
DR NIH-ARP; 9948-54
RX PubMed=12021323;
CC Transfected with: HGNC; 13523; CLEC4M.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-3T3 4-2
AC CVCL_7219
DR CLO; CLO_0008173
DR CLDB; cl3700
DR ECACC; 86041101
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-3T3 clone 5611
AC CVCL_7220
SY NIH/3T3 clone 5611
DR JCRB; JCRB0615
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-3T3-A14
AC CVCL_L990
SY NIH 3T3-A14; NIH3T3-A14; A14
DR BTO; BTO:0004245
RX PubMed=2022184;
CC Transfected with: HGNC; 6091; INSR.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-3T3-G185
AC CVCL_L991
SY NIH 3T3-G185; NIH 3T3 G185; NIH3T3-G185; NIH MDR1-G185; G185
DR BTO; BTO:0002396
RX PubMed=1356986;
CC Transfected with: HGNC; 40; ABCB1.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-3T3D4
AC CVCL_7218
SY NIH 3T3 D4; NIH-3T3 D4; NIH3T3-D4; NIH 3T3 clone D4; NIH3T3 clone D4
DR CLO; CLO_0008174
DR CLDB; cl3701
DR ECACC; 85111801
DR IZSLER; BS CL 213
DR NCBI_Iran; C155
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH-SaPe-4
AC CVCL_Z550
SY NIH-Sape-4; NIH SaPe4
DR NISES; SK0014
DR RCB; RCB0280
RX DOI=10.1111/j.1440-169X.1980.00011.x;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275009
CC Group: Insect cell line.
CC Discontinued: RCB; RCB0280; true.
OX NCBI_TaxID=7386; ! Sarcophaga peregrina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIH/3T3 Tet-On 3G
AC CVCL_V360
WW http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-On_3G_Cell_Lines
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIH3T3-3
AC CVCL_L992
DR RCB; RCB0150
CC Discontinued: RCB; RCB0150; true.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID NIH3T3-3-4
AC CVCL_L993
DR CLO; CLO_0050553
DR RCB; RCB1862
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L992 ! NIH3T3-3
SX Male
CA Transformed cell line
//
ID NIH3T3/13C7
AC CVCL_M025
DR CLO; CLO_0050550
DR RCB; RCB0057
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID NIH3T3/14-1
AC CVCL_L995
DR CLO; CLO_0050549
DR RCB; RCB0056
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID NIH3T3/ATCC/CMV-Luc
AC CVCL_4Y01
DR JCRB; JCRB1503
DR JCRB; NIHS0730
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NIID-CTR
AC CVCL_Z827
RX PubMed=22706601;
CC Group: Insect cell line.
CC Doubling time: 20 hours (at 30th passage in the presence of 12% FBS), 46 hours (at 60th passage in 5% FBS), 76 hours (at 60th passage in the absence of FBS) (PubMed=22706601).
OX NCBI_TaxID=7178; ! Culex tritaeniorhynchus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIL 1c1
AC CVCL_8737
SY Nil1C1
DR CLO; CLO_0050253
DR RCB; RCB0245
RX PubMed=4337244;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8743 ! NIL B1
SX Male
CA Spontaneously immortalized cell line
//
ID NIL 2c1
AC CVCL_8739
SY Nil2C1
DR CLO; CLO_0050254
DR RCB; RCB0244
RX PubMed=4337244;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8742 ! Nil-2E
SX Male
CA Spontaneously immortalized cell line
//
ID NIL 2c2
AC CVCL_8740
SY Nil2C2
DR CLO; CLO_0050255
DR RCB; RCB0243
RX PubMed=4337244;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8742 ! Nil-2E
SX Male
CA Spontaneously immortalized cell line
//
ID NIL 2c3
AC CVCL_8741
SY Nil2C3
RX PubMed=4337244;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8742 ! Nil-2E
SX Male
CA Spontaneously immortalized cell line
//
ID NIL B1
AC CVCL_8743
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8738 ! Nil-2
SX Male
CA Spontaneously immortalized cell line
//
ID Nil-1
AC CVCL_W454
RX PubMed=6039764;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_8738 ! Nil-2
SX Male
CA Spontaneously immortalized cell line
//
ID Nil-2
AC CVCL_8738
AS CVCL_3071
SY NIL-2; NIL 2; Nil 2; NIL2; NIL
DR ATCC; CRL-6443
DR IFO; IFO50018
RX PubMed=6039764;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6443; true.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_W454 ! Nil-1
SX Male
CA Spontaneously immortalized cell line
//
ID Nil-2E
AC CVCL_8742
SY NIL 2e; NIL 2E; Nil-2 clone E
RX PubMed=5650922;
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8738 ! Nil-2
SX Male
CA Spontaneously immortalized cell line
//
ID NIL-SF2
AC CVCL_3072
DR IFO; IFO50426
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_8738 ! Nil-2
CA Spontaneously immortalized cell line
//
ID NIM-1
AC CVCL_5344
SY NIM
DR Cosmic; 849974
DR Cosmic; 931240
RX PubMed=1372885;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NIM-1
DI NCIt; C4035; Thyroid gland papillary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NIPBC-1
AC CVCL_U921
RX PubMed=24502646;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NIPBC-2
AC CVCL_U922
RX PubMed=24502646;
DI NCIt; C4194; Invasive ductal carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Nips-B2
AC CVCL_T775
SY iPS-B2
DR RCB; HPS0223
DR SKIP; SKIP000266
RX PubMed=22912751;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NIS-G
AC CVCL_6005
DR CLS; 300303/p580_NIS-G
ST Source(s): CLS
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 21
ST D21S11: 31,31.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 12,14
ST FGA: 21
ST Penta D: 9
ST Penta E: 12,13
ST TH01: 7,9.3
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NISES-AnPe-426
AC CVCL_Z103
DR NISES; SK0024
RX PubMed=1748622;
RX DOI=10.11416/kontyushigen1930.64.79;
CC Group: Insect cell line.
OX NCBI_TaxID=7119; ! Antheraea pernyi
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-AnPe-428
AC CVCL_AV48
RX CelloPub=CLPUB00320;
RX DOI=10.11416/jibs.72.79;
RX DOI=10.11416/kontyushigen1930.64.79;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=7119; ! Antheraea pernyi
HI CVCL_Z103 ! NISES-AnPe-426
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-Anya-0611
AC CVCL_Z107
SY Anya-0611
RX PubMed=12892519;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275035
CC Group: Insect cell line.
OX NCBI_TaxID=7121; ! Antheraea yamamai
SX Female
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-15AIIc
AC CVCL_Z420
SY NISES-BoMo-15 AIIc
DR NISES; SK0018
RX CelloPub=CLPUB00184;
CC Group: Insect cell line.
CC Breed/subspecies: Kuroko.
OX NCBI_TaxID=7091; ! Bombyx mori
HI CVCL_Z419 ! SES-BoMo-15AII
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-Cam1
AC CVCL_Z844
SY NIAS-BoMo-Cam1
DR NISES; SK0026
RX CelloPub=CLPUB00197;
RX PubMed=15827172;
RX PubMed=16756546;
CC Group: Insect cell line.
CC Breed/subspecies: Cambodge.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-DZ
AC CVCL_Z552
RX DOI=10.1303/aez.34.259;
RX PubMed=16756546;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17389.
CC Breed/subspecies: Daizo.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-E2
AC CVCL_Z556
RX PubMed=16756546;
CC Group: Insect cell line.
CC Breed/subspecies: J147 x C145.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-E3
AC CVCL_Z557
SY NIAS-BoMo-E3
RX DOI=10.11416/jibs.74.117;
CC Group: Insect cell line.
CC Breed/subspecies: N137 x C146.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-E4
AC CVCL_Z558
SY NIAS-BoMo-E4
RX DOI=10.11416/jibs.74.117;
CC Group: Insect cell line.
CC Breed/subspecies: N137 x C146.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-KG
AC CVCL_Z553
RX DOI=10.1303/aez.34.259;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17390.
CC Breed/subspecies: Kokuga.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-MK
AC CVCL_Z554
RX DOI=10.1303/aez.34.259;
RX PubMed=16756546;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17391.
CC Breed/subspecies: Murasaki kaiko.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-BoMo-OH
AC CVCL_Z555
RX DOI=10.1303/aez.34.259;
RX PubMed=16756546;
CC Group: Insect cell line.
CC Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM P-17392.
CC Breed/subspecies: Ohha.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISES-SaCy-12
AC CVCL_Z104
DR NISES; SK0025
RX DOI=10.11416/kontyushigen1930.64.270;
WW http://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275033
CC Group: Insect cell line.
CC Misspelling: Occasionally 'NISE-Sacy-12'.
OX NCBI_TaxID=7127; ! Samia cynthia
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NISH
AC CVCL_U225
RX PubMed=9590506;
CC Breed/subspecies: Booroola x Assaf.
OX NCBI_TaxID=9940; ! Ovis aries
SX Female
CA Spontaneously immortalized cell line
//
ID NIT-1
AC CVCL_3561
DR CLO; CLO_0008175
DR ATCC; CRL-2055
DR BCRC; 60452
DR IZSLER; BS TCL 192
RX PubMed=1647994;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID NIT-2
AC CVCL_3562
DR CLO; CLO_0008176
DR ATCC; CRL-2364
RX PubMed=9348219;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Transformed cell line
//
ID NIT-3
AC CVCL_U269
RX PubMed=9348219;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BLKS/J-Cpefat/1 x NOD/Lt-Tg(RIPTag)1Lt.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID NIV-AA-706
AC CVCL_Z268
RX PubMed=19533252;
CC Group: Insect cell line.
OX NCBI_TaxID=7159; ! Aedes aegypti
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-AK-453
AC CVCL_Z347
DR Wikidata; Q28470898
RX PubMed=1429352;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=1579483; ! Aedes krombeini
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-BM-1296
AC CVCL_Z309
RX PubMed=12362558;
RX PubMed=16037617;
CC Group: Insect cell line.
CC Misspelling: 'NIV-HA-1296' in PubMed=16037617.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID NIV-BM-197
AC CVCL_Z310
RX PubMed=12362558;
RX PubMed=16037617;
CC Group: Insect cell line.
CC Misspelling: 'NIV-HA-197' in PubMed=16037617.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID NIV-BtEPC
AC CVCL_T049
RX PubMed=24056599;
CC Group: Bat cell line.
OX NCBI_TaxID=1081694; ! Pipistrellus ceylonicus
CA Spontaneously immortalized cell line
//
ID NIV-CT-894
AC CVCL_Z348
RX PubMed=12693860;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=7178; ! Culex tritaeniorhynchus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-HA-1195
AC CVCL_Z308
RX PubMed=12561972;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-HA-197
AC CVCL_Z307
RX PubMed=12418922;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=29058; ! Helicoverpa armigera
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-PTM-1095
AC CVCL_Z349
RX PubMed=15802757;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-SU-1095
AC CVCL_Z306
RX PubMed=11411040;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIV-SU-893
AC CVCL_Z350
RX PubMed=9112123;
RX PubMed=10475268;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID NIV-SU-992
AC CVCL_Z351
RX CelloPub=CLPUB00176;
RX PubMed=10475268;
RX PubMed=16037617;
CC Group: Insect cell line.
OX NCBI_TaxID=69820; ! Spodoptera litura
SX Female
CA Spontaneously immortalized cell line
//
ID NIVI-CH-440
AC CVCL_Z885
RX DOI=10.1007/BF02624190;
CC Group: Insect cell line.
OX NCBI_TaxID=757355; ! Cimex hemipterus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIVI-CH-442
AC CVCL_Z886
RX DOI=10.1007/BF02624190;
CC Group: Insect cell line.
OX NCBI_TaxID=757355; ! Cimex hemipterus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NIVI-CH-445
AC CVCL_Z887
RX DOI=10.1007/BF02624190;
CC Group: Insect cell line.
OX NCBI_TaxID=757355; ! Cimex hemipterus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NJB
AC CVCL_L113
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=4530294;
RX PubMed=14114966;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NJG
AC CVCL_3073
DR BioSample; SAMN03470970
DR IFO; IFO50322
RX PubMed=3611867;
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 11
ST D16S539: 12
ST D18S51: 17
ST D19S433: 14
ST D21S11: 30
ST D2S1338: 23
ST D3S1358: 16
ST D5S818: 13
ST D7S820: 10
ST D8S1179: 12
ST FGA: 23
ST Penta D: 9
ST Penta E: 18
ST TH01: 9
ST TPOX: 8
ST vWA: 16
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NK 62
AC CVCL_8267
SY NK62; NK line 62
RX PubMed=10318937;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NK 70
AC CVCL_8268
SY NK70; NK line 70
RX PubMed=10318937;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NK m-1
AC CVCL_8269
SY NK line m-1
RX PubMed=10318937;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NK-92
AC CVCL_2142
SY NK92
DR BTO; BTO:0003287
DR CLO; CLO_0008177
DR ATCC; CRL-2407
DR ATCC; PTA-6670
DR BCRC; 60414
DR BioSample; SAMN03471836
DR CCRID; 3131C0001000200020
DR Cosmic; 1534874
DR Cosmic; 1542071
DR Cosmic; 2025326
DR Cosmic; 2390215
DR DSMZ; ACC-488
DR GEO; GSM472001
DR Wikidata; Q17149636
RX PubMed=8152260;
RX PubMed=9118301;
RX PubMed=10803505;
RX PubMed=11454312;
RX PubMed=19194464;
RX PubMed=21052088;
RX PubMed=25586472;
WW https://en.wikipedia.org/wiki/NK-92
WW http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk92.htm
CC Characteristics: IL2 dependent.
CC Characteristics: Does not express FCGR3A/CD16.
CC Doubling time: ~40-50 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; PTA-6670; true.
ST Source(s): ATCC; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 18 (ATCC)
ST vWA: 16,18 (DSMZ)
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NK-92CI
AC CVCL_U271
SY NK-92 ci; NK92CI; NK-92 transfected with pCEP4-LTR-hIL2
DR ATCC; CRL-2409
DR ATCC; PTA-6672
DR BioSample; SAMN03471837
RX Patent=US8034332;
RX PubMed=10365666;
CC Transfected with: HGNC; 6001; IL2.
CC Discontinued: ATCC; CRL-2409; true.
CC Discontinued: ATCC; PTA-6672; probable.
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2142 ! NK-92
SX Male
CA Cancer cell line
//
ID NK-92MI
AC CVCL_3755
SY NK-92 MI; NK-92 mi; NK92-MI; NK92MI; NK-92 transfected with MFG-hIL2
DR CLO; CLO_0008178
DR ATCC; CRL-2408
DR ATCC; PTA-6671
DR BCRC; 60438
DR CCRID; 3111C0002000000065
DR CCRID; 3131C0001000200022
DR Cosmic-CLP; 1330981
DR GDSC; 1330981
DR GEO; GSM1670278
DR KCB; KCB 200677YJ
RX Patent=US8034332;
RX PubMed=10365666;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transfected with: HGNC; 6001; IL2.
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Discontinued: ATCC; PTA-6671; probable.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 16,18
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2142 ! NK-92
SX Male
CA Cancer cell line
//
ID NK-YS
AC CVCL_8461
AS CVCL_AX40
SY NKYS
DR Cosmic; 1534872
DR Cosmic; 1542075
DR Cosmic; 2025325
DR Cosmic; 2390119
DR GEO; GSM472002
RX PubMed=9694726;
RX PubMed=10803505;
RX PubMed=19194464;
RX PubMed=21052088;
RX PubMed=25586472;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NK14
AC CVCL_DG47
SY NK1-4; NKI-4
DR Cosmic; 928726
RX PubMed=4549213;
RX PubMed=6090953;
RX PubMed=23039341;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NK3.3
AC CVCL_7994
SY NK 3.3
DR Lonza; 78
RX PubMed=6982944;
WW http://www2.kumc.edu/soalab/LabLinks/cell%20lines/nk33.htm
WW http://www.slu.edu/x27874.xml
CC Characteristics: IL2 dependent.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Factor-dependent cell line
//
ID NK7801
AC CVCL_F976
SY NK-7801; Nara Kidney Tumor
DR TKG; TKG 0133
RX CelloPub=CLPUB00283;
CC Breed/subspecies: BDIX.
DI NCIt; C64111; Carcinoma of the rat kidney
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID NKB-1
AC CVCL_3919
SY NKB1
DR BTO; BTO:0003481
DR TKG; TKG 0699
RX PubMed=9183630;
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 18,19
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NKC3
AC CVCL_6006
RX PubMed=6983881;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NKC3
CC Characteristics: IL2 dependent.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID NKK1
AC CVCL_G365
RX PubMed=9183637;
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NKL
AC CVCL_0466
DR MCCL; MCC:0000364
DR Cosmic; 1534875
DR Cosmic; 2025324
RX PubMed=10803505;
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NKM-1
AC CVCL_1607
DR BioSample; SAMN03472796
DR ChEMBL-Cells; CHEMBL3308212
DR ChEMBL-Targets; CHEMBL2366133
DR Cosmic; 908448
DR Cosmic; 1523824
DR Cosmic; 2131549
DR Cosmic; 2306228
DR Cosmic-CLP; 908448
DR GDSC; 908448
DR GEO; GSM1670279
DR IFO; IFO50476
RX PubMed=1701353;
RX PubMed=9737686;
RX PubMed=9738977;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,13
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 9,11
ST vWA: 17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NKNT-3
AC CVCL_S905
RX PubMed=10678831;
RX PubMed=10937342;
RX PubMed=16970284;
CC Characteristics: The SV40 T antigen is flanked by LoxP recombination targets so that it can be excised by Cre/Lox site-specific recombination.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NKY113
AC CVCL_J276
DR IFO; IFO50279
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NL/T4
AC CVCL_HA80
RX PubMed=2472008;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pZIPneoSV(X)1/SV40T].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NL20
AC CVCL_3756
SY NL20SV; NL-20
DR CLO; CLO_0008179
DR ATCC; CRL-2503
DR BCRC; 60361
DR BioSample; SAMN03471599
DR GEO; GSM185872
RX PubMed=21566947;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Omics: Transcriptome analysis.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NL20T-A
AC CVCL_3757
SY NL20-TA; NL20TA
DR CLO; CLO_0008180
DR ATCC; CRL-2504
DR GEO; GSM827477
RX PubMed=8521416;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12
ST D5S818: 12
ST D7S820: 12
ST TH01: 6,7
ST TPOX: 9,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3756 ! NL20
SX Female
CA Transformed cell line
//
ID NL9980
AC CVCL_X187
RX PubMed=21310132;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X186 ! WCQH-9801
CA Cancer cell line
//
ID NLF
AC CVCL_E217
DR Cosmic; 697276
DR Cosmic; 717423
DR Cosmic; 848928
DR Cosmic; 923824
DR Cosmic; 930072
DR Cosmic; 1019953
DR Cosmic; 1162000
DR Cosmic; 1526638
DR Cosmic; 2393639
RX DOI=10.1007/0-306-46872-7_2;
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=6888561;
RX PubMed=11550280;
RX PubMed=23202128;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NLS-6-5
AC CVCL_U863
DR CLO; CLO_0050416
DR RCB; RCB0733
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID NM-1
AC CVCL_3074
DR JCRB; JCRB0155
DR JCRB; NIHS0232
CC Characteristics: Estimated life-span is 110 PDL.
CC Discontinued: JCRB; NIHS0232; true.
OX NCBI_TaxID=9913; ! Bos taurus
CA Finite cell line
//
ID NM-1/E
AC CVCL_8302
DR JCRB; JCRB0155.1
CC Discontinued: JCRB; JCRB0155.1; probable.
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_3074 ! NM-1
CA Finite cell line
//
ID NM-1/F
AC CVCL_8303
DR JCRB; JCRB0155.2
CC Discontinued: JCRB; JCRB0155.2; probable.
OX NCBI_TaxID=9913; ! Bos taurus
HI CVCL_3074 ! NM-1
CA Finite cell line
//
ID NM-D4
AC CVCL_IQ44
SY K562-D4
RX Patent=US8283161;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2605.
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID NM-F9
AC CVCL_IQ45
SY K562-F9
RX Patent=US8283161;
CC Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2606.
CC Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID NM-M2
AC CVCL_L772
DR KCLB; 60024
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L175 ! TMT-081NM
SX Female
CA Cancer cell line
//
ID NM-M2/TC
AC CVCL_M053
DR KCLB; 60026
CC Breed/subspecies: Wistar Furth.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L772 ! NM-M2
SX Female
CA Cancer cell line
//
ID NM008
AC CVCL_W755
DR Cosmic; 929203
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM1007
AC CVCL_W756
DR Cosmic; 929207
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM11
AC CVCL_X014
RX PubMed=8609053;
CC Breed/subspecies: BALB/c.
DI NCIt; C120044; Mouse colon adenocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0240 ! MC-26
SX Female
CA Cancer cell line
//
ID NM112
AC CVCL_W757
DR Cosmic; 929198
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM123
AC CVCL_W758
SY Nm123
DR Cosmic; 929199
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM16
AC CVCL_W759
DR Cosmic; 929194
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM176
AC CVCL_W760
DR Cosmic; 929200
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM177
AC CVCL_W761
SY Nm177
DR Cosmic; 929195
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM179
AC CVCL_W762
DR Cosmic; 929205
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM182
AC CVCL_W763
DR Cosmic; 929193
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM2C5
AC CVCL_B064
SY NM-2C5
DR ATCC; CRL-2918
DR BioSample; SAMN03151834
RX PubMed=14506175;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0417 ! MDA-MB-435
SX Male
CA Cancer cell line
//
ID NM2C5 GFP
AC CVCL_B065
SY NM2C5-GFP; NM-2C5-GFP
DR ATCC; CRL-2919
RX PubMed=14506175;
WW http://www.atcc.org/Products/Cells_and_Microorganisms/Cell_Lines/Misidentified_Cell_Lines.aspx
CC Problematic cell line: Contaminated. Grand-parent cell line (MDA-MB-435) has been shown to be a M14 derivative.
CC Transfected with: UniProtKB; P42212; GFP.
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 13
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B064 ! NM2C5
SX Male
CA Cancer cell line
//
ID NM39
AC CVCL_W764
DR Cosmic; 929204
DR Cosmic; 1102378
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM47
AC CVCL_W765
DR Cosmic; 929196
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NM78-AM
AC CVCL_W286
RX PubMed=20590915;
DI NCIt; C5915; Oral cavity mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W287 ! NM78-MM
SX Female
CA Cancer cell line
//
ID NM78-MM
AC CVCL_W287
RX PubMed=20590915;
CC Doubling time: 62 hours (at 5th passage), 55 hours (at 21th passage) (PubMed=20590915).
DI NCIt; C5915; Oral cavity mucosal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W286 ! NM78-AM
SX Female
CA Cancer cell line
//
ID NM87-26Xt
AC CVCL_1Q39
SY NM87-26XT
RX PubMed=8314575;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=10029; ! Cricetulus griseus
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1Q38 ! GM07965
HI CVCL_4595 ! UV135
CA Hybrid cell line
//
ID NM88
AC CVCL_W766
SY Nm88
DR Cosmic; 929197
RX PubMed=10338330;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NMB
AC CVCL_2143
DR BTO; BTO:0005872
DR BioSample; SAMN03473470
DR Cosmic; 717422
DR Cosmic; 848937
DR Cosmic; 930073
DR Cosmic; 1019940
DR Cosmic; 1109119
DR Cosmic; 1109368
DR Cosmic; 1162001
DR Cosmic; 1167991
DR Cosmic; 1518072
DR Cosmic; 1526639
DR Cosmic; 1543774
DR Cosmic; 2239465
DR DSMZ; ACC-657
DR GEO; GSM692862
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=922665;
RX PubMed=3000378;
RX PubMed=6888561;
RX PubMed=11550280;
RX PubMed=22213050;
CC Doubling time: ~40-50 hours (DSMZ).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Bone marrow.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10
ST TH01: 7,8
ST TPOX: 7,9
ST vWA: 17,18,20
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NMB-7
AC CVCL_8901
SY NMB7
DR BTO; BTO:0003534
DR Cosmic; 922654
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=7139592;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2143 ! NMB
SX Female
CA Cancer cell line
//
ID NMC-G1
AC CVCL_1608
SY NMCG-1; NMCG1; National Medical Center-Glioma 1
DR BioSample; SAMN03472793
DR CCLE; NMCG1_CENTRAL_NERVOUS_SYSTEM
DR CGH-DB; 150-1
DR ChEMBL-Cells; CHEMBL3308842
DR ChEMBL-Targets; CHEMBL2366349
DR Cosmic; 685874
DR Cosmic; 908449
DR Cosmic; 1746963
DR Cosmic; 2302335
DR Cosmic; 2367540
DR Cosmic-CLP; 908449
DR GDSC; 908449
DR GEO; GSM326197
DR GEO; GSM887457
DR GEO; GSM888537
DR GEO; GSM1670280
DR IFO; IFO50467
RX PubMed=8428960;
RX PubMed=16232199;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 10,13
ST D5S818: 12
ST D7S820: 8,12
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID nMED1
AC CVCL_IR47
RX PubMed=20978004;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID nMED2
AC CVCL_IR48
RX PubMed=20978004;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NMFH-1 [JCRB]
AC CVCL_AT70
DR JCRB; JCRB1507
CC Caution: There seems to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male and distributed by RCB, and one from Shimada Y. established from a 43 year old male and distributed by JCRB. The two cell lines have very different STR profiles.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10,12
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,20
DI NCIt; C6496; Myxofibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NMFH-1 [RCB]
AC CVCL_4661
SY NMFH1
DR CLO; CLO_0050023
DR BioSample; SAMN03471964
DR Cosmic; 1172182
DR RCB; RCB2346
RX PubMed=15173092;
RX PubMed=16080955;
RX PubMed=19335880;
RX PubMed=25760144;
CC Caution: There seems to be two NMFH-1 cell lines, both from myxofibrosarcomas (malignant fibrous histiocytomas). One from Niigata University (Kawashima H. et al) established from a 89 year old male and distributed by RCB, and one from Shimada Y. established from a 43 year old male and distributed by JCRB. The two cell lines have very different STR profiles.
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,10
ST vWA: 14,18
DI NCIt; C6496; Myxofibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NMFH-2
AC CVCL_4W18
SY NMFH2
DR GEO; GSM1098532
RX PubMed=19335880;
DI NCIt; C6496; Myxofibrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NMR-1
AC CVCL_B912
DR ISCR; 2229
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=533
CC From: University of Texas Health Science Center at Houston; Houston; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0159.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID NMR52
AC CVCL_J707
DR CLO; CLO_0050339
DR RCB; RCB2039
CC Monoclonal antibody target: nLc4Cer.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID NMS-2
AC CVCL_4662
DR CLO; CLO_0050138
DR BioSample; SAMN03471965
DR Cosmic; 1319814
DR RCB; RCB2347
RX PubMed=9849858;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 12,13
ST D7S820: 9,12
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,19
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L810 ! NMS-2PC
SX Male
CA Cancer cell line
//
ID NMS-2PC
AC CVCL_L810
RX PubMed=9849858;
DI NCIt; C3798; Malignant peripheral nerve sheath tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4662 ! NMS-2
SX Male
CA Cancer cell line
//
ID NMSG 10
AC CVCL_M832
SY NMSG10
RX PubMed=1962790;
RX PubMed=8927571;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NMU
AC CVCL_3563
DR CLO; CLO_0008183
DR CLDB; cl3718
DR ATCC; CRL-1743
DR BCRC; 60099
RX PubMed=7118137;
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID NMu2Li
AC CVCL_S358
DR ATCC; CRL-6446
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6446; true.
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID NMu3Li
AC CVCL_6424
DR CLO; CLO_0008184
DR ATCC; CRL-6447
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID NMuLi
AC CVCL_6425
DR CLO; CLO_0008185
DR ATCC; CRL-1638
DR ATCC; CRL-6591
DR IZSLER; BS CL 164
RX PubMed=4366196;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6591; true.
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID NMuMG
AC CVCL_0075
DR BTO; BTO:0004183
DR CLO; CLO_0008186
DR CLDB; cl3719
DR ATCC; CRL-1636
DR BCRC; 60087
DR ECACC; 94081121
DR IZSLER; BS CL 188
RX PubMed=4366196;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-151.html
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID NMuMG-Fucci
AC CVCL_E069
DR CLO; CLO_0050967
DR RCB; RCB2813
RX PubMed=18267078;
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0075 ! NMuMG
SX Female
CA Spontaneously immortalized cell line
//
ID NMuMG-Fucci2
AC CVCL_U135
DR CLO; CLO_0050968
DR RCB; RCB2868
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0075 ! NMuMG
SX Female
CA Spontaneously immortalized cell line
//
ID NMuMG-ST
AC CVCL_5U35
RX PubMed=9855001;
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0075 ! NMuMG
SX Female
CA Transformed cell line
//
ID NN
AC CVCL_Z600
RX PubMed=8943096;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z601 ! NNR
SX Female
CA Cancer cell line
//
ID NN-1
AC CVCL_Z283
DR NISES; SK0032
RX CelloPub=CLPUB00181;
RX DOI=10.2183/pjab.60.198;
CC Group: Insect cell line.
OX NCBI_TaxID=1563985; ! Nephotettix nigropictus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NN-3
AC CVCL_G674
DR CLO; CLO_0008187
DR ATCC; HB-8474
RX Patent=US4752582;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NN-4
AC CVCL_G675
DR CLO; CLO_0008188
DR ATCC; HB-8473
RX Patent=US4752582;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NN-5
AC CVCL_G676
DR CLO; CLO_0008189
DR ATCC; HB-8476
RX Patent=US4752582;
CC Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a (with L-20 and E-24; recognizes N blood group antigen).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NNR
AC CVCL_Z601
RX PubMed=8943096;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z600 ! NN
SX Female
CA Cancer cell line
//
ID No Per
AC CVCL_3321
DR CLO; CLO_0008190
DR ATCC; CRL-1327
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID NO0001
AC CVCL_8Y24
DR ECACC; 02032223
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35078; Tourette syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NO36
AC CVCL_2658
DR CBA; CBA-0142
DR Cosmic; 1522764
DR Cosmic; 1963331
DR ECACC; 10092312
DR GEO; GSM796439
RX PubMed=1703129;
RX PubMed=21642991;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOC-S
AC CVCL_W495
RX PubMed=2085480;
DI NCIt; C4878; Lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NOC-Ts
AC CVCL_W496
RX PubMed=1958631;
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NoCa1
AC CVCL_HB90
DR GEO; GSM29783
DR GEO; GSM29784
DR GEO; GSM29785
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa10
AC CVCL_HB99
DR GEO; GSM29816
DR GEO; GSM29817
DR GEO; GSM29819
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa11
AC CVCL_HC00
DR GEO; GSM29821
DR GEO; GSM29822
DR GEO; GSM29823
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa12
AC CVCL_HC01
DR GEO; GSM29824
DR GEO; GSM29825
DR GEO; GSM29826
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa13
AC CVCL_HC02
DR GEO; GSM29827
DR GEO; GSM29828
DR GEO; GSM29829
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa14
AC CVCL_HC03
DR GEO; GSM29830
DR GEO; GSM29831
DR GEO; GSM29832
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa15
AC CVCL_HC04
DR GEO; GSM29833
DR GEO; GSM29834
DR GEO; GSM29835
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa2
AC CVCL_HB91
DR GEO; GSM29786
DR GEO; GSM29787
DR GEO; GSM29788
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa3
AC CVCL_HB92
DR GEO; GSM29789
DR GEO; GSM29790
DR GEO; GSM29791
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa4
AC CVCL_HB93
DR GEO; GSM29792
DR GEO; GSM29793
DR GEO; GSM29794
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa5
AC CVCL_HB94
DR GEO; GSM29795
DR GEO; GSM29796
DR GEO; GSM29797
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa6
AC CVCL_HB95
DR GEO; GSM29798
DR GEO; GSM29799
DR GEO; GSM29800
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa7
AC CVCL_HB96
DR GEO; GSM29801
DR GEO; GSM29802
DR GEO; GSM29803
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa8
AC CVCL_HB97
DR GEO; GSM29804
DR GEO; GSM29805
DR GEO; GSM29806
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NoCa9
AC CVCL_HB98
DR GEO; GSM29807
DR GEO; GSM29814
DR GEO; GSM29815
RX PubMed=15096622;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NOCC
AC CVCL_GQ01
RX PubMed=27541369;
CC Doubling time: ~29 hours (PubMed=27541369).
CC Derived from metastatic site: Ascites.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOD.ESA
AC CVCL_U868
DR RCB; AES0118
DR RCB; RCB2608
CC Discontinued: RCB; RCB2608; true.
CC Breed/subspecies: NOD.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID Nody-1
AC CVCL_L368
RX PubMed=23196801;
CC Doubling time: 21.5 hours (PubMed=23196801).
CC Breed/subspecies: Shiba.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID NOE
AC CVCL_W381
RX PubMed=17645726;
CC Doubling time: 15.5 hours (PubMed=17645726).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOF137
AC CVCL_2G71
SY Normal Ovarian Fibroblast 137
RX PubMed=17060621;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NOF150
AC CVCL_2G72
SY Normal Ovarian Fibroblast 150
RX PubMed=17060621;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NOF151
AC CVCL_2G73
SY Normal Ovarian Fibroblast 151
DR EFO; EFO_0006699
RX PubMed=17060621;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID NOF151-hTERT
AC CVCL_2G76
SY NOF151-hTert
DR GEO; GSE40266
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2G73 ! NOF151
SX Female
CA Telomerase immortalized cell line
//
ID NOG8
AC CVCL_5846
RX PubMed=3127778;
CC Breed/subspecies: Namru.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0075 ! NMuMG
SX Female
CA Spontaneously immortalized cell line
//
ID NoGFP-CD16.NK92
AC CVCL_V429
DR ATCC; PTA-6967
RX Patent=US8313943;
CC Transfected with: HGNC; 3619; FCGR3A (with V-176).
DI NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2142 ! NK-92
SX Male
CA Cancer cell line
//
ID NOI-90
AC CVCL_8462
DR BioSample; SAMN03151906
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9140; Childhood B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1650 ! Reh
SX Female
CA Cancer cell line
//
ID NOK-SI
AC CVCL_BW57
SY NOKSI; NOKsi; Normal Oral Keratinocytes-Spontaneously Immortalized
DR Cosmic; 2296312
RX PubMed=20463891;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 9,11
ST D13S317: 10,12
ST D16S539: 9,12
ST D18S51: 12
ST D21S11: 28,30.2
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 9,11
ST D8S1179: 14
ST FGA: 24
ST Penta D: 11,13
ST Penta E: 7,12
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID NOL-3
AC CVCL_Y587
RX CelloPub=CLPUB00157;
RX PubMed=1465024;
RX PubMed=9737686;
RX PubMed=9738977;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID nOLIG1
AC CVCL_IR51
RX PubMed=20978004;
DI NCIt; C3288; Oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NOM9-CT
AC CVCL_AT83
SY NOM9-TK; NOM9/TK; Normal oral mucosa 9-CDK4/TERT immortalized
RX PubMed=20145189;
RX PubMed=21868764;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID NOM9/TKp53
AC CVCL_AT84
RX PubMed=21868764;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AT83 ! NOM9-CT
SX Male
CA Telomerase immortalized cell line
//
ID NOMH-1
AC CVCL_L038
RX PubMed=23379414;
CC Doubling time: 273 hours (PubMed=23379414).
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOMO-1
AC CVCL_1609
SY Nomo-1; NOMO1
DR BTO; BTO:0005916
DR BioSample; SAMN01821652
DR BioSample; SAMN01821737
DR BioSample; SAMN03473105
DR CCLE; NOMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308243
DR ChEMBL-Targets; CHEMBL2366198
DR Cosmic; 787464
DR Cosmic; 908451
DR Cosmic; 975286
DR Cosmic; 1281342
DR Cosmic; 1523827
DR Cosmic; 1524839
DR Cosmic; 2131550
DR Cosmic; 2297030
DR Cosmic; 2306229
DR Cosmic-CLP; 908451
DR DSMZ; ACC-542
DR GDSC; 908451
DR GEO; GSM236799
DR GEO; GSM236835
DR GEO; GSM482496
DR GEO; GSM887458
DR GEO; GSM888538
DR GEO; GSM1374774
DR GEO; GSM1670283
DR IFO; IFO50474
RX PubMed=9738977;
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 55 hours (PubMed=25984343); ~35 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 9,11
ST D18S51: 17,22
ST D21S11: 29,32.2
ST D3S1358: 15,17
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 21,22
ST Penta D: 9,12
ST Penta E: 15,17
ST TH01: 6,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOMO-1/ADM
AC CVCL_3077
DR GEO; GSM827275
DR JCRB; JCRB1069
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1609 ! NOMO-1
SX Female
CA Cancer cell line
//
ID NOMO-1s
AC CVCL_3078
DR IFO; IFO50475
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 8,10
ST TH01: 6,9
ST TPOX: 8,12
ST vWA: 17,18
DI NCIt; C8263; Adult acute monocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1609 ! NOMO-1
SX Female
CA Cancer cell line
//
ID NON,L
AC CVCL_E795
SY NON, L
DR dbMHC; 48989
DR ECACC; 94082292
DR IHW; IHW9192
DR IMGT/HLA; 11734
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl192.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NOP-1
AC CVCL_M503
SY NOP1
RX CelloPub=CLPUB00090;
RX PubMed=9737686;
RX PubMed=9738977;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=11429052;
RX PubMed=12886255;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOP-2
AC CVCL_M502
SY NOP2
RX PubMed=1747447;
RX PubMed=9738977;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOR-10
AC CVCL_3939
SY NOR 10; NOR10; Nor10; Normal fibroblast-10
DR CLO; CLO_0008191
DR CLDB; cl3720
DR CLDB; cl5238
DR ATCC; CCL-197
DR BCRC; 60121
DR ECACC; 90112701
DR IZSLER; BS CL 114
DR KCLB; 10197
RX PubMed=20889;
RX PubMed=7065527;
CC Breed/subspecies: C57BL/10.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID NOR-P1
AC CVCL_4716
DR BTO; BTO:0003533
DR CLO; CLO_0050103
DR BioSample; SAMN03472013
DR RCB; RCB2139
DR TKG; TKG 0630
RX PubMed=10822130;
ST Source(s): RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 7,10
ST D13S317: 11
ST D16S539: 10 (RCB)
ST D16S539: 9,10 (TKG)
ST D5S818: 10,11
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NORIg 7.16.2
AC CVCL_J853
DR ECACC; 11060818
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID NOS-1 [Human HNSCC]
AC CVCL_M837
RX PubMed=11291288;
RX PubMed=11337272;
CC Doubling time: 16.1 hours, at 100th passage (PubMed=11337272).
DI NCIt; C8171; Lower gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOS-1 [Human osteosarcoma]
AC CVCL_1610
SY NOS1
DR CLO; CLO_0050812
DR BioSample; SAMN03472210
DR ChEMBL-Cells; CHEMBL3308836
DR ChEMBL-Targets; CHEMBL2366141
DR Cosmic; 925345
DR Cosmic-CLP; 925345
DR GDSC; 925345
DR GEO; GSM1670284
DR RCB; RCB1032
RX PubMed=1449054;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 9,13
ST D13S317: 9,12
ST D16S539: 10,12,13
ST D5S818: 10,12
ST D7S820: 8,13 (Cosmic-CLP)
ST D7S820: 8,12,13 (RCB)
ST TH01: 6
ST TPOX: 11
ST vWA: 14,16
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOS-1.C8
AC CVCL_T745
RX PubMed=8100098;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1610 ! NOS-1 [Human osteosarcoma]
SX Male
CA Cancer cell line
//
ID NOS-10
AC CVCL_4663
SY NOS10
DR CLO; CLO_0050013
DR BioSample; SAMN03471966
DR RCB; RCB2348
RX PubMed=15173092;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,13
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOS-2
AC CVCL_3351
SY NOS2
DR CLO; CLO_0050811
DR BioSample; SAMN03472152
DR RCB; RCB1033
RX PubMed=1449054;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 9
ST D5S818: 12
ST D7S820: 8,11
ST TH01: 6
ST TPOX: 11
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NOS1
AC CVCL_T746
RX PubMed=12767062;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOS2
AC CVCL_T747
SY NOS-2
DR BTO; BTO:0004923
RX PubMed=12767062;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOS4
AC CVCL_4464
SY NOS-4
DR BTO; BTO:0004924
RX PubMed=10403549;
RX PubMed=11865194;
RX PubMed=12767062;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOSE-06
AC CVCL_X010
SY NOSE06
DR BioSample; SAMN03151635
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6774 ! DOV13
SX Female
CA Cancer cell line
//
ID NOSE-07
AC CVCL_X011
SY NOSE07
DR BioSample; SAMN03151636
RX PubMed=22710073;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a DOV13 derivative (PubMed=22710073).
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6774 ! DOV13
SX Female
CA Cancer cell line
//
ID NOTT1
AC CVCL_A000
SY NOTT-1; Nott 1; Nott1; UNOTe001-A
DR hPSCreg; UNOTe001-A
DR ISCR; 1390
RX PubMed=20177995;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/nott-1.aspx
CC From: University of Nottingham; Nottingham; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-001, Steering comm. appl. SCSC06-12.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NOTT2
AC CVCL_A001
SY NOTT-2; Nott 2; Nott2; UNOTe002-A
DR hPSCreg; UNOTe002-A
DR ISCR; 1391
RX PubMed=20177995;
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/nott-2.aspx
CC From: University of Nottingham; Nottingham; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-002, Steering comm. appl. SCSC06-31.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NOU-1
AC CVCL_S912
SY Nou-1; NOU1; AG13904
DR CLO; CLO_0022358
DR Coriell; AG13904
DR Cosmic; 2030480
RX PubMed=12419584;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NOV-31
AC CVCL_DD17
DR ATCC; CRL-11733
RX Patent=US5710038;
RX PubMed=11641787;
CC Omics: Transcriptome analysis.
CC Discontinued: ATCC; CRL-11733; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Spontaneously immortalized cell line
//
ID Novikoff-Hepatoma
AC CVCL_1D01
SY Novikoff Hepatoma; NK
DR BTO; BTO:0000950
DR CLS; 500373/p734_Novikoff_Hepatoma
DI NCIt; C60416; Rat hepatocellular carcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID NovrA2
AC CVCL_4Y50
RX PubMed=2433772;
RX PubMed=2845588;
CC Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID NovrA41
AC CVCL_4Y51
RX PubMed=2433772;
CC Selected for resistance to: ChEBI; CHEBI:28368; Novobiocin.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
HI CVCL_1915 ! BHK-21 clone 13
SX Male
CA Spontaneously immortalized cell line
//
ID NOY1
AC CVCL_0P30
SY NOY-1; Nagoya Ovarian Yolk sac tumor cell line clone 1
DR BTO; BTO:0005874
RX PubMed=18547965;
RX PubMed=21150160;
WW https://www.kerafast.com/product/1280/human-ovarian-yolk-sac-tumor-cell-line-noy1
CC Doubling time: 28 hours (PubMed=18547965).
DI NCIt; C8107; Ovarian yolk sac tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P31 ! NOY2
SX Female
CA Cancer cell line
//
ID NOY1-CR
AC CVCL_0P32
RX PubMed=21150160;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C8107; Ovarian yolk sac tumor
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0P30 ! NOY1
SX Female
CA Cancer cell line
//
ID NOY2
AC CVCL_0P31
SY Nagoya Ovarian Yolk sac tumor cell line clone 2
RX PubMed=18547965;
CC Doubling time: 31 hours (PubMed=18547965).
DI NCIt; C8107; Ovarian yolk sac tumor
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0P30 ! NOY1
SX Female
CA Cancer cell line
//
ID NOZ
AC CVCL_3079
SY NOZC-1
DR BioSample; SAMN03472480
DR Cosmic; 1122352
DR JCRB; JCRB1033
DR JCRB; NIHS0283
RX DOI=10.1007/BF02348185;
RX PubMed=3154020;
CC Doubling time: 48 hours (JCRB).
CC Discontinued: JCRB; NIHS0283; true.
CC Derived from metastatic site: Ascites.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 8,12
ST D16S539: 9,11
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NP cl.120
AC CVCL_J900
DR ECACC; 95040312
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NP cl.25
AC CVCL_J901
DR ECACC; 95051114
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NP-2
AC CVCL_1R15
SY NP 2; Case 4
DR JCRB; JCRB1566
DR RCB; RCB4498
RX CelloPub=CLPUB00260;
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NP-2/APJ
AC CVCL_1R19
RX PubMed=11112502;
CC Transfected with: HGNC; 339; APLNR.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/CCR3
AC CVCL_1R20
RX PubMed=11112502;
CC Transfected with: HGNC; 1604; CCR3.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/CCR5
AC CVCL_1R21
SY NP2/CCR5
RX PubMed=11112502;
CC Transfected with: HGNC; 1606; CCR5.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/CCR8
AC CVCL_1R22
RX PubMed=11112502;
CC Transfected with: HGNC; 1609; CCR8.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/CD4
AC CVCL_1R18
SY NP2/CD4; NP2-CD4
RX PubMed=10329384;
RX PubMed=11112502;
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/CD4/APJ
AC CVCL_1R25
RX PubMed=11112502;
CC Transfected with: HGNC; 339; APLNR.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CD4/CCR3
AC CVCL_1R26
RX PubMed=11112502;
CC Transfected with: HGNC; 1604; CCR3.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CD4/CCR5
AC CVCL_1R27
SY NP2/CD4/CCR5; NP2-CD4/CCR5; NP2/CD4/R5
RX PubMed=11112502;
CC Transfected with: HGNC; 1606; CCR5.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CD4/CCR8
AC CVCL_1R28
RX PubMed=11112502;
CC Transfected with: HGNC; 1609; CCR8.
CC Transfected with: HGNC; 1678; CD4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CD4/CXCR4
AC CVCL_1R29
SY NP2/CD4/CXCR4; NP2-CD4/CXCR4
RX PubMed=11112502;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CD4/GPR1
AC CVCL_1R30
RX PubMed=11112502;
CC Transfected with: HGNC; 1678; CD4.
CC Transfected with: HGNC; 4463; GPR1.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R18 ! NP-2/CD4
SX Male
CA Cancer cell line
//
ID NP-2/CXCR4
AC CVCL_1R23
RX PubMed=11112502;
CC Transfected with: HGNC; 2561; CXCR4.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-2/GPR1
AC CVCL_1R24
RX PubMed=11112502;
CC Transfected with: HGNC; 4463; GPR1.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1R15 ! NP-2
SX Male
CA Cancer cell line
//
ID NP-3
AC CVCL_1R16
SY NP 3; Case 2
DR JCRB; JCRB1567
DR RCB; RCB4504
RX CelloPub=CLPUB00260;
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 11
ST D5S818: 9,10
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 9,11
ST vWA: 17,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NP-5
AC CVCL_1R17
SY NP 5; Case 5; NB4135
DR JCRB; JCRB1569
DR RCB; RCB4505
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 9
ST D16S539: 10,12
ST D5S818: 13
ST D7S820: 12,13
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NP-8
AC CVCL_4W66
SY NP 8; Case 1
DR JCRB; JCRB1608
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NP11
AC CVCL_D557
SY Nonparenchymal 11
RX PubMed=9648910;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NP26
AC CVCL_D558
SY Nonparenchymal 26
RX PubMed=9648910;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NP31
AC CVCL_D559
SY Nonparenchymal 31
RX PubMed=9648910;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NP32
AC CVCL_D560
SY Nonparenchymal 32
RX PubMed=9648910;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NP369
AC CVCL_E796
DR dbMHC; 48990
DR ECACC; 94082255
DR IHW; IHW9155
DR IMGT/HLA; 11698
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl155.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NP39E6/E7
AC CVCL_F754
RX PubMed=12063178;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NP460hTert
AC CVCL_X205
SY NP460 hTert; NP460
RX PubMed=16688717;
RX PubMed=18196576;
CC Transfected with: HGNC; 11730; TERT.
ST Source(s): PubMed=18196576
ST Amelogenin: X,Y
ST CSF1PO: 13,14
ST D13S317: 9,10
ST D16S539: 11,12
ST D18S51: 13,21
ST D19S433: 15,15.2
ST D21S11: 29,32.2
ST D2S1338: 20,21
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 22,25
ST TH01: 7,10
ST TPOX: 9,11
ST vWA: 17,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Telomerase immortalized cell line
//
ID NP69SV40T
AC CVCL_F755
SY NP69
DR GEO; GSM375841
RX PubMed=12063178;
RX PubMed=18196576;
RX PubMed=19724690;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): PubMed=18196576
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 13
ST D19S433: 13,14,14.2
ST D21S11: 31
ST D2S1338: 19
ST D3S1358: 17
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 15,16
ST FGA: 21
ST TH01: 7
ST TPOX: 11
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NPA
AC CVCL_0467
AS CVCL_6475
SY NPA-87; NPA'87; NPA 87; NPA87; NPA87-1; UCLA NPA-87-1; UCLA NPA871
DR BTO; BTO:0004771
DR MCCL; MCC:0000365
DR BioSample; SAMN03151835
DR Cosmic; 685605
DR Cosmic; 686727
DR Cosmic; 849968
DR Cosmic; 886547
DR Cosmic; 918183
DR Cosmic; 928835
DR Cosmic; 931239
DR Cosmic; 990533
DR Cosmic; 1005456
DR Cosmic; 1021384
DR Cosmic; 1071908
DR Cosmic; 1094772
DR Cosmic; 1132596
DR Cosmic; 1152122
DR Cosmic; 1155264
DR Cosmic; 1155328
DR Cosmic; 1161613
DR Cosmic; 1162848
DR Cosmic; 1176608
DR Cosmic; 1699416
DR TOKU-E; 4068
RX PubMed=8871538;
RX PubMed=18713817;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a M14 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764). Originally thought to originate from a thyroid gland papillary carcinoma.
CC Derived from metastatic site: Subcutaneous; right buttock.
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9,13
ST D18S51: 13,17
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 13
ST FGA: 21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1395 ! M14
SX Male
CA Cancer cell line
//
ID NPC-BM1
AC CVCL_6007
RX PubMed=9595045;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NPC-KT
AC CVCL_X204
DR TOKU-E; 4071
RX PubMed=3008992;
RX PubMed=6088881;
RX PubMed=24991015;
CC Omics: Deep RNAseq analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X200 ! Ad-AH
CA Hybrid cell line
//
ID NPC-TW01
AC CVCL_6008
SY NPC-TW 01; NPC-tW01; TW 01; TW01; NPC-TW039; NPC-039; NPC-TW-039; NPC-TW 039; TW-039
DR BTO; BTO:0004895
DR ChEMBL-Cells; CHEMBL3307329
DR ChEMBL-Targets; CHEMBL614202
DR Cosmic; 1193459
DR GEO; GSM378799
DR GEO; GSM378800
DR TOKU-E; 3584
RX PubMed=2162997;
RX PubMed=2397471;
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC-TW02
AC CVCL_6009
SY NPC-TW 02; TW 02; TW02; NPC-TW076; NPC-076; NPC-TW-076; NPC-TW 076
DR BTO; BTO:0003961
RX PubMed=2162997;
RX PubMed=7685844;
RX PubMed=21617861;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NPC-TW03
AC CVCL_6010
SY NPC-TW 03; TW 03; TW03
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC-TW04
AC CVCL_6011
SY NPC-TW 04; TW 04; TW04
DR BTO; BTO:0003962
DR Cosmic; 1193460
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NPC-TW05
AC CVCL_6012
SY NPC-TW 05; NPC.T.W.05; TW 05; TW05
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC-TW06
AC CVCL_6013
SY NPC-TW 06; TW 06; TW06
DR Cosmic; 1193461
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NPC-TW07
AC CVCL_6014
SY NPC-TW 07; TW 07; TW07
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC-TW08
AC CVCL_6015
SY NPC-TW 08; TW 08; TW08
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC-TW09
AC CVCL_6016
SY NPC-TW 09; TW 09; TW09
RX PubMed=7685844;
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPC/HK1
AC CVCL_7084
SY HK1; HK-1
DR BTO; BTO:0004899
DR Cosmic; 755503
DR Cosmic; 923772
DR Cosmic; 1017618
DR Cosmic; 1300997
RX PubMed=6259064;
RX PubMed=12645650;
RX PubMed=18196576;
ST Source(s): PubMed=18196576
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 17
ST D19S433: 14
ST D21S11: 28,29
ST D2S1338: 20,23
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 8,11
ST D8S1179: 11,13
ST FGA: 26
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C3871; Nasopharyngeal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NPK
AC CVCL_9T10
SY Newborn Pig Kidney
DR IZSLER; BS CL 24
RX PubMed=2555655;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID NPLC/PRF/5
AC CVCL_B449
SY N-PLC/PRF/5
DR BTO; BTO:0002906
RX PubMed=2827003;
CC Characteristics: Has lost chromosome Y.
CC Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI NCIt; C3099; Hepatocellular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0485 ! PLC/PRF/5
SX Male
CA Cancer cell line
//
ID NPN 43C9
AC CVCL_L686
SY NPN 43C9 (SCRF 43.3); NPN43C9
DR ATCC; HB-9721
RX Patent=US5126258;
RX PubMed=3413482;
CC Characteristics: Produces a catalytic monoclonal antibody that acts as an amidase.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID NPrEC
AC CVCL_0061
SY PrEC; Prostate Epithelial Cell
DR BTO; BTO:0005301
DR ChEMBL-Cells; CHEMBL3307346
DR ChEMBL-Targets; CHEMBL614239
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID NPTh
AC CVCL_9T11
SY Newborn Pig Thyroid
DR IZSLER; BS CL 124
RX PubMed=8264428;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID NPTr
AC CVCL_8376
SY Newborn Pig Trachea
DR IZSLER; BS CL 176
RX PubMed=12505635;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID NR-1
AC CVCL_6689
SY NR1
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-2
AC CVCL_6690
SY NR2
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-3
AC CVCL_6691
SY NR3
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-4
AC CVCL_6692
SY NR4
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-5
AC CVCL_6693
SY NR5
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-6
AC CVCL_6694
SY NR6
DR BTO; BTO:0001867
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-6-R
AC CVCL_6695
SY NR6R; NR6R-3T3
WW http://www.unemed.com/wp-content/uploads/2012/07/a0I50000004Hbez-1_0.pdf
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6694 ! NR-6
CA Spontaneously immortalized cell line
//
ID NR-7
AC CVCL_6696
SY NR7
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR-8
AC CVCL_6697
SY NR8
RX PubMed=302945;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0120 ! 3T3-Swiss albino
SX Male
CA Spontaneously immortalized cell line
//
ID NR6M
AC CVCL_6698
RX PubMed=8845302;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6694 ! NR-6
CA Spontaneously immortalized cell line
//
ID NR6V
AC CVCL_6699
RX PubMed=8845302;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6694 ! NR-6
CA Spontaneously immortalized cell line
//
ID NR6W
AC CVCL_6700
RX PubMed=8845302;
CC Breed/subspecies: Swiss albino.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6694 ! NR-6
CA Spontaneously immortalized cell line
//
ID NR8383
AC CVCL_4396
SY NR-8383; NR 8383; NR8383.1; AgC11x3A; Normal Rat, August 3, 1983
DR BTO; BTO:0002907
DR CLO; CLO_0008193
DR ATCC; CRL-2192
DR BCRC; 60423
DR CCRID; 3131C0001000500009
DR KCB; KCB 2010189YJ
RX PubMed=2914814;
RX PubMed=3497918;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID NRbM
AC CVCL_4397
DR CLO; CLO_0008194
DR ATCC; CRL-1839
DR ECACC; 91073008
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID NRCC
AC CVCL_U280
SY LoMeT-ccRcc
RX Patent=CN101550407A;
RX PubMed=23442546;
RX PubMed=27993170;
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200910.
CC Doubling time: 35.5 hours (PubMed=23442546).
DI NCIt; C4033; Clear cell renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NRCE
AC CVCL_9Y58
SY New-zealand white Rabbit Corneal Endothelial cells
RX PubMed=19503740;
CC Breed/subspecies: New Zealand white.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Spontaneously immortalized cell line
//
ID NRG
AC CVCL_5565
DR CLO; CLO_0051028
DR JCRB; JCRB1138
DR RCB; RCB1921
CC Breed/subspecies: C3H/He.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_L287 ! KUSA
SX Female
CA Adult stem cell
//
ID NRK
AC CVCL_3758
SY Normal Rat Kidney
DR CLO; CLO_0008195
DR CLO; CLO_0051425
DR CLDB; cl3724
DR CLDB; cl3725
DR ATCC; CRL-6509
DR CCRID; 3111C0001CCC000198
DR CCRID; 3131C0001000500002
DR CCRID; 3142C0001000000081
DR ChEMBL-Cells; CHEMBL3307266
DR ChEMBL-Targets; CHEMBL613518
DR ECACC; 86032002
DR KCB; KCB 92014YJ
DR RCB; RCB0043
DR TOKU-E; 2772
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/nrk/nrkcells.html
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID NRK-49F
AC CVCL_2144
SY NRK 49F; NRK49F; NRK clone 49F; Normal Rat Kidney-49F
DR BTO; BTO:0002409
DR CLO; CLO_0008196
DR CLO; CLO_0008197
DR CLO; CLO_0051426
DR CLDB; cl3726
DR CLDB; cl3727
DR CLDB; cl3728
DR CLDB; cl3729
DR CLDB; cl3730
DR CLDB; cl3731
DR ATCC; CRL-1570
DR BCRC; 60084
DR ChEMBL-Cells; CHEMBL3308395
DR ChEMBL-Targets; CHEMBL614203
DR CLS; 500427/p718_NRK-49F
DR DSMZ; ACC-172
DR ECACC; 86101301
DR IZSLER; BS CL 71
DR IFO; IFO50481
DR JCRB; JCRB9067
DR RCB; RCB0112
RX PubMed=304450;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NRK-49F
CC Doubling time: ~30-40 hours (DSMZ).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-4xlambdaN22-3xmEGFP-M9
AC CVCL_AV97
DR CLS; 500672/p6173_NRK-4xlambdaN22-3xmEGFP-M9_growing
RX PubMed=17603490;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-52E
AC CVCL_0468
SY NRK 52E; NRK52E; NRK clone 52E; Normal Rat Kidney-52E; NRK-E52
DR BTO; BTO:0002408
DR CLO; CLO_0008198
DR MCCL; MCC:0000366
DR CLDB; cl3732
DR CLDB; cl3733
DR ATCC; CRL-1571
DR BCRC; 60086
DR CCRID; 3131C0001000500008
DR DSMZ; ACC-199
DR ECACC; 87012902
DR IFO; IFO50480
DR TOKU-E; 2774
RX PubMed=304450;
RX PubMed=7732277;
CC Doubling time: ~45 hours (DSMZ).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-EGFP-H2B
AC CVCL_AV92
DR CLS; 500724/p6175_NRK-EGFP-H2B
RX PubMed=17558394;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-EGFP2-Nup50
AC CVCL_AV93
DR CLS; 500726/p6185_NRK-EGFP2-Nup50_growing
RX PubMed=15502822;
CC Transfected with: RGD; 3191; Npap60.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-EGFP3-Seh1
AC CVCL_AV94
DR CLS; 500731/p6187_NRK-EGFP3-Seh1
RX PubMed=15502822;
CC Transfected with: RGD; 6490353; Seh1l.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-IBB-DiHcRed1
AC CVCL_AV95
DR CLS; 500671/p6180_NRK-IBB-DiHcRed1
RX PubMed=19804719;
CC Transfected with: UniProtKB; Q95W85; HcRed.
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRK-Pom121-EGFP3
AC CVCL_AV96
SY NRK-Pom121-3EGFP
DR CLS; 500669/p866_NRK-Pom121-3EGFP
RX PubMed=15502822;
CC Transfected with: RGD; 620680; Pom121.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: Osborne-Mendel.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_3758 ! NRK
CA Spontaneously immortalized cell line
//
ID NRm
AC CVCL_DR18
SY NRL2
DR CCRID; 3153C0001000000031
DR KCB; KCB 85008M
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Undefined cell line type
//
ID NRP-152
AC CVCL_4869
SY NRP152
DR BTO; BTO:0001349
RX PubMed=8012960;
RX PubMed=8912849;
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Transformant: ChEBI; CHEBI:9466; Testosterone propionate.
CC Breed/subspecies: Lobund-Wistar (L-W).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NRP-154
AC CVCL_4870
SY NRP154
DR BTO; BTO:0001352
RX PubMed=8012960;
RX PubMed=8912849;
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Transformant: ChEBI; CHEBI:9466; Testosterone propionate.
CC Breed/subspecies: Lobund-Wistar (L-W).
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID NRS-1
AC CVCL_4871
DR CLO; CLO_0050021
DR BioSample; SAMN03472176
DR RCB; RCB1188
RX PubMed=7599791;
RX PubMed=23882450;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8,11
ST D16S539: 9,10
ST D5S818: 11,12
ST D7S820: 8
ST TH01: 9
ST TPOX: 9,11
ST vWA: 18,20
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NS-1-503
AC CVCL_J593
RX PubMed=6869833;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Cancer cell line
//
ID NS-10
AC CVCL_C799
SY IMHe013-A
DR hPSCreg; IMHe013-A
DR ISCR; 1135
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NS-3 [Human colon carcinoma]
AC CVCL_8377
DR BioSample; SAMN03151625
DR JCRB; JCRB1076
DR JCRB; NIHS0335
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a COLO 201 derivative (PubMed=20143388).
CC Discontinued: JCRB; JCRB1076; true.
CC Discontinued: JCRB; NIHS0335; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 10,12
ST D16S539: 12,13
ST D5S818: 10,13
ST D7S820: 9,10
ST TH01: 8,9
ST TPOX: 11
ST vWA: 15
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1987 ! COLO 201
SX Male
CA Cancer cell line
//
ID NS-3 [Human ESC]
AC CVCL_C800
SY IMHe001-A
DR hPSCreg; IMHe001-A
DR ISCR; 1136
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NS-4
AC CVCL_C801
SY IMHe002-A
DR hPSCreg; IMHe002-A
DR ISCR; 1137
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NS-5
AC CVCL_C802
SY IMHe003-A
DR hPSCreg; IMHe003-A
DR ISCR; 1138
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NS-6
AC CVCL_C803
SY IMHe004-A
DR hPSCreg; IMHe004-A
DR ISCR; 1139
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NS-7
AC CVCL_C804
SY IMHe005-A
DR hPSCreg; IMHe005-A
DR ISCR; 1140
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NS-8 [Human ESC]
AC CVCL_C805
SY IMHe006-A
DR hPSCreg; IMHe006-A
DR ISCR; 1141
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NS-8 [Human gastric carcinoma]
AC CVCL_G372
DR TKG; TKG 0339
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8,12
ST D16S539: 13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NS-9
AC CVCL_C806
SY IMHe012-A
DR hPSCreg; IMHe012-A
DR ISCR; 1142
RX DOI=10.5772/25010;
RX PubMed=20349214;
CC From: Istanbul Memorial Hospital; Istanbul; Turkey.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NS-Meg
AC CVCL_S966
SY NS-MEG
DR Cosmic; 1012108
RX PubMed=7719248;
RX PubMed=16408098;
DI NCIt; C7965; Adult acute megakaryoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NS0
AC CVCL_3940
SY NSO; NS/0; NS/O
DR BTO; BTO:0004968
DR CLO; CLO_0008203
DR CLO; CLO_0008206
DR CLO; CLO_0050179
DR CLDB; cl3737
DR CLDB; cl3738
DR CLDB; cl3739
DR ChEMBL-Cells; CHEMBL3307752
DR ChEMBL-Targets; CHEMBL615003
DR ECACC; 85110503
DR IZSLER; BS TCL 48
DR NCBI_Iran; C142
DR RCB; RCB0213
DR TKG; TKG 0594
DR Wikidata; Q20164415
WW https://en.wikipedia.org/wiki/NS0_cell
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
SX Female
CA Cancer cell line
//
ID NS0-SFM
AC CVCL_G345
SY NSO-SFM; NS0-Serum-Free
DR ECACC; 03061601
DR TKG; TKG 0596
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
SX Female
CA Cancer cell line
//
ID NS0-Turbodoma
AC CVCL_G346
DR ECACC; 06020202
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
SX Female
CA Cancer cell line
//
ID NS0bcl-2
AC CVCL_DD16
SY NSObcl-2; NS0 Bcl-2; NSO-Bcl-2; NSO-bcl2; NS0-bcl2
DR ATCC; CRL-11705
RX Patent=US5565337;
RX PubMed=8202525;
CC Group: Hybridoma fusion partner cell line.
CC Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC Transfected with: HGNC; 990; BCL2.
CC Discontinued: ATCC; CRL-11705; probable.
CC Breed/subspecies: BALB/c.
DI NCIt; C125417; Mouse plasma cell myeloma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
SX Female
CA Cancer cell line
//
ID NS1
AC CVCL_IV58
SY Nittby-Salford 1
RX DOI=10.4172/2475-3203.1000101;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64069; Rat malignant glioma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID NS20Y
AC CVCL_0469
SY NS-20Y; NS20-Y
DR BTO; BTO:0002639
DR CLO; CLO_0008205
DR MCCL; MCC:0000367
DR CLDB; cl3736
DR DSMZ; ACC-94
DR ECACC; 08062517
RX PubMed=4400294;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-236.html
CC Doubling time: ~30-50 hours (DSMZ).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4343 ! C-1300
SX Male
CA Cancer cell line
//
ID NS20Y-BU-2
AC CVCL_4351
DR ECACC; 08062502
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NS20Y-BU-4
AC CVCL_4352
DR ECACC; 08062503
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NS20Y-BU-5
AC CVCL_4353
DR ECACC; 08062504
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NS20Y-BU-6
AC CVCL_4354
DR ECACC; 08062507
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NS20Y-BU-7
AC CVCL_4355
DR ECACC; 08062510
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NS20Y-TG
AC CVCL_4356
DR ECACC; 08062512
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: A/J.
DI NCIt; C21993; Mouse neuroblastoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0469 ! NS20Y
SX Male
CA Cancer cell line
//
ID NSC-34
AC CVCL_D356
SY NSC34
DR BTO; BTO:0004488
RX PubMed=17896795;
RX PubMed=25193168;
WW https://www.cedarlanelabs.com/Products/Detail/CLU140?lob=Cellutions
CC Omics: Deep proteome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID NSC-H14
AC CVCL_U174
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h14.cmsx
ST Source(s): WiCell
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8
ST vWA: 15,16
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9775 ! WA14
SX Male
CA Adult stem cell
//
ID NSC-H14iPSZeng
AC CVCL_U175
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h14ipszeng.cmsx
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_U174 ! NSC-H14
SX Male
CA Adult stem cell
//
ID NSC-H9
AC CVCL_U176
RX PubMed=19774075;
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/nsc-h9.cmsx
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 9
ST D16S539: 12,13
ST D18S51: 13
ST D21S11: 21
ST D3S1358: 13,16
ST D5S818: 11,12
ST D7S820: 9,11
ST D8S1179: 8,14
ST FGA: 26,28
ST Penta D: 9,13
ST Penta E: 11,14
ST TH01: 9.3
ST TPOX: 10,11
ST vWA: 17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Adult stem cell
//
ID NSCLC-N6
AC CVCL_H623
SY NSCLCN6
DR ChEMBL-Cells; CHEMBL3307850
DR ChEMBL-Targets; CHEMBL614016
RX PubMed=1776865;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NSCLC-N6 clone C15
AC CVCL_H624
RX PubMed=9568077;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H623 ! NSCLC-N6
CA Cancer cell line
//
ID NSCLC-N6 clone C65
AC CVCL_H625
RX PubMed=9568077;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H623 ! NSCLC-N6
CA Cancer cell line
//
ID NSCLC-N6 clone C92
AC CVCL_H626
RX PubMed=9568077;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H623 ! NSCLC-N6
CA Cancer cell line
//
ID NSCLC-N6 clone C98
AC CVCL_H627
RX PubMed=9568077;
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H623 ! NSCLC-N6
CA Cancer cell line
//
ID NSK
AC CVCL_8378
SY Newborn Swine Kidney
DR IZSLER; BS CL 177
RX PubMed=12505635;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Spontaneously immortalized cell line
//
ID NSK-RC
AC CVCL_X542
DR Cosmic; 849383
RX PubMed=11146448;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NT-1 [Human leukemia]
AC CVCL_X338
RX PubMed=25012564;
DI NCIt; C3519; Atypical chronic myeloid leukemia, BCR-ABL1 negative
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NT-1 [Human tongue SCC]
AC CVCL_GZ02
RX DOI=10.3353/omp.9.133;
CC Doubling time: 26.8 hours (DOI=10.3353/omp.9.133).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NT-2
AC CVCL_GZ03
RX DOI=10.3353/omp.9.133;
CC Doubling time: 42.4 hours (DOI=10.3353/omp.9.133).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NT-68
AC CVCL_9713
RX PubMed=1320624;
CC From: Van Valen F.; University of Munster; Germany.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NT-8e
AC CVCL_E328
RX PubMed=9310268;
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NT-92
AC CVCL_2145
DR DSMZ; ACC-639
RX CelloPub=CLPUB00363;
CC Doubling time: ~3-4 days (DSMZ).
CC Transformant: ChEBI; CHEBI:50102; N-methyl-N-nitrosourea (NMU).
CC Breed/subspecies: Wistar-AF/Han.
DI NCIt; C60372; Rat cholangiocarcinoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID NT-hESC
AC CVCL_C807
SY ITSe001-A
DR hPSCreg; ITSe001-A
RX PubMed=17112910;
CC From: Civil Hospital Campus; India.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-1
AC CVCL_M327
SY SCNT-hES-1; NT-1; Sooam-hES1; Sooam-hES-1
RX PubMed=14963337;
RX PubMed=16410485;
RX PubMed=24159464;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=14963337) has been retracted due to fraud (see PubMed=16410485).
CC Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016006.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NT-hESC-10
AC CVCL_M328
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-11
AC CVCL_M329
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-12
AC CVCL_M330
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-2
AC CVCL_M331
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-3
AC CVCL_M332
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NT-hESC-4
AC CVCL_M333
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-5
AC CVCL_M334
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT-hESC-6
AC CVCL_M335
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NT-hESC-7
AC CVCL_M336
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NT-hESC-8
AC CVCL_M337
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NT-hESC-9
AC CVCL_M338
RX PubMed=15905366;
RX PubMed=16410485;
WW http://www.nytimes.com/2006/01/09/science/text-clonereport.html?pagewanted=all&_r=0
CC Problematic cell line: Retracted. The paper reporting this cell line (PubMed=15905366) has been retracted due to fraud (see PubMed=16410485).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NT/T-S
AC CVCL_D886
RX PubMed=10875873;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID NT00669
AC CVCL_V377
DR IMGT/HLA; 14456
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NT00670
AC CVCL_V378
DR IMGT/HLA; 14455
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NT00671
AC CVCL_V379
DR IMGT/HLA; 14453
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NT00672
AC CVCL_V380
DR IMGT/HLA; 14454
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NT00673
AC CVCL_V381
DR IMGT/HLA; 14452
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID NT2-B9
AC CVCL_4U33
SY NT2/B9
RX PubMed=6144603;
RX PubMed=6694356;
CC Derived from metastatic site: Lung.
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0034 ! NTERA-2
SX Male
CA Cancer cell line
//
ID NT2-D1
AC CVCL_3407
SY NT2/D1; NT2D1; Nt2D1; NTERA-2 clone D1; NTERA2-cloneD1; NTERA-2 cl.D1; NTera2 cl.D1; NTERA-2cl.D1; NTera 2/cl.D1; NTERA-2/D1; NTera2/D1; Ntera2/D1; NTERA2-D1; NTera-2D1; NTERA2/D1; NTERA2D1; NTera2D1
DR BTO; BTO:0000946
DR CLO; CLO_0008207
DR EFO; EFO_0005236
DR CLDB; cl3740
DR CLDB; cl5088
DR ATCC; CRL-1973
DR BCRC; 60356
DR BCRJ; 0303
DR ChEMBL-Cells; CHEMBL3307482
DR ChEMBL-Targets; CHEMBL614206
DR Cosmic; 687052
DR Cosmic; 908454
DR Cosmic; 1995598
DR Cosmic; 2077191
DR Cosmic; 2163756
DR Cosmic-CLP; 908454
DR ECACC; 01071221
DR ENCODE; ENCBS374ENC
DR ENCODE; ENCBS578HFO
DR ENCODE; ENCBS631LTU
DR ENCODE; ENCBS810EWQ
DR GDSC; 908454
DR GEO; GSM824855
DR GEO; GSM824856
DR GEO; GSM1040297
DR GEO; GSM1040367
DR GEO; GSM1670285
DR ICLC; HTL97025
DR IZSLER; BS TCL 204
RX PubMed=3293662;
RX PubMed=6144603;
RX PubMed=6694356;
RX PubMed=8411264;
RX PubMed=23325432;
RX PubMed=24812411;
RX PubMed=27397505;
WW https://en.wikipedia.org/wiki/NTERA-2
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/NT2-D1_protocol.pdf
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/n/cell-lines-detail-113.html
CC Part of: ENCODE project common cell types; tier 3.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Misspelling: 'NTERA-S-cl-D1' in Cosmic 1995598 and ChEMBL CHEMBL614206 and CHEMBL3307482.
CC Misspelling: 'NTL-D1' in Cosmic 2077191.
CC Misspelling: 'NT2101' in PubMed=24812411 and Cosmic 2163756.
CC Derived from metastatic site: Lung.
ST Source(s): ATCC; Cosmic-CLP; ECACC
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12,13
ST D5S818: 9,12
ST D7S820: 10,12
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0034 ! NTERA-2
SX Male
CA Cancer cell line
//
ID NT2-D3
AC CVCL_4U27
SY NT2/D3; NT2 D3
RX PubMed=6694356;
CC Derived from metastatic site: Lung.
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0034 ! NTERA-2
SX Male
CA Cancer cell line
//
ID NT2-N
AC CVCL_7929
SY NT2N; NTERA-2N; hNT
DR BTO; BTO:0002574
CC Derived from metastatic site: Lung.
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3407 ! NT2-D1
SX Male
CA Cancer cell line
//
ID NT2-Rho0
AC CVCL_K047
SY NT-2 rho(0); NT-2 rho0; NT2 rho0
DR BTO; BTO:0005075
RX PubMed=16050988;
CC Derived from metastatic site: Lung.
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0034 ! NTERA-2
SX Male
CA Cancer cell line
//
ID NTERA-2
AC CVCL_0034
SY NTera-2; Ntera-2; NTera 2; NTERA2; NTera2; N-Tera-2; NT-2; NT2
DR BTO; BTO:0000891
DR CLO; CLO_0008208
DR EFO; EFO_0002959
DR BioSample; SAMN03472969
DR CCRID; 3111C0001CCC000019
DR ChEMBL-Cells; CHEMBL3308505
DR ChEMBL-Targets; CHEMBL614205
DR Cosmic; 821809
DR Cosmic; 2439936
DR DSMZ; ACC-527
DR RSCB; RSCB0150
DR Wikidata; Q17092091
RX PubMed=3293662;
RX PubMed=6694356;
RX PubMed=16919167;
RX PubMed=25485619;
WW https://en.wikipedia.org/wiki/NTERA-2
WW http://www.proteinatlas.org/learn/cellines
CC Doubling time: ~50-60 hours (DSMZ).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Lung.
ST Source(s): DSMZ; PubMed=16919167; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 11,12,13
ST D18S51: 14
ST D21S11: 30,31
ST D3S1358: 16
ST D5S818: 9,12
ST D7S820: 10,12
ST D8S1179: 13,15
ST FGA: 23
ST Penta D: 12,13
ST Penta E: 5,14
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3752; Embryonal carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2777 ! Tera-2
SX Male
CA Cancer cell line
//
ID NTES-2
AC CVCL_E142
SY NTES2
RX PubMed=18253492;
CC Breed/subspecies: 129.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Nthy-ori 3-1
AC CVCL_2659
SY Nthy ori 3.1; Nthy-ori 3.1; NTHY-ORI3.1; HTori-3.1
DR BTO; BTO:0004859
DR CLO; CLO_0008209
DR CLDB; cl3741
DR ECACC; 90011609
DR GEO; GSM827409
RX PubMed=22087789;
RX PubMed=21868764;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
ST Source(s): ECACC; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 7,12
ST TH01: 7
ST TPOX: 9
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4W02 ! HTori-3
SX Female
CA Transformed cell line
//
ID Nthy-ts1
AC CVCL_2660
SY N-thy-ts.1; ts.1
DR CLO; CLO_0008210
DR CLDB; cl3742
DR ECACC; 90011610
RX PubMed=1697930;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Conditionally immortalized cell line
//
ID NTI-4
AC CVCL_3080
DR BioSample; SAMN03471658
DR JCRB; JCRB0220
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NTI-5
AC CVCL_3081
DR JCRB; JCRB0222
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 9,12
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 7,8
ST TPOX: 8
ST vWA: 16,19
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID NTM-5
AC CVCL_5G34
SY NTM5; Normal Trabecular Meshwork-5; HTM-5; Human Trabecular Meshwork-5
RX PubMed=8156826;
RX PubMed=16303956;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G32 ! HTM-4
SX Male
CA Transformed cell line
//
ID NTU-G
AC CVCL_M031
RX PubMed=8473267;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NTU-LY-1
AC CVCL_Z964
RX PubMed=16989856;
CC Group: Insect cell line.
OX NCBI_TaxID=78901; ! Lymantria xylina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-LY-2
AC CVCL_Z965
RX PubMed=16989856;
CC Group: Insect cell line.
OX NCBI_TaxID=78901; ! Lymantria xylina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-LY-3
AC CVCL_Z966
RX PubMed=16989856;
CC Group: Insect cell line.
OX NCBI_TaxID=78901; ! Lymantria xylina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-LY-4
AC CVCL_Z967
RX PubMed=16989856;
CC Group: Insect cell line.
OX NCBI_TaxID=78901; ! Lymantria xylina
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-MV
AC CVCL_Z991
RX PubMed=17521666;
CC Group: Insect cell line.
CC Doubling time: 46.53 hours (in 0% FBS), 33.29 hours (in 4% FBS), 27.76 hours (in 8% FBS), 27.24 hours (in 16% FBS), 37.47 hours (in Sf900 medium) (PubMed=17521666).
OX NCBI_TaxID=497515; ! Maruca vitrata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-Pn-HF
AC CVCL_Z329
SY NTU-PN-HF
RX DOI=10.1303/aez.2002.171;
CC Group: Insect cell line.
OX NCBI_TaxID=497517; ! Perina nuda
SX Female
CA Spontaneously immortalized cell line
//
ID NTU-Pn-HH
AC CVCL_Z328
SY NTU-PN-HH; PN-HH
RX PubMed=8812599;
CC Group: Insect cell line.
OX NCBI_TaxID=497517; ! Perina nuda
SX Female
CA Spontaneously immortalized cell line
//
ID NTU-SE
AC CVCL_Z963
RX PubMed=22867846;
CC Group: Insect cell line.
CC Doubling time: 35.5 hours (PubMed=22867846).
OX NCBI_TaxID=7107; ! Spodoptera exigua
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU-YB
AC CVCL_Z956
SY YB
RX PubMed=19761771;
CC Group: Insect cell line.
CC Doubling time: 38.85 hours (in 0% TNM-FH), 31.27 hours (in 5% TNM-FH), 26.87 hours (in 8% TNM-FH), 31.3 hours (in 16% TNM-FH) (PubMed=19761771).
OX NCBI_TaxID=76203; ! Eurema hecabe
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID NTU1
AC CVCL_C108
SY NTUe001-A; National-Taiwan-University 1
DR BCRC; SC81006
DR GEO; GSM674604
DR hPSCreg; NTUe001-A
DR ISCR; 1649
RX PubMed=17071820;
CC From: National Taiwan University; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NTU2
AC CVCL_C109
SY NTUe002-A; National-Taiwan-University 2
DR BCRC; SC81007
DR hPSCreg; NTUe002-A
DR ISCR; 1650
RX PubMed=17071820;
CC From: National Taiwan University; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NTU3
AC CVCL_C110
SY NTUe003-A; National-Taiwan-University 3
DR BCRC; SC81008
DR hPSCreg; NTUe003-A
DR ISCR; 1651
RX PubMed=17071820;
CC From: National Taiwan University; Taiwan.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID NTUH-iPSC-01-05
AC CVCL_GT41
DR BCRC; SC81034
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NTUH-iPSC-02-02
AC CVCL_GT30
DR BCRC; SC81035
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NU 2-26
AC CVCL_Y104
RX PubMed=6305379;
DI NCIt; C3017; Ependymoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NU-AMB-1
AC CVCL_C249
SY NU-AmB-1
RX PubMed=2581902;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NU-DHL-1
AC CVCL_1876
SY NUDHL1; NuDHL 1
DR BioSample; SAMN03473488
DR CCLE; NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 850208
DR Cosmic; 1629931
DR Cosmic; 2361378
DR DSMZ; ACC-583
DR GEO; GSM380139
DR GEO; GSM380140
DR GEO; GSM887459
DR GEO; GSM888539
DR GEO; GSM1374775
RX PubMed=2581902;
RX PubMed=8547074;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-50 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Genome sequenced.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12,14
ST D13S317: 10,13
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NU-DUL-1
AC CVCL_1877
SY NUDUL1
DR EFO; EFO_0006700
DR ATCC; CRL-2969
DR BioSample; SAMN03473485
DR CCLE; NUDUL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1629936
DR Cosmic-CLP; 1330982
DR DSMZ; ACC-579
DR GDSC; 1330982
DR GEO; GSM887460
DR GEO; GSM888540
DR GEO; GSM1670286
RX PubMed=2581902;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30-36 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: miRNA expression profiling.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): ATCC; Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11,13
ST D5S818: 12,14
ST D7S820: 11,13
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Nu6-1
AC CVCL_7085
SY NU6-1; Nu-6-1; Nu 6-1
DR Cosmic; 877397
DR Cosmic; 1152492
RX PubMed=3422461;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7114 ! RH-SLC-L11
SX Female
CA Cancer cell line
//
ID Nu61
AC CVCL_7086
SY NU61; nu61; nu61-8-4000
RX PubMed=14755057;
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=80
DI NCIt; C34447; Head and neck squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_7118 ! SCC-61
SX Male
CA Cancer cell line
//
ID NUB-20
AC CVCL_5G81
RX DOI=10.1016/B978-0-12-333530-2.50006-X;
RX PubMed=2158399;
DI NCIt; C3716; Primitive neuroectodermal tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NUB-6
AC CVCL_9896
RX PubMed=3243386;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUB-7
AC CVCL_9897
RX DOI=10.1007/0-306-46872-7_2;
RX PubMed=3243386;
RX PubMed=8043511;
DI NCIt; C3270; Neuroblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NUC-1 [Human choriocarcinoma]
AC CVCL_M685
RX PubMed=6579923;
RX PubMed=11014955;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NUC-1 [Mouse urothelial]
AC CVCL_2146
DR CLO; CLO_0008211
DR CLDB; cl3743
DR DSMZ; ACC-225
RX PubMed=7687588;
CC Doubling time: ~24 hours (DSMZ).
CC Breed/subspecies: C3H/Law.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID NUC-5
AC CVCL_2147
DR CLO; CLO_0008212
DR CLDB; cl3744
DR DSMZ; ACC-226
RX PubMed=7687588;
CC Doubling time: ~60-75 hours (DSMZ).
CC Breed/subspecies: C3H/Law.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID NUGC-2
AC CVCL_1611
AS CVCL_8370
SY NUGC2; NU-GC-2
DR BTO; BTO:0002596
DR EFO; EFO_0006701
DR BioSample; SAMN03472517
DR BioSample; SAMN03473090
DR CCLE; NUGC2_STOMACH
DR CGH-DB; 133-1
DR Cosmic; 1187287
DR GEO; GSM887461
DR GEO; GSM888541
DR JCRB; JCRB0821
RX PubMed=1778766;
RX PubMed=3172586;
RX PubMed=9290701;
RX PubMed=15723654;
RX PubMed=19132987;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 36.1 hours (PubMed=3172586).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'MUGC-2' in Cosmic 1187287 and PubMed=19132987.
CC Derived from metastatic site: Lymph node.
ST Source(s): JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 7,12 (JCRB)
ST D16S539: 7 (PubMed=25877200)
ST D18S51: 21
ST D21S11: 29
ST D3S1358: 15,16
ST D5S818: 10,12
ST D7S820: 11
ST D8S1179: 13
ST FGA: 21
ST Penta D: 12
ST Penta E: 11
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NUGC-3
AC CVCL_1612
AS CVCL_8371
SY NUGC3; NU-GC-3
DR BTO; BTO:0002597
DR EFO; EFO_0006702
DR BioSample; SAMN03473123
DR CCLE; NUGC3_STOMACH
DR CGH-DB; 134-1
DR ChEMBL-Cells; CHEMBL3307562
DR ChEMBL-Targets; CHEMBL614208
DR Cosmic; 801341
DR Cosmic; 877046
DR Cosmic; 908455
DR Cosmic; 918499
DR Cosmic; 968351
DR Cosmic; 1187288
DR Cosmic; 1518256
DR Cosmic; 1995599
DR Cosmic; 2484968
DR Cosmic-CLP; 908455
DR GDSC; 908455
DR GEO; GSM827405
DR GEO; GSM828828
DR GEO; GSM844666
DR GEO; GSM887462
DR GEO; GSM888542
DR GEO; GSM1374776
DR GEO; GSM1670287
DR JCRB; JCRB0822
RX PubMed=1778766;
RX PubMed=3172586;
RX PubMed=9290701;
RX PubMed=15723654;
RX PubMed=15767549;
RX PubMed=19132987;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR45 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 38.2 hours (PubMed=3172586); 32 hours (JCRB).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'MUGC-3' in Cosmic 1187288 and PubMed=19132987.
CC Misspelling: 'NVGC3' in Cosmic 801341.
CC Derived from metastatic site: Brachialis muscle.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 13
ST D13S317: 10,11
ST D16S539: 10,11
ST D18S51: 18,19
ST D21S11: 30,31
ST D3S1358: 16,17
ST D5S818: 11
ST D7S820: 8,9
ST D8S1179: 12,13,16,17
ST FGA: 17
ST Penta D: 11
ST Penta E: 11,18
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NUGC-3-Luc
AC CVCL_4Y07
DR JCRB; NIHS0731
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Derived from metastatic site: Brachialis muscle.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1612 ! NUGC-3
SX Male
CA Cancer cell line
//
ID NUGC-3/5-FU/L
AC CVCL_L502
SY NUGC-3/5FU/L; NUGC-3/5-FU; NUGC-3/5FU
RX PubMed=8609072;
RX PubMed=10359051;
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC Derived from metastatic site: Brachialis muscle.
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1612 ! NUGC-3
SX Male
CA Cancer cell line
//
ID NUGC-4
AC CVCL_3082
AS CVCL_8372
SY NUGC4; NU-GC-4
DR BTO; BTO:0005917
DR CLO; CLO_0050789
DR EFO; EFO_0006703
DR BioSample; SAMN01821711
DR BioSample; SAMN03473124
DR CCLE; NUGC4_STOMACH
DR CGH-DB; 135-1
DR ChEMBL-Cells; CHEMBL3307267
DR ChEMBL-Targets; CHEMBL613519
DR Cosmic; 1187289
DR Cosmic; 1329186
DR Cosmic; 1460702
DR Cosmic; 1518257
DR Cosmic; 1890473
DR Cosmic; 2009530
DR Cosmic; 2484971
DR Cosmic-CLP; 1298357
DR GDSC; 1298357
DR GEO; GSM827575
DR GEO; GSM844667
DR GEO; GSM887463
DR GEO; GSM888543
DR GEO; GSM1374777
DR GEO; GSM1670288
DR JCRB; JCRB0834
DR RCB; RCB1939
DR TKG; TKG 0449
RX PubMed=1778766;
RX PubMed=3172586;
RX PubMed=9290701;
RX PubMed=15723654;
RX PubMed=19132987;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 29.9 hours (PubMed=3172586).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'MUGC-4' in Cosmic 1187289 and PubMed=19132987.
CC Derived from metastatic site: Paragastric lymph node.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 9
ST D18S51: 16,19
ST D21S11: 30.3,31
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 12
ST FGA: 23,26
ST Penta D: 9,12
ST Penta E: 13,15
ST TH01: 7,9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NUH2
AC CVCL_N272
SY NUH-2
DR ATCC; HB-9762
RX Patent=US5227160;
RX PubMed=2509467;
CC Monoclonal antibody target: UniProtKB; P04626; Disialogangliosides with binary 2-3 sialosyllactosamine structure.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID NUL1
AC CVCL_R788
SY NUL 1
RX PubMed=3001399;
RX PubMed=3409226;
RX PubMed=4067735;
RX PubMed=6713549;
CC Transformant: ChEBI; CHEBI:17967; Urethane.
CC Breed/subspecies: BALB/c.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID NUL1 clone B3
AC CVCL_5U97
SY NUL1 B3; NULB3; B3
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
RX PubMed=9347924;
CC Transformant: ChEBI; CHEBI:17967; Urethane.
CC Breed/subspecies: BALB/c.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R788 ! NUL1
CA Cancer cell line
//
ID NUL1 clone B5
AC CVCL_5U98
SY NUL1 B5; NULB5; b5
RX PubMed=2152771;
RX PubMed=2177605;
RX PubMed=3409226;
RX PubMed=9347924;
CC Transformant: ChEBI; CHEBI:17967; Urethane.
CC Breed/subspecies: BALB/c.
DI NCIt; C21762; Adenoma of the mouse pulmonary system
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_R788 ! NUL1
CA Cancer cell line
//
ID NuLi-1
AC CVCL_C455
SY Normal Lung, University of Iowa-1
DR ATCC; CRL-4011
DR BioSample; SAMN03471719
RX PubMed=12676769;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 10,12
ST D16S539: 8,13
ST D5S818: 11,13
ST D7S820: 12,13
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NuLi-2
AC CVCL_S915
SY Normal Lung, University of Iowa-2
RX PubMed=12676769;
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NuLi-3
AC CVCL_C456
SY Normal Lung, University of Iowa-3
DR ATCC; CRL-4012
DR BioSample; SAMN03471720
CC Transfected with: HGNC; 11730; TERT.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
CC Discontinued: ATCC; CRL-4012; true.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NULLI-SCC1
AC CVCL_3408
DR CLO; CLO_0008213
DR CLDB; cl3745
DR CLDB; cl7206
DR ATCC; CRL-1566
DR ICLC; ATL06001
CC Breed/subspecies: 129/Sv.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Cancer cell line
//
ID Nur-1
AC CVCL_1Q60
RX PubMed=25627346;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NUTLC-1
AC CVCL_L423
RX PubMed=8025020;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUTLC-2
AC CVCL_L424
RX PubMed=1339008;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUTLC-3
AC CVCL_L425
RX PubMed=8025020;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUTLC-4
AC CVCL_L426
RX PubMed=1339008;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUTLC-5
AC CVCL_L427
RX PubMed=1339008;
DI NCIt; C4450; Large cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NUTOS
AC CVCL_D658
RX PubMed=20712710;
DI NCIt; C3749; Alveolar rhabdomyosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NuTu-19
AC CVCL_HA28
SY NUTU-19; NuTu 19
RX PubMed=8168110;
RX PubMed=8828419;
CC Breed/subspecies: Fischer 344.
DI NCIt; C129858; Adenocarcinoma of the rat ovary
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID NUZ
AC CVCL_V411
SY NUZ-1
DR Cosmic; 877472
DR Cosmic; 1152546
RX CelloPub=CLPUB00091;
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NW-16
AC CVCL_5219
SY NW16
DR BTO; BTO:0003055
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_0513 ! Rat2
CA Spontaneously immortalized cell line
//
ID NW0004
AC CVCL_8Y25
DR ECACC; 03041506
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID NW0005
AC CVCL_8Y26
DR ECACC; 03041507
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NW0006
AC CVCL_8Y27
DR ECACC; 03110420
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID NW145
AC CVCL_2148
SY NW-145; NW 145; NW-MEL-145; NW-Mel-145; EST57
DR Cosmic; 972264
DR Cosmic; 1047648
DR Cosmic; 2163798
DR ESTDAB; ESTDAB-057
DR GEO; GSM156014
RX PubMed=17260012;
CC Omics: Array-based CGH.
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 10
ST FGA: 20
ST TH01: 7
ST TPOX: 11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NW145/E7
AC CVCL_C538
SY NW-145/E7; NW145 clone E7
DR Cosmic; 972259
DR ESTDAB; ESTDAB-058
ST Source(s): ESTDAB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,12
ST D3S1358: 14,15
ST D5S818: 11
ST D7S820: 10
ST FGA: 20
ST TH01: 7
ST TPOX: 11
ST vWA: 19
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2148 ! NW145
SX Male
CA Cancer cell line
//
ID NW1539
AC CVCL_S590
SY NW-1539; NW-MEL-1539; NW-Mel-1539
DR BTO; BTO:0005427
RX PubMed=12747757;
RX PubMed=15087389;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NW38
AC CVCL_S591
SY NW-38; NW-MEL-38
RX PubMed=9432985;
RX PubMed=12747757;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NW450
AC CVCL_S592
SY MW-450; NW-MEL-450; NW-Mel-450
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NW624
AC CVCL_S589
SY NW-624; NW-Mel-624
DR BTO; BTO:0005428
RX PubMed=15087389;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NW726
AC CVCL_S593
SY NW-726; NW-Mel-726
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NW745
AC CVCL_S594
SY NW-745; NW-Mel-745
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NWR A
AC CVCL_R793
RX PubMed=21892153;
OX NCBI_TaxID=9807; ! Ceratotherium simum
OI CVCL_R794 ! NWR B
OI CVCL_R795 ! NWR C
SX Female
CA Induced pluripotent stem cell
//
ID NWR B
AC CVCL_R794
RX PubMed=21892153;
OX NCBI_TaxID=9807; ! Ceratotherium simum
OI CVCL_R793 ! NWR A
OI CVCL_R795 ! NWR C
SX Female
CA Induced pluripotent stem cell
//
ID NWR C
AC CVCL_R795
RX PubMed=21892153;
OX NCBI_TaxID=9807; ! Ceratotherium simum
OI CVCL_R793 ! NWR A
OI CVCL_R794 ! NWR B
SX Female
CA Induced pluripotent stem cell
//
ID NWT-21
AC CVCL_D206
SY NWT21
RX PubMed=15050915;
CC Transfected with: HGNC; 5465; IGF1R.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID NY
AC CVCL_1613
DR BioSample; SAMN03471633
DR ChEMBL-Cells; CHEMBL3308123
DR ChEMBL-Targets; CHEMBL1075552
DR Cosmic; 910849
DR Cosmic-CLP; 910849
DR GDSC; 910849
DR GEO; GSM320822
DR GEO; GSM827276
DR GEO; GSM1670289
DR JCRB; JCRB0614
RX PubMed=6596455;
RX PubMed=9290701;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8
ST D16S539: 10,13
ST D5S818: 13
ST D7S820: 11
ST TH01: 7,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NYAES-PR4A
AC CVCL_Z961
RX DOI=10.1016/0022-2011(88)90135-8;
CC Group: Insect cell line.
OX NCBI_TaxID=64459; ! Pieris rapae
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Nyalim
AC CVCL_0D20
RX PubMed=25711304;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Nyalimx
AC CVCL_0D21
RX PubMed=25711304;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0D20 ! Nyalim
SX Male
CA Cancer cell line
//
ID Nyevu
AC CVCL_IU24
RX PubMed=178913;
RX PubMed=4364259;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NYGM
AC CVCL_9278
RX PubMed=15859160;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NYH/187/162
AC CVCL_0B24
SY NYH/187
RX PubMed=10416608;
RX PubMed=12044890;
CC Selected for resistance to: ChEBI; CHEBI:50223; (+)-dexrazoxane (Cardioxane; ICRF-187).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYH/187/165
AC CVCL_0B25
RX PubMed=12044890;
CC Selected for resistance to: ChEBI; CHEBI:50223; (+)-dexrazoxane (Cardioxane; ICRF-187).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYH/CAM
AC CVCL_0B26
RX PubMed=9062409;
CC Selected for resistance to: ChEBI; CHEBI:27656; Camptothecin (CPT).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYH/CIS
AC CVCL_0B27
RX PubMed=9062409;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYH/TPT
AC CVCL_0B28
RX PubMed=7640225;
RX PubMed=9062409;
CC Selected for resistance to: ChEBI; CHEBI:63632; Topotecan.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYH/VM
AC CVCL_0B29
SY OC-NYH/VM
RX PubMed=8390259;
RX PubMed=9062409;
CC Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8207 ! GLC-2
SX Male
CA Cancer cell line
//
ID NYSCF-10005-1044-1044-Skin-mR-iPSC
AC CVCL_AB86
WW http://shared.eagle-i.net/i/00000149-1589-b8ee-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1046-1046-Skin-mR-iPSC
AC CVCL_AB87
WW http://shared.eagle-i.net/i/00000149-15ac-a13a-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1047-1047-Skin-mR-iPSC
AC CVCL_AB88
WW http://shared.eagle-i.net/i/00000149-15b4-bf9c-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1048-1048-Skin-mR-iPSC
AC CVCL_AB89
WW http://shared.eagle-i.net/i/00000149-15b7-4014-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1049-1049-Skin-mR-iPSC
AC CVCL_AB90
WW http://shared.eagle-i.net/i/00000149-15bb-9f8f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1050-1050-Skin-mR-iPSC
AC CVCL_AB91
WW http://shared.eagle-i.net/i/00000149-16b8-157f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1051-1051-Skin-mR-iPSC
AC CVCL_AB92
WW http://shared.eagle-i.net/i/00000149-16ba-b3a9-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1058-1058-Skin-mR-iPSC
AC CVCL_AB93
WW http://shared.eagle-i.net/i/00000149-16bb-aa74-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1059-1059-Skin-mR-iPSC
AC CVCL_AB94
WW http://shared.eagle-i.net/i/00000149-16bc-b251-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1062-1062-Skin-mR-iPSC
AC CVCL_AB95
WW http://shared.eagle-i.net/i/00000149-16bd-c475-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1063-1063-Skin-mR-iPSC
AC CVCL_AB96
WW http://shared.eagle-i.net/i/00000149-16be-c4ce-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1064-1064-Skin-mR-iPSC
AC CVCL_AB97
WW http://shared.eagle-i.net/i/00000149-16c0-1779-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1065-1065-Skin-mR-iPSC
AC CVCL_AB98
WW http://shared.eagle-i.net/i/00000149-16c0-d7d3-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1067-1067-Skin-mR-iPSC
AC CVCL_AB99
WW http://shared.eagle-i.net/i/00000149-16c1-bd44-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1069-1069-Skin-mR-iPSC
AC CVCL_AC00
WW http://shared.eagle-i.net/i/00000149-16c2-8040-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1070-1070-Skin-mR-iPSC
AC CVCL_AC01
WW http://shared.eagle-i.net/i/00000149-16c3-655f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1071-1071-Skin-mR-iPS
AC CVCL_AC02
WW http://shared.eagle-i.net/i/00000149-16c4-9fcf-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1073-1073-Skin-mR-iPS
AC CVCL_AC03
WW http://shared.eagle-i.net/i/00000149-16c5-ba23-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1076-1076-Skin-mR-iPS
AC CVCL_AC04
WW http://shared.eagle-i.net/i/00000149-16c7-60dd-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1081-1081-Skin-mR-iPS
AC CVCL_AC05
WW http://shared.eagle-i.net/i/00000149-16c8-c97a-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1082-1082-Skin-mR-iPS
AC CVCL_AC06
WW http://shared.eagle-i.net/i/00000149-16c9-c937-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-1085-1085-Skin-mR-iPS
AC CVCL_AC07
WW http://shared.eagle-i.net/i/00000149-16cb-01a0-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-117-117-Skin-sv-iPSC
AC CVCL_AC08
WW http://shared.eagle-i.net/i/00000149-16cf-7e9b-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-118-118-Skin-mR-iPSC
AC CVCL_AC09
WW http://shared.eagle-i.net/i/00000149-14ff-9aeb-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-128-128-Skin-mR-iPSC
AC CVCL_AC10
WW http://shared.eagle-i.net/i/00000149-1504-e92c-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-141-141-Skin-mR-iPSC
AC CVCL_AC11
WW http://shared.eagle-i.net/i/00000149-1508-d6c9-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-177-177-Skin-mR-iPSC
AC CVCL_AC12
WW http://shared.eagle-i.net/i/00000149-150c-48f8-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-186-186-Skin-mR-iPSC
AC CVCL_AC13
WW http://shared.eagle-i.net/i/00000149-150f-20d1-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-370-370-Skin-mR-iPSC
AC CVCL_AC14
WW http://shared.eagle-i.net/i/00000146-8fac-486f-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-375-375-Skin-mR-iPSC
AC CVCL_AC15
WW http://shared.eagle-i.net/i/00000146-8fac-6553-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-384-384-Skin-mR-iPSC
AC CVCL_AC16
WW http://shared.eagle-i.net/i/00000146-8fac-7e96-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-392-392-Skin-mR-iPSC
AC CVCL_AC17
WW http://shared.eagle-i.net/i/00000146-8fac-96e6-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-401-401-Skin-mR-iPSC
AC CVCL_AC18
WW http://shared.eagle-i.net/i/00000149-1438-36f8-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-405-405-Skin-mR-iPSC
AC CVCL_AC19
WW http://shared.eagle-i.net/i/00000149-14d4-7c92-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-406-406-Skin-mR-iPSC
AC CVCL_AC20
WW http://shared.eagle-i.net/i/00000146-8fac-a910-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-411-411-Skin-mR-iPSC
AC CVCL_AC21
WW http://shared.eagle-i.net/i/00000149-14dd-bf9c-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-415-415-Skin-mR-iPSC
AC CVCL_AC22
WW http://shared.eagle-i.net/i/00000146-8fac-cdfa-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-417-417-Skin-mR-iPSC
AC CVCL_AC23
WW http://shared.eagle-i.net/i/00000146-8fac-e152-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-425-425-Skin-mR-iPSC
AC CVCL_AC24
WW http://shared.eagle-i.net/i/00000146-8fad-0819-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-432-432-Skin-mR-iPSC
AC CVCL_AC25
WW http://shared.eagle-i.net/i/00000149-1511-c177-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-433-433-Skin-mR-iPSC
AC CVCL_AC26
WW http://shared.eagle-i.net/i/00000146-8fad-1dd6-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-434-434-Skin-mR-iPSC
AC CVCL_AC27
WW http://shared.eagle-i.net/i/00000146-8fad-3004-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-437-437-Skin-mR-iPSC
AC CVCL_AC28
WW http://shared.eagle-i.net/i/00000146-8fad-4688-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-438-438-Skin-mR-iPSC
AC CVCL_AC29
WW http://shared.eagle-i.net/i/00000146-8fad-5a0a-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-459-459-Skin-mR-iPSC
AC CVCL_AC30
WW http://shared.eagle-i.net/i/00000149-1515-22c6-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-460-460-Skin-mR-iPSC
AC CVCL_AC31
WW http://shared.eagle-i.net/i/00000149-1519-62e0-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-465-465-Skin-mR-iPSC
AC CVCL_AC32
WW http://shared.eagle-i.net/i/00000149-1522-4d9e-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-469-469-Skin-mR-iPSC
AC CVCL_AC33
WW http://shared.eagle-i.net/i/00000149-1525-db6e-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-470-470-Skin-mR-iPSC
AC CVCL_AC34
WW http://shared.eagle-i.net/i/00000149-1528-e8e2-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-476-476-Skin-mR-iPSC
AC CVCL_AC35
WW http://shared.eagle-i.net/i/00000146-8fad-6f9b-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-478-478-Skin-mR-iPSC
AC CVCL_AC36
WW http://shared.eagle-i.net/i/00000149-152f-4bba-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-491-491-Skin-mR-iPSC
AC CVCL_AC37
WW http://shared.eagle-i.net/i/00000149-1531-a557-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-555-555-Skin-mR-iPSC
AC CVCL_AC38
WW http://shared.eagle-i.net/i/00000149-1533-72f5-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-558-558-Skin-mR-iPSC
AC CVCL_AC39
WW http://shared.eagle-i.net/i/00000146-8fad-8234-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-562-562-Skin-mR-iPSC
AC CVCL_AC40
WW http://shared.eagle-i.net/i/00000149-14e7-ef13-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-566-566-Skin-mR-iPSC
AC CVCL_AC41
WW http://shared.eagle-i.net/i/00000146-8fad-a940-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-568-568-Skin-mR-iPSC
AC CVCL_AC42
WW http://shared.eagle-i.net/i/00000146-8fad-ba06-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-569-569-Skin-mR-iPSC
AC CVCL_AC43
WW http://shared.eagle-i.net/i/00000146-8fad-d153-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-570-570-Skin-mR-iPSC
AC CVCL_AC44
WW http://shared.eagle-i.net/i/00000149-1535-9606-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-580-580-Skin-mR-iPSC
AC CVCL_AC45
WW http://shared.eagle-i.net/i/00000146-8fad-e1fa-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-582-582-Skin-mR-iPSC
AC CVCL_AC46
WW http://shared.eagle-i.net/i/00000146-8fad-fa5f-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-583-583-Skin-mR-iPSC
AC CVCL_AC47
WW http://shared.eagle-i.net/i/00000149-1538-7ddb-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-585-585-Skin-mR-iPSC
AC CVCL_AC48
WW http://shared.eagle-i.net/i/00000146-8fae-254c-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-590-590-Skin-mR-iPSC
AC CVCL_AC49
WW http://shared.eagle-i.net/i/00000146-8fae-3875-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-592-592-Skin-mR-iPSC
AC CVCL_AC50
WW http://shared.eagle-i.net/i/00000146-8fae-5113-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-596-596-Skin-mR-iPSC
AC CVCL_AC51
WW http://shared.eagle-i.net/i/00000146-8fae-6308-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-597-597-Skin-mR-iPSC
AC CVCL_AC52
WW http://shared.eagle-i.net/i/00000146-8fae-7850-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-598-598-Skin-mR-iPSC
AC CVCL_AC53
WW http://shared.eagle-i.net/i/00000146-8fae-8a5a-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-605-605-Skin-mR-iPSC
AC CVCL_AC54
WW http://shared.eagle-i.net/i/00000146-8fae-9a6b-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-611-611-Skin-mR-iPSC
AC CVCL_AC55
WW http://shared.eagle-i.net/i/00000146-8fae-b2da-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-617-617-Skin-mR-iPSC
AC CVCL_AC56
WW http://shared.eagle-i.net/i/00000146-8fae-c91e-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-623-623-Skin-mR-iPSC
AC CVCL_AC57
WW http://shared.eagle-i.net/i/00000146-8fae-dbb3-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-632-632-Skin-mR-iPSC
AC CVCL_AC58
WW http://shared.eagle-i.net/i/00000146-8fae-f258-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-635-635-Skin-mR-iPSC
AC CVCL_AC59
WW http://shared.eagle-i.net/i/00000149-153a-a6d3-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-636-636-Skin-mR-iPSC
AC CVCL_AC60
WW http://shared.eagle-i.net/i/00000146-8faf-0616-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-642-642-Skin-mR-iPSC
AC CVCL_AC61
WW http://shared.eagle-i.net/i/00000146-8faf-1bd4-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-644-644-Skin-mR-iPSC
AC CVCL_AC62
WW http://shared.eagle-i.net/i/00000146-8faf-32dd-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-645-645-Skin-mR-iPSC
AC CVCL_AC63
WW http://shared.eagle-i.net/i/00000149-14ed-db90-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-648-648-Skin-mR-iPSC
AC CVCL_AC64
WW http://shared.eagle-i.net/i/00000146-8faf-4481-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-650-650-Skin-mR-iPSC
AC CVCL_AC65
WW http://shared.eagle-i.net/i/00000146-8faf-5be3-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-660-660-Skin-mR-iPSC
AC CVCL_AC66
WW http://shared.eagle-i.net/i/00000146-8faf-80c8-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-661-661-Skin-mR-iPSC
AC CVCL_AC67
WW http://shared.eagle-i.net/i/00000146-8faf-986c-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-669-669-Skin-mR-iPSC
AC CVCL_AC68
WW http://shared.eagle-i.net/i/00000149-153c-3493-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-675-675-Skin-mR-iPSC
AC CVCL_AC69
WW http://shared.eagle-i.net/i/00000149-153d-9395-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-684-684-Skin-mR-iPSC
AC CVCL_AC70
WW http://shared.eagle-i.net/i/00000149-153f-2010-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-686-686-Skin-mR-iPSC
AC CVCL_AC71
WW http://shared.eagle-i.net/i/00000149-1541-0610-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-689-689-Skin-mR-iPSC
AC CVCL_AC72
WW http://shared.eagle-i.net/i/00000149-1542-caee-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-694-694-Skin-mR-iPSC
AC CVCL_AC73
WW http://shared.eagle-i.net/i/00000146-8faf-a92c-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-699-699-Skin-mR-iPSC
AC CVCL_AC74
WW http://shared.eagle-i.net/i/00000146-8faf-c16d-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-700-700-Skin-mR-iPSC
AC CVCL_AC75
WW http://shared.eagle-i.net/i/00000149-1544-392b-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-702-702-Skin-mR-iPSC
AC CVCL_AC76
WW http://shared.eagle-i.net/i/00000149-1546-1c4c-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-705-705-Skin-mR-iPSC
AC CVCL_AC77
WW http://shared.eagle-i.net/i/00000149-1547-73a7-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-709-709-Skin-mR-iPSC
AC CVCL_AC78
WW http://shared.eagle-i.net/i/00000149-1549-5fd0-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-716-716-Skin-mR-iPSC
AC CVCL_AC79
WW http://shared.eagle-i.net/i/00000149-154a-aea0-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-733-733-Skin-mR-iPSC
AC CVCL_AC80
WW http://shared.eagle-i.net/i/00000149-154c-7ab1-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-739-739-Skin-mR-iPSC
AC CVCL_AC81
WW http://shared.eagle-i.net/i/00000149-1550-6026-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-743-743-Skin-mR-iPSC
AC CVCL_AC82
WW http://shared.eagle-i.net/i/00000149-1552-0510-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-750-750-Skin-mR-iPSC
AC CVCL_AC83
WW http://shared.eagle-i.net/i/00000149-1553-5fce-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-752-752-Skin-mR-iPSC
AC CVCL_AC84
WW http://shared.eagle-i.net/i/00000149-1554-9653-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-767-767-Skin-mR-iPSC
AC CVCL_AC85
WW http://shared.eagle-i.net/i/00000149-1558-1c7a-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-773-773-Skin-mR-iPSC
AC CVCL_AC86
WW http://shared.eagle-i.net/i/00000149-155a-440e-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-780-780-Skin-mR-iPSC
AC CVCL_AC87
WW http://shared.eagle-i.net/i/00000149-155d-0461-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-794-794-Skin-mR-iPSC
AC CVCL_AC88
WW http://shared.eagle-i.net/i/00000149-155e-971f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-808-808-Skin-mR-iPSC
AC CVCL_AC89
WW http://shared.eagle-i.net/i/00000149-1560-0151-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-818-818-Skin-mR-iPSC
AC CVCL_AC90
WW http://shared.eagle-i.net/i/00000149-1561-5579-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-819-819-Skin-mR-iPSC
AC CVCL_AC91
WW http://shared.eagle-i.net/i/00000149-1562-6309-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-824-824-Skin-mR-iPSC
AC CVCL_AC92
WW http://shared.eagle-i.net/i/00000149-1563-a316-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-825-825-Skin-mR-iPSC
AC CVCL_AC93
WW http://shared.eagle-i.net/i/00000149-1564-be42-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-830-830-Skin-mR-iPSC
AC CVCL_AC94
WW http://shared.eagle-i.net/i/00000149-1567-e2ff-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-835-835-Skin-mR-iPSC
AC CVCL_AC95
WW http://shared.eagle-i.net/i/00000149-156f-7f7d-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-841-841-Skin-mR-iPSC
AC CVCL_AC96
WW http://shared.eagle-i.net/i/00000149-1571-7e8f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-845-845-Skin-mR-iPSC
AC CVCL_AC97
WW http://shared.eagle-i.net/i/00000149-1575-2de6-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-861-861-Skin-mR-iPSC
AC CVCL_AC98
WW http://shared.eagle-i.net/i/00000149-1577-5392-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-876-876-Skin-mR-iPSC
AC CVCL_AC99
WW http://shared.eagle-i.net/i/00000149-157a-3a37-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-882-882-Skin-mR-iPSC
AC CVCL_AD00
WW http://shared.eagle-i.net/i/00000149-157b-6ee9-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-10005-885-885-Skin-mR-iPSC
AC CVCL_AD01
WW http://shared.eagle-i.net/i/00000149-157c-f80b-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-888-888-Skin-mR-iPSC
AC CVCL_AD02
WW http://shared.eagle-i.net/i/00000149-157f-8bba-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-900-900-Skin-mR-iPSC
AC CVCL_AD03
WW http://shared.eagle-i.net/i/00000149-14f6-7a2d-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-10005-901-901-Skin-mR-iPSC
AC CVCL_AD04
WW http://shared.eagle-i.net/i/00000149-1587-1fa8-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1000-ASC2-Dura-SV-iPSC1
AC CVCL_AD05
WW http://shared.eagle-i.net/i/00000146-8fc9-99b9-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C84909; Multiple system atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD06 ! NYSCF-AD-1000-ASC2-Skin-SV-iPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1000-ASC2-Skin-SV-iPSC1
AC CVCL_AD06
WW http://shared.eagle-i.net/i/00000146-8fc9-da69-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C84909; Multiple system atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD05 ! NYSCF-AD-1000-ASC2-Dura-SV-iPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1001-ASC7-Dura-SV-iPSC1
AC CVCL_AD07
WW http://shared.eagle-i.net/i/00000146-8fca-1655-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1007-ASC19-Dura-SV-iPSC1
AC CVCL_AD08
WW http://shared.eagle-i.net/i/00000146-8fca-6832-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C34373; Amyotrophic lateral sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1011-ASC27-Dura-SV-iPSC1
AC CVCL_AD09
WW http://shared.eagle-i.net/i/00000146-8fca-bb53-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD10 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC2
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1011-ASC27-Dura-SV-iPSC2
AC CVCL_AD10
WW http://shared.eagle-i.net/i/00000146-8fca-d15d-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C82342; Huntington's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD09 ! NYSCF-AD-1011-ASC27-Dura-SV-iPSC1
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1012-ASC30-Dura-SV-iPSC1
AC CVCL_AD11
WW http://shared.eagle-i.net/i/00000146-8fcb-0c5a-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1013-AG06842-Skin-RV-IPSC1
AC CVCL_AD12
SY 6842A
RX PubMed=24416243;
WW http://shared.eagle-i.net/i/00000146-8fb0-7800-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H777 ! AG06842
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1015-AG07671-Skin-RV-IPSC1
AC CVCL_AD13
SY 7671C
RX PubMed=24416243;
WW http://shared.eagle-i.net/i/00000146-8fb1-3e14-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4P39 ! AG07671
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1016-AG07768-Skin-RV-IPSC1
AC CVCL_AD14
SY 7768C
RX PubMed=24416243;
WW http://shared.eagle-i.net/i/00000146-8fb1-f5a7-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C123412; Familial Alzheimer's disease, type 3
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_T877 ! AG07768
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1019-AG07889-Skin-RV-IPSC1
AC CVCL_AD15
RX PubMed=24416243;
WW http://shared.eagle-i.net/i/00000146-8fb4-2dbe-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4K02 ! AG07889
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-AD-1021-AG08446-Skin-RV-IPSC1
AC CVCL_AD16
RX PubMed=24416243;
WW http://shared.eagle-i.net/i/00000146-8fb4-b595-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2866; Alzheimer's disease
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4K58 ! AG08446
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1016-1016-Skin-RV-IPSC1
AC CVCL_AD91
RX PubMed=21979046;
WW http://shared.eagle-i.net/i/00000146-8fb8-b8a7-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1018-1018-Skin-RV-IPSC11
AC CVCL_AD17
WW http://shared.eagle-i.net/i/00000146-8fb8-faff-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1019-1019-Skin-MR-iPSC1
AC CVCL_AD18
WW http://shared.eagle-i.net/i/00000149-1959-bf1b-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD19 ! NYSCF-DE-1019-1019-Skin-RV-iPSC1
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1019-1019-Skin-RV-iPSC1
AC CVCL_AD19
WW http://shared.eagle-i.net/i/00000146-8fb9-ba25-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD18 ! NYSCF-DE-1019-1019-Skin-MR-iPSC1
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1020-1020-Skin-MR-iPSC1
AC CVCL_AD20
WW http://shared.eagle-i.net/i/00000149-1961-a95c-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1024-1024-Skin-MR-iPSC1
AC CVCL_AD21
WW http://shared.eagle-i.net/i/00000149-1962-ef68-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD22 ! NYSCF-DE-1024-1024-Skin-RV-iPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1024-1024-Skin-RV-iPSC1
AC CVCL_AD22
WW http://shared.eagle-i.net/i/00000146-8fbb-4930-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD21 ! NYSCF-DE-1024-1024-Skin-MR-iPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1028-1028-Skin-MR-iPSC1
AC CVCL_AD23
WW http://shared.eagle-i.net/i/00000149-1964-6cb5-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1034-1034-Skin-RV-IPSC1
AC CVCL_AD92
RX PubMed=21979046;
WW http://shared.eagle-i.net/i/00000146-8fbd-3cba-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD93 ! NYSCF-DE-1034-1034-Skin-SV-IPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1034-1034-Skin-SV-IPSC1
AC CVCL_AD93
RX PubMed=21979046;
WW http://shared.eagle-i.net/i/00000146-8fcf-864f-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD92 ! NYSCF-DE-1034-1034-Skin-RV-IPSC1
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1035-1035-Skin-MR-iPSC1
AC CVCL_AD24
WW http://shared.eagle-i.net/i/00000149-1965-8348-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1039-1039-Skin-MR-iPSC1
AC CVCL_AD25
WW http://shared.eagle-i.net/i/00000149-1966-777e-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1044-1044-Skin-MR-iPSC1
AC CVCL_AD26
WW http://shared.eagle-i.net/i/00000149-1967-6482-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1045-1045-Skin-MR-iPSC1
AC CVCL_AD27
WW http://shared.eagle-i.net/i/00000149-1968-7a94-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1046-1046-Skin-MR-iPSC1
AC CVCL_AD28
WW http://shared.eagle-i.net/i/00000149-1969-18a3-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1048-1048-Skin-MR-iPSC1
AC CVCL_AD29
WW http://shared.eagle-i.net/i/00000149-1969-cad7-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1051-1051-Skin-MR-iPSC1
AC CVCL_AD30
WW http://shared.eagle-i.net/i/00000149-196a-824f-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1052-1052-Skin-MR-iPSC1
AC CVCL_AD31
WW http://shared.eagle-i.net/i/00000149-196b-8a1e-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1057-1057-Skin-MR-iPSC1
AC CVCL_AD32
WW http://shared.eagle-i.net/i/00000149-1972-e252-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1060-1060-Skin-MR-iPSC1
AC CVCL_AD33
WW http://shared.eagle-i.net/i/00000149-1973-94ef-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1064-1064-Skin-MR-iPSC1
AC CVCL_AD34
WW http://shared.eagle-i.net/i/00000149-1974-6ab2-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1086-1086-Skin-MR-iPSC1
AC CVCL_AD35
WW http://shared.eagle-i.net/i/00000149-1975-2f83-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1091-1091-Skin-MR-iPSC1
AC CVCL_AD36
WW http://shared.eagle-i.net/i/00000149-1976-2e12-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1109-1109-Skin-MR-iPSC1
AC CVCL_AD37
WW http://shared.eagle-i.net/i/00000149-1977-1000-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1113-1113-Skin-MR-iPSC1
AC CVCL_AD38
WW http://shared.eagle-i.net/i/00000149-1978-15d2-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-DE-1158-1158-Skin-MR-iPSC1
AC CVCL_AD39
WW http://shared.eagle-i.net/i/00000149-1951-3c56-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1000-10006-101-Skin-mi-iPSC1
AC CVCL_AD40
WW http://shared.eagle-i.net/i/00000146-8faa-81f1-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1001-10006-102-Skin-mi-iPSC4
AC CVCL_AD41
SY iPSC102
RX PubMed=25254339;
WW http://shared.eagle-i.net/i/00000146-8faa-c4a4-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1002-10006-103-Skin-mi-iPSC4
AC CVCL_AD42
WW http://shared.eagle-i.net/i/00000146-8fab-0348-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1003-10006-104-Skin-mi-iPSC1
AC CVCL_AD43
SY iPSC104
RX PubMed=25254339;
WW http://shared.eagle-i.net/i/00000146-8fab-14b3-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1004-10006-105-Skin-mi-iPSC1
AC CVCL_AD44
WW http://shared.eagle-i.net/i/00000146-8fab-2b7a-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1005-10006-106-Skin-mi-iPSC1
AC CVCL_AD45
WW http://shared.eagle-i.net/i/00000146-8fab-3c65-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1006-10006-107-Skin-mi-iPSC1
AC CVCL_AD46
SY iPSC107
RX PubMed=25254339;
WW http://shared.eagle-i.net/i/00000146-8fab-53c7-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1007-10006-108-Skin-mi-iPSC1
AC CVCL_AD47
WW http://shared.eagle-i.net/i/00000146-8fab-8c7e-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1008-10006-109-Skin-mi-iPSC1
AC CVCL_AD48
SY iPSC109
RX PubMed=25254339;
WW http://shared.eagle-i.net/i/00000146-8fab-a483-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1011-10006-112-Skin-mi-iPSC1
AC CVCL_AD49
WW http://shared.eagle-i.net/i/00000146-8fab-dd7c-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1017-10006-113-Skin-mi-iPSC1
AC CVCL_AD50
WW http://shared.eagle-i.net/i/00000149-1920-31fb-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-MS-1019-10006-115-Skin-mi-iPSC1
AC CVCL_AD51
WW http://shared.eagle-i.net/i/00000149-1926-bebe-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C3243; Multiple sclerosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Induced pluripotent stem cell
//
ID NYSCF-PD-1030-10001.130.01-Skin-SV-iPSC7
AC CVCL_AD52
WW http://shared.eagle-i.net/i/00000146-8fd8-4a86-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2
AC CVCL_AD53
WW http://shared.eagle-i.net/i/00000146-8fda-9b0c-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD54 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC5
AC CVCL_AD54
WW http://shared.eagle-i.net/i/00000146-8fda-d117-b0a0-8e9480000000
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD53 ! NYSCF-PD-1039-10001.197.01-Skin-SV-iPSC2
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4
AC CVCL_AD55
WW http://shared.eagle-i.net/i/00000149-1936-8413-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD56 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC5
AC CVCL_AD56
WW http://shared.eagle-i.net/i/00000149-1937-4432-6df5-792d80000000
CC From: New York Stem Cell Foundation; New York; USA.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AD55 ! NYSCF-PD-1040-10001.198.01-Skin-SV-iPSC4
SX Male
CA Induced pluripotent stem cell
//
ID NYSCF1
AC CVCL_AD94
RX PubMed=21979046;
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NYSCF2
AC CVCL_AX70
RX PubMed=26982723;
CC From: New York Stem Cell Foundation; New York; USA.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID NYU08-175
AC CVCL_T592
RX PubMed=22404973;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NYU09-085
AC CVCL_T593
RX PubMed=22404973;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NYU09-203
AC CVCL_T594
RX PubMed=22404973;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NYU10-040
AC CVCL_T595
RX PubMed=22404973;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NYU10-230
AC CVCL_T596
RX PubMed=22404973;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NYUES1
AC CVCL_B869
SY NYUES 1
DR ISCR; 793
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=180
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0045.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NYUES10
AC CVCL_B876
DR ISCR; 1895
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=683
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0240.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NYUES11
AC CVCL_B877
DR ISCR; 1896
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=640
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0236.
DI NCIt; C116344; Trisomy 14
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NYUES12
AC CVCL_B878
DR ISCR; 1897
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=638
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0235.
DI NCIt; C37865; Trisomy 17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID NYUES13
AC CVCL_M246
DR ISCR; 2281
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=641
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0237.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID NYUES2
AC CVCL_B870
SY NYUES 2
DR ISCR; 794
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=181
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0046.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NYUES3
AC CVCL_B871
SY NYUES 3
DR ISCR; 795
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=182
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0047.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NYUES4
AC CVCL_B872
SY NYUES 4
DR ISCR; 796
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=183
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0048.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NYUES5
AC CVCL_B873
SY NYUES 5
DR ISCR; 797
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=184
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0049.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NYUES6
AC CVCL_B874
SY NYUES 6
DR ISCR; 798
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=185
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0050.
DI NCIt; C118631; Alpha thalassemia X-linked mental retardation syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NYUES7
AC CVCL_B875
SY NYUES 7
DR ISCR; 799
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=186
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0051.
DI NCIt; C36100; BRCA1 syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID NYUES8
AC CVCL_B879
DR ISCR; 1898
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=681
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0238.
DI NCIt; C85239; Zellweger syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NYUES9
AC CVCL_B880
DR ISCR; 1899
RX PubMed=22204497;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=682
CC From: New York University School of Medicine; New York; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0239.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Embryonic stem cell
//
ID NZM1
AC CVCL_D815
SY NZM01; NZM001
DR Cosmic; 2007642
DR Cosmic; 2141929
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Obturator lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D823 ! NZM2
SX Male
CA Cancer cell line
//
ID NZM10
AC CVCL_D816
DR Cosmic; 1660296
DR Cosmic; 2007650
RX PubMed=11216673;
RX PubMed=22475322;
RX PubMed=23658559;
CC Derived from metastatic site: Lung.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM100
AC CVCL_0B53
DR Cosmic; 2141924
RX PubMed=23755070;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM101
AC CVCL_0D60
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM102
AC CVCL_0D61
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM103
AC CVCL_0D62
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM104
AC CVCL_0D63
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM105
AC CVCL_0D64
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM106
AC CVCL_0D65
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM11
AC CVCL_D817
SY NZM011
DR Cosmic; 2007651
DR Cosmic; 2141926
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous lesion.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM12
AC CVCL_D818
DR Cosmic; 1660300
RX CelloPub=CLPUB00227;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23755070;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Small intestine.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM13
AC CVCL_D819
DR Cosmic; 2007652
RX CelloPub=CLPUB00227;
RX PubMed=11216673;
RX PubMed=23658559;
RX PubMed=23755070;
CC Derived from metastatic site: Neck nodule.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZM14
AC CVCL_D820
DR Cosmic; 2007653
RX PubMed=11216673;
RX PubMed=23658559;
CC Derived from metastatic site: Thigh skeletal muscle.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM15
AC CVCL_D821
DR Cosmic; 1660297
DR Cosmic; 2007654
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=23755070;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Subcutaneous neck nodule.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM16
AC CVCL_S436
RX CelloPub=CLPUB00227;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM17
AC CVCL_S437
SY NZM017; NZM 017
DR Cosmic; 2007655
DR Cosmic; 2141931
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM18
AC CVCL_S438
RX CelloPub=CLPUB00227;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM19
AC CVCL_D822
DR Cosmic; 2007656
RX CelloPub=CLPUB00227;
RX PubMed=20041153;
RX PubMed=23658559;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM2
AC CVCL_D823
SY NZM02
DR Cosmic; 2007643
RX CelloPub=CLPUB00227;
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Deep iliac lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D815 ! NZM1
SX Male
CA Cancer cell line
//
ID NZM20
AC CVCL_D824
SY NZM020
DR Cosmic; 2007657
DR Cosmic; 2141927
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM21
AC CVCL_S435
DR Cosmic; 2007658
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM22
AC CVCL_D825
DR Cosmic; 2007659
RX CelloPub=CLPUB00227;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM23
AC CVCL_D826
DR Cosmic; 2007660
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM24
AC CVCL_D827
DR Cosmic; 2007661
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S430 ! NZM25
CA Cancer cell line
//
ID NZM25
AC CVCL_S430
RX CelloPub=CLPUB00227;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D827 ! NZM24
CA Cancer cell line
//
ID NZM26
AC CVCL_S431
RX CelloPub=CLPUB00227;
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM27
AC CVCL_S432
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM28
AC CVCL_S433
DR Cosmic; 2007662
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM29
AC CVCL_S434
DR Cosmic; 2007663
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM3
AC CVCL_D828
SY NZM03; NZM003
DR Cosmic; 1660299
DR Cosmic; 2007644
DR Cosmic; 2406331
RX CelloPub=CLPUB00227;
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM30
AC CVCL_D829
SY NZM030
DR Cosmic; 1660292
DR Cosmic; 2007664
DR Cosmic; 2406334
RX CelloPub=CLPUB00227;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM31
AC CVCL_S439
DR Cosmic; 2007665
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM32
AC CVCL_0D28
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM33
AC CVCL_S440
DR Cosmic; 2007666
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM34
AC CVCL_D830
SY NZM034
DR Cosmic; 1660290
DR Cosmic; 2007667
DR Cosmic; 2406335
RX CelloPub=CLPUB00227;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM35
AC CVCL_S427
DR Cosmic; 2007668
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM36
AC CVCL_S428
DR Cosmic; 2007669
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM37
AC CVCL_S449
DR Cosmic; 2007670
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM38
AC CVCL_S450
DR Cosmic; 2007671
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM39
AC CVCL_S429
DR Cosmic; 2007672
RX PubMed=23658559;
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM4
AC CVCL_D831
SY NZM04; NZM004
DR Cosmic; 2007645
DR Cosmic; 2141925
RX CelloPub=CLPUB00227;
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM40
AC CVCL_D832
SY NZM040; NZM 040
DR Cosmic; 1660293
DR Cosmic; 2007673
DR Cosmic; 2406332
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM41
AC CVCL_S426
DR Cosmic; 2007674
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM42
AC CVCL_D833
DR Cosmic; 1660298
RX PubMed=20041153;
RX PubMed=22475322;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_S423 ! NZM48
CA Cancer cell line
//
ID NZM43
AC CVCL_D834
DR Cosmic; 1660291
DR Cosmic; 2007675
RX PubMed=22475322;
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM44
AC CVCL_S425
DR Cosmic; 2007676
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM45
AC CVCL_D835
DR Cosmic; 2007677
RX PubMed=20041153;
RX PubMed=23658559;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM46
AC CVCL_D836
SY NZM046
DR Cosmic; 1660294
DR Cosmic; 2007678
DR Cosmic; 2406336
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM47
AC CVCL_S424
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM48
AC CVCL_S423
DR Cosmic; 2007679
RX PubMed=23658559;
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D833 ! NZM42
CA Cancer cell line
//
ID NZM49
AC CVCL_S422
DR Cosmic; 2007680
RX PubMed=23658559;
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM5
AC CVCL_D837
SY NZM05
DR Cosmic; 2007646
RX CelloPub=CLPUB00227;
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM50
AC CVCL_S421
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM51
AC CVCL_S420
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM52
AC CVCL_D838
DR Cosmic; 1660295
RX PubMed=20041153;
RX PubMed=22475322;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM53
AC CVCL_D839
RX PubMed=20041153;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM54
AC CVCL_0D29
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM55
AC CVCL_S419
SY NZM055
DR Cosmic; 2007681
DR Cosmic; 2141921
RX PubMed=23658559;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM56
AC CVCL_S418
DR Cosmic; 2007682
RX CelloPub=CLPUB00227;
RX PubMed=23658559;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM57
AC CVCL_D840
RX PubMed=20041153;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM58
AC CVCL_D841
DR Cosmic; 2007683
RX PubMed=20041153;
RX PubMed=23658559;
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM59
AC CVCL_0B54
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM6
AC CVCL_D842
SY NZM06; NZM006
DR Cosmic; 1660289
DR Cosmic; 2007647
DR Cosmic; 2406333
RX CelloPub=CLPUB00227;
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=22475322;
RX PubMed=23658559;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Small intestine.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZM60
AC CVCL_S416
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM61
AC CVCL_S417
SY NZM061
DR Cosmic; 2007684
DR Cosmic; 2141922
RX PubMed=23658559;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM62
AC CVCL_0D26
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D27 ! NZM64
CA Cancer cell line
//
ID NZM63
AC CVCL_S441
SY NZM063
DR Cosmic; 2007685
DR Cosmic; 2141932
RX PubMed=23658559;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM64
AC CVCL_0D27
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_0D26 ! NZM62
CA Cancer cell line
//
ID NZM65
AC CVCL_0D30
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM66
AC CVCL_0D31
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM67
AC CVCL_0D32
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM68
AC CVCL_0D33
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM69
AC CVCL_0D34
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM7
AC CVCL_D843
SY NZM07; NZM007
DR Cosmic; 2007648
DR Cosmic; 2141920
RX PubMed=7999427;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM7.2
AC CVCL_D844
SY NZM07.2
RX PubMed=11216673;
RX PubMed=20041153;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D843 ! NZM7
SX Male
CA Cancer cell line
//
ID NZM7.4
AC CVCL_D845
SY NZM07.4
RX PubMed=11216673;
RX PubMed=20041153;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D843 ! NZM7
SX Male
CA Cancer cell line
//
ID NZM70
AC CVCL_0D35
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM71
AC CVCL_0C85
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM72
AC CVCL_0D36
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM73
AC CVCL_0D37
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM74
AC CVCL_0D38
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM75
AC CVCL_0D39
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM76
AC CVCL_0B51
SY NZM076
DR Cosmic; 2141928
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM77
AC CVCL_0D40
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM78
AC CVCL_0D41
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM79
AC CVCL_0D42
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM8
AC CVCL_D846
SY NZM08
RX PubMed=7718330;
RX PubMed=11216673;
CC Miscellaneous: Cell line has been lost.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM80
AC CVCL_0D43
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM81
AC CVCL_0D44
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM82
AC CVCL_0B55
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM83
AC CVCL_0D45
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM84
AC CVCL_0D46
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM85
AC CVCL_0B56
RX PubMed=23755070;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM86
AC CVCL_0B52
SY NZM086
DR Cosmic; 2141923
RX PubMed=23755070;
RX PubMed=24455489;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM87
AC CVCL_0D47
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM88
AC CVCL_0D48
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM89
AC CVCL_0D49
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM9
AC CVCL_D847
SY NZM09; NZM009
DR Cosmic; 2007649
DR Cosmic; 2141930
RX CelloPub=CLPUB00227;
RX PubMed=11216673;
RX PubMed=20041153;
RX PubMed=23658559;
RX PubMed=23755070;
RX PubMed=24455489;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID NZM90
AC CVCL_0D50
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM91
AC CVCL_0D51
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM92
AC CVCL_0D52
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM93
AC CVCL_0D53
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM94
AC CVCL_0D54
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM95
AC CVCL_0D55
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM96
AC CVCL_0D56
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM97
AC CVCL_0D57
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM98
AC CVCL_0D58
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZM99
AC CVCL_0D59
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID NZOV1
AC CVCL_D811
SY NZ-OV1
RX PubMed=7718330;
RX PubMed=21912889;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZOV10
AC CVCL_D814
RX PubMed=21912889;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZOV11
AC CVCL_D810
RX PubMed=21912889;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZOV2
AC CVCL_D812
RX PubMed=21912889;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZOV8
AC CVCL_D813
RX PubMed=21912889;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID NZP-12
AC CVCL_3759
SY National Zoological Park-12
DR CLO; CLO_0008216
DR ATCC; CRL-1921
OX NCBI_TaxID=71111; ! Crossarchus obscurus
CA Finite cell line
//
ID NZP-29
AC CVCL_3760
SY National Zoological Park-29
DR CLO; CLO_0008217
DR ATCC; CRL-1925
OX NCBI_TaxID=59534; ! Oryx dammah
CA Finite cell line
//
ID NZP-36
AC CVCL_3761
SY National Zoological Park-36
DR CLO; CLO_0008218
DR ATCC; CRL-1922
OX NCBI_TaxID=9790; ! Equus burchelli
CA Finite cell line
//
ID NZP-46
AC CVCL_6340
SY National Zoological Park-46
DR ATCC; CRL-1926
OX NCBI_TaxID=64678; ! Callosciurus notatus
CA Finite cell line
//
ID NZP-53
AC CVCL_V311
SY National Zoological Park-53
DR ATCC; CRL-1920
CC Discontinued: ATCC; CRL-1920; true.
OX NCBI_TaxID=9646; ! Ailuropoda melanoleuca
CA Finite cell line
//
ID NZP-60
AC CVCL_3762
SY National Zoological Park-60
DR CLO; CLO_0008220
DR ATCC; CRL-1924
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9482; ! Callithrix argentata
CA Finite cell line
//
ID O-342
AC CVCL_5847
DR CLS; 500305/p662_O-342
RX PubMed=1744159;
RX PubMed=2121738;
CC Doubling time: ~24 hours (PubMed=1744159).
CC Breed/subspecies: BDIX.
DI NCIt; C129858; Adenocarcinoma of the rat ovary
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID O-342/DDP
AC CVCL_5J47
RX PubMed=1744159;
RX PubMed=2121738;
CC Doubling time: ~24 hours (PubMed=1744159).
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
CC Breed/subspecies: BDIX.
DI NCIt; C129858; Adenocarcinoma of the rat ovary
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_5847 ! O-342
SX Female
CA Cancer cell line
//
ID O24B
AC CVCL_W083
DR Cosmic; 1522767
DR GEO; GSM726280
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID O9-1
AC CVCL_GS42
DR Millipore; SCC049
RX PubMed=22889333;
CC Characteristics: Neural crest cell line capable of differentiating into four cell types: osteoblasts, chondrocytes, smooth muscle cells, and glial cells.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID OA1
AC CVCL_3763
DR CLO; CLO_0008224
DR CLDB; cl3754
DR ATCC; CRL-6538
DR IZSLER; BS CL 109
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9940; ! Ovis aries
SX Female
CA Finite cell line
//
ID OA2.Sk
AC CVCL_S362
DR ATCC; CRL-6539
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6539; true.
OX NCBI_TaxID=9940; ! Ovis aries
SX Sex undetermined
CA Finite cell line
//
ID OA3.Bm
AC CVCL_S363
DR ATCC; CRL-6540
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6540; true.
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_R786 ! OA3.Lu
OI CVCL_3764 ! OA3.Ts
SX Male
CA Finite cell line
//
ID OA3.Lu
AC CVCL_R786
DR ATCC; CRL-6545
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6545; true.
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_S363 ! OA3.Bm
OI CVCL_3764 ! OA3.Ts
SX Male
CA Finite cell line
//
ID OA3.Ts
AC CVCL_3764
SY OAT-T3
DR CLO; CLO_0008225
DR ATCC; CRL-6546
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_S363 ! OA3.Bm
OI CVCL_R786 ! OA3.Lu
SX Male
CA Finite cell line
//
ID OA4.Bm
AC CVCL_3765
DR CLO; CLO_0008226
DR ATCC; CRL-6547
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6547; true.
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_R785 ! OA4.K
OI CVCL_6426 ! OA4.K/S1
OI CVCL_S364 ! OA4.Tes
SX Male
CA Finite cell line
//
ID OA4.K
AC CVCL_R785
DR ATCC; CRL-6548
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6548; true.
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_3765 ! OA4.Bm
OI CVCL_6426 ! OA4.K/S1
OI CVCL_S364 ! OA4.Tes
SX Male
CA Finite cell line
//
ID OA4.K/S1
AC CVCL_6426
DR CLO; CLO_0008227
DR ATCC; CRL-6549
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_3765 ! OA4.Bm
OI CVCL_R785 ! OA4.K
OI CVCL_S364 ! OA4.Tes
SX Male
CA Finite cell line
//
ID OA4.Tes
AC CVCL_S364
DR ATCC; CRL-6550
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6550; true.
OX NCBI_TaxID=9940; ! Ovis aries
OI CVCL_3765 ! OA4.Bm
OI CVCL_R785 ! OA4.K
OI CVCL_6426 ! OA4.K/S1
SX Male
CA Finite cell line
//
ID OACM4.1 C
AC CVCL_2249
SY OAC-M4.1 C
RX PubMed=11407472;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1843 ! OACP4 C
SX Male
CA Cancer cell line
//
ID OACM5.1 C
AC CVCL_1842
SY OAC-M5.1 C; OAC-M5.1; OACM5-1; OACM5.1; OACM5_1
DR BioSample; SAMN03473445
DR Cosmic; 1599344
DR Cosmic-CLP; 1503363
DR DSMZ; ACC-696
DR ECACC; 11012006
DR GDSC; 1503363
DR GEO; GSM1670290
RX PubMed=11407472;
RX PubMed=20075370;
RX PubMed=23795680;
RX PubMed=27397505;
CC Doubling time: ~48 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Lymph node.
ST Source(s): Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 11,12
ST D7S820: 8 (Cosmic-CLP; DSMZ)
ST D7S820: 8.2 (ECACC)
ST TH01: 6,9.3
ST TPOX: 8
ST vWA: 19,20
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OACP4 C
AC CVCL_1843
SY OAC-P4C; OACP4C; OACp4C
DR BioSample; SAMN03473391
DR Cosmic; 1599345
DR Cosmic-CLP; 1503362
DR DSMZ; ACC-704
DR ECACC; 11012005
DR GDSC; 1503362
DR GEO; GSM1670291
RX PubMed=11407472;
RX PubMed=20075370;
RX PubMed=23795680;
RX PubMed=27397505;
CC Doubling time: ~35-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Misspelling: 'OACP4CE' in PubMed=23795680.
ST Source(s): Cosmic-CLP; DSMZ; ECACC
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 12
ST D5S818: 9
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 16
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2249 ! OACM4.1 C
SX Male
CA Cancer cell line
//
ID OAD2
AC CVCL_Z080
RX PubMed=12569360;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OANC1
AC CVCL_W891
DR Cosmic; 2030752
RX PubMed=24077944;
DI NCIt; C7027; Barrett adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OAT-1975
AC CVCL_X185
SY OAT 75; Oat 75; Oat-75
RX PubMed=195719;
CC Doubling time: 24 hours (PubMed=195719).
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OAW28
AC CVCL_1614
SY OAW-28; OAW 28
DR CLO; CLO_0008228
DR EFO; EFO_0006704
DR CLDB; cl3756
DR BioSample; SAMN03472477
DR CCLE; OAW28_OVARY
DR ChEMBL-Cells; CHEMBL3308479
DR ChEMBL-Targets; CHEMBL1075553
DR Cosmic; 946360
DR Cosmic; 1707570
DR Cosmic-CLP; 946360
DR ECACC; 85101601
DR GDSC; 946360
DR GEO; GSM659383
DR GEO; GSM827435
DR GEO; GSM887464
DR GEO; GSM888544
DR GEO; GSM1374778
DR GEO; GSM1670292
RX PubMed=2653399;
RX PubMed=8795574;
RX PubMed=22460905;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'OWA28' in Cosmic 1707570.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 13
ST D18S51: 12,14
ST D19S433: 13
ST D21S11: 29
ST D2S1338: 20,23
ST D3S1358: 14,18
ST D5S818: 12
ST D7S820: 11
ST D8S1179: 11,15
ST FGA: 21,24
ST Penta D: 9
ST Penta E: 7
ST TH01: 9
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OAW42
AC CVCL_1615
SY OAW-42; OAW 42
DR CLO; CLO_0008229
DR EFO; EFO_0006705
DR CLDB; cl3757
DR BioSample; SAMN03472455
DR CCLE; OAW42_OVARY
DR ChEMBL-Cells; CHEMBL3308397
DR ChEMBL-Targets; CHEMBL1075554
DR CLS; 300304/p577_OAW-42
DR Cosmic; 688103
DR Cosmic; 910548
DR Cosmic; 1609537
DR Cosmic; 1707560
DR Cosmic-CLP; 910548
DR ECACC; 85073102
DR GDSC; 910548
DR GEO; GSM313710
DR GEO; GSM659384
DR GEO; GSM827350
DR GEO; GSM887465
DR GEO; GSM888545
DR GEO; GSM1374779
DR GEO; GSM1670293
RX PubMed=2653399;
RX PubMed=8795574;
RX PubMed=11414198;
RX PubMed=22460905;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=25230021;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: OCCP ovarian cancer cell line panel.
CC Doubling time: 40 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): CLS; Cosmic-CLP; ECACC; PubMed=25230021; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11
ST D16S539: 12,13
ST D18S51: 16,21
ST D19S433: 13,14
ST D21S11: 26
ST D2S1338: 17
ST D3S1358: 15,16
ST D5S818: 11,12
ST D7S820: 8
ST D8S1179: 13
ST FGA: 22,25
ST Penta D: 10
ST Penta E: 12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,16 (CLS; Cosmic-CLP; ECACC; PubMed=25877200)
ST vWA: 14,16 (PubMed=25230021)
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OAW42-A
AC CVCL_W125
RX PubMed=8100138;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Derived from metastatic site: Ascites.
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1615 ! OAW42
SX Female
CA Cancer cell line
//
ID ob 17
AC CVCL_S603
SY OB 17; ob17; Ob17
RX PubMed=216011;
RX PubMed=6352350;
CC Doubling time: 12.5 hours (in 10% fetal calf serum), 19 hours (in 1% fetal calf serum) (PubMed=216011).
CC Breed/subspecies: C57BL/6J ob/ob.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID OB-6
AC CVCL_D626
DR TOKU-E; 4092
RX PubMed=10412038;
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID Ob1754
AC CVCL_S606
RX PubMed=3800927;
CC Breed/subspecies: C57BL/6J ob/ob.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S603 ! ob 17
CA Spontaneously immortalized cell line
//
ID Ob1771
AC CVCL_0476
SY OB1771; Ob 1771
DR MCCL; MCC:0000374
RX PubMed=3800927;
RX PubMed=3814078;
CC Breed/subspecies: C57BL/6J ob/ob.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S603 ! ob 17
CA Spontaneously immortalized cell line
//
ID ob17MT
AC CVCL_S604
SY Ob17MT; ob17MT1
RX PubMed=6089203;
CC Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC Breed/subspecies: C57BL/6J ob/ob.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S603 ! ob 17
CA Transformed cell line
//
ID ob17PY
AC CVCL_S605
SY Ob17PY; ob17PY1
RX PubMed=6089203;
CC Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV).
CC Breed/subspecies: C57BL/6J ob/ob.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_S603 ! ob 17
CA Transformed cell line
//
ID Oba-BL
AC CVCL_W931
SY OBA-BL; OBA BL; OBA
RX PubMed=2824665;
RX PubMed=2898508;
RX PubMed=2943927;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OBC13
AC CVCL_9W25
RX PubMed=2307979;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: v-Myc.
CC Breed/subspecies: C57BL/6 x CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OBCK6
AC CVCL_U886
RX PubMed=2246327;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID OBGF400
AC CVCL_AS93
RX PubMed=18358537;
RX PubMed=19937495;
CC Transfected with: HGNC; 11730; TERT.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9823; ! Sus scrofa
SX Female
CA Telomerase immortalized cell line
//
ID OBL21
AC CVCL_9W26
SY OBL-21
RX PubMed=2307979;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: v-Myc.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OBL21A
AC CVCL_9W27
SY OBL21a; OBL 21A
RX PubMed=2307979;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: v-Myc.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9W26 ! OBL21
CA Transformed cell line
//
ID OBL24
AC CVCL_9W28
RX PubMed=2307979;
CC Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: v-Myc.
CC Breed/subspecies: CD-1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OC 314
AC CVCL_1616
SY OC-314; OC314
DR CLO; CLO_0008231
DR CCLE; OC314_OVARY
DR ChEMBL-Cells; CHEMBL3308244
DR ChEMBL-Targets; CHEMBL2366288
DR Cosmic; 909257
DR Cosmic-CLP; 909257
DR GDSC; 909257
DR GEO; GSM459736
DR GEO; GSM887466
DR GEO; GSM888546
DR GEO; GSM1670294
DR ICLC; HTL98015
RX PubMed=8690298;
RX PubMed=15677628;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (PubMed=15677628; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL98015; true.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8,9
ST D16S539: 10,11,12
ST D5S818: 10,12
ST D7S820: 11
ST TH01: 6,8
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC 315
AC CVCL_1617
SY OC-315; OC315
DR CLO; CLO_0008232
DR CCLE; OC315_OVARY
DR GEO; GSM459737
DR ICLC; HTL98013
RX PubMed=8690298;
RX PubMed=15677628;
CC Problematic cell line: Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-high) (PubMed=15677628).
CC Discontinued: ICLC; HTL98013; true.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC 316
AC CVCL_1618
SY OC-316; OC316
DR CLO; CLO_0008233
DR CCLE; OC316_OVARY
DR GEO; GSM887467
DR GEO; GSM888547
DR ICLC; HTL98014
RX PubMed=8690298;
RX PubMed=15677628;
RX PubMed=22460905;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Possibly contaminated. May be identical to OC 314 (CVCL_1616) according to STR profiling done at ICLC and to MSI data (PubMed=15677628).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Instable (MSI-high) (PubMed=15677628).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Discontinued: ICLC; HTL98014; true.
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-109
AC CVCL_GT33
RX PubMed=7947929;
RX PubMed=7959295;
CC Derived from metastatic site: Ascites.
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-109-VGH
AC CVCL_GT34
DR BCRC; 60601
RX CelloPub=CLPUB00352;
CC Derived from metastatic site: Ascites.
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-117-VGH
AC CVCL_GT35
SY VGH-OC-117
DR BCRC; 60602
RX PubMed=10592434;
RX PubMed=16138714;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-238
AC CVCL_GT36
RX PubMed=7947929;
RX PubMed=7959295;
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-3-VGH
AC CVCL_GT37
DR BCRC; 60599
RX PubMed=3455323;
CC Doubling time: 48 hours (BCRC).
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-7-NU
AC CVCL_GT38
RX PubMed=7947929;
RX PubMed=7959295;
CC Derived from metastatic site: Ascites.
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-89-VGH
AC CVCL_GT39
SY VGH-OC-89
RX CelloPub=CLPUB00350;
RX PubMed=10592434;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OC-k1
AC CVCL_D799
RX PubMed=10562438;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OC-k2
AC CVCL_D800
RX PubMed=10562438;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OC-k3
AC CVCL_D801
SY OCk3
RX PubMed=10562438;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OC-k4
AC CVCL_D802
RX PubMed=10562438;
RX PubMed=12382283;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OC/CDE 14
AC CVCL_U975
RX PubMed=7679995;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID OC/CDE 22
AC CVCL_U976
SY OC/CDE-22; OC/CDE22
DR BTO; BTO:0002198
RX PubMed=7526039;
RX PubMed=7532542;
RX PubMed=7679995;
RX PubMed=11751433;
RX PubMed=12075625;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID OC/CDE 6
AC CVCL_U977
SY OC/CDE6
RX PubMed=7526039;
RX PubMed=7532542;
RX PubMed=7679995;
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Cancer cell line
//
ID OC10B
AC CVCL_6G52
RX PubMed=9495512;
CC Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Spontaneously immortalized cell line
//
ID OC15
AC CVCL_0E97
SY OC 15
RX PubMed=988033;
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID Oc2T(VX7)
AC CVCL_S376
SY OC 2T
DR ATCC; CRL-6594
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6594; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_3470 ! Vx7
CA Cancer cell line
//
ID OC3
AC CVCL_D859
SY OC-3
DR BTO; BTO:0004006
RX PubMed=14720193;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Oc4T/cc
AC CVCL_T725
SY Oc 4T
DR ATCC; CRL-6501
RX PubMed=6500159;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6501; true.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_3470 ! Vx7
CA Cancer cell line
//
ID OCC/PI
AC CVCL_EG06
SY OCC/Permanent I
RX PubMed=27356577;
CC Derived from metastatic site: Ascites.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCC/PII
AC CVCL_EG07
SY OCC/Permanent II
RX PubMed=27356577;
CC Derived from metastatic site: Ascites.
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCC1
AC CVCL_C829
SY OCC-1
RX PubMed=2354825;
RX PubMed=23415752;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Ascites.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCCC33
AC CVCL_EI99
DR Cosmic; 1493899
RX PubMed=21381030;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCD
AC CVCL_5848
DR CLS; 400417/p2781_OCD
CC Breed/subspecies: NMRI.
DI NCIt; C22964; Osteochondroma of the mouse skeletal system
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID OCI-AML1
AC CVCL_5228
SY OCI/AML1; OCI/AML-1; OCI-AML-1; OCIAML1
DR Cosmic; 787465
DR Cosmic; 975287
DR Cosmic; 1281343
DR Cosmic; 1319544
DR Cosmic; 2306230
DR DSMZ; ACC-726
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~3-4 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,14
ST D13S317: 12,13
ST D16S539: 11
ST D5S818: 11,13
ST D7S820: 10
ST TH01: 8,9.3
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-AML1a
AC CVCL_5225
SY OCI/AML1a; OCI/AML-1a
WW http://www.cells-talk.com/index.php/page/copelibrary?key=OCI%2fAML1a
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5228 ! OCI-AML1
SX Female
CA Cancer cell line
//
ID OCI-AML2
AC CVCL_1619
SY OCI AML2; OCI-AML-2; OCI/AML-2; OCIAML2; AML-2
DR BTO; BTO:0004619
DR CLO; CLO_0008235
DR EFO; EFO_0006706
DR CLDB; cl3760
DR CLDB; cl7059
DR BioSample; SAMN03473106
DR BCRJ; 0383
DR CCLE; OCIAML2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308300
DR ChEMBL-Targets; CHEMBL2366220
DR Cosmic; 787466
DR Cosmic; 910947
DR Cosmic; 975288
DR Cosmic; 1012109
DR Cosmic; 1281344
DR Cosmic; 1319545
DR Cosmic; 1582386
DR Cosmic; 2131551
DR Cosmic; 2306231
DR Cosmic-CLP; 910947
DR DSMZ; ACC-99
DR GDSC; 910947
DR GEO; GSM482511
DR GEO; GSM887468
DR GEO; GSM888548
DR GEO; GSM1374780
DR GEO; GSM1670295
DR ICLC; HTL01010
RX PubMed=15843827;
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: 30 hours (PubMed=25984343); ~30-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 12,13
ST D18S51: 14
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 12
ST D8S1179: 12,15
ST FGA: 19,24
ST Penta D: 12
ST Penta E: 12,14
ST TH01: 6,9.3
ST TPOX: 11
ST vWA: 14,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-AML3
AC CVCL_1844
SY OCI AML3; OCI-AML-3; OCI/AML-3; OCI/AML3; OCIAML3
DR BTO; BTO:0004620
DR EFO; EFO_0006289
DR BioSample; SAMN03473107
DR CCLE; OCIAML3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787467
DR Cosmic; 975289
DR Cosmic; 1012110
DR Cosmic; 1127258
DR Cosmic; 1245831
DR Cosmic; 1319546
DR Cosmic; 1557602
DR Cosmic; 1582387
DR Cosmic; 1696140
DR Cosmic; 1779129
DR Cosmic; 2131552
DR Cosmic; 2306232
DR Cosmic-CLP; 1290455
DR DSMZ; ACC-582
DR GDSC; 1290455
DR GEO; GSM482512
DR GEO; GSM887469
DR GEO; GSM888549
DR GEO; GSM1670296
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: 28 hours (PubMed=25984343); ~35-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,13
ST D16S539: 11,13
ST D18S51: 12,18
ST D21S11: 29,30
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 9,10
ST D8S1179: 10,12
ST FGA: 22
ST Penta D: 12,13
ST Penta E: 11,13
ST TH01: 8,10
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-AML4
AC CVCL_5224
SY OCI AML4; OCI-AML-4; OCI/AML-4; OCIAML4
DR Cosmic; 787468
DR Cosmic; 975290
DR Cosmic; 1281345
DR Cosmic; 1319547
DR Cosmic; 2306233
DR DSMZ; ACC-729
RX PubMed=1715961;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~24-30 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 12
ST TH01: 7
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-AML5
AC CVCL_1620
SY OCI AML5; OCI-AML-5; OCI/AML-5; OCIAML5
DR BTO; BTO:0004621
DR CLO; CLO_0008236
DR EFO; EFO_0006707
DR BioSample; SAMN03472968
DR BioSample; SAMN03473389
DR CCLE; OCIAML5_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787469
DR Cosmic; 975291
DR Cosmic; 1012111
DR Cosmic; 1281346
DR Cosmic; 1319548
DR Cosmic; 2131553
DR Cosmic; 2306234
DR Cosmic-CLP; 1330983
DR DSMZ; ACC-247
DR GDSC; 1330983
DR GEO; GSM887470
DR GEO; GSM888550
DR GEO; GSM1374781
DR GEO; GSM1374782
DR GEO; GSM1670297
RX PubMed=16408098;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: 28 hours (PubMed=25984343); ~30-50 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11,14
ST D16S539: 11,13
ST D18S51: 15,17
ST D21S11: 28,32.2
ST D3S1358: 18
ST D5S818: 12,13
ST D7S820: 11,12
ST D8S1179: 13,14
ST FGA: 19,24
ST Penta D: 9
ST Penta E: 13,18
ST TH01: 7,9.3 (Cosmic-CLP; DSMZ)
ST TH01: 9.3 (PubMed=25877200)
ST TPOX: 8,11
ST vWA: 16,18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-AML6
AC CVCL_5226
SY OCI AML6; OCI-AML-6; OCI/AML-6; OCI/AML6; OCIAML6
DR Cosmic; 787470
DR Cosmic; 975292
DR Cosmic; 1281347
DR DSMZ; ACC-730
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~3-5 days (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10,13
ST D16S539: 9,12
ST D5S818: 11
ST D7S820: 12
ST TH01: 7,9.3
ST TPOX: 10,11
ST vWA: 17
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-AML6.2
AC CVCL_5227
SY OCI AML6.2; OCI-AML-6.2; OCI/AML-6.2
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5226 ! OCI-AML6
SX Female
CA Cancer cell line
//
ID OCI-C1p
AC CVCL_DH02
DR GEO; GSM1001406
DR GEO; GSM1001443
DR GEO; GSM1001467
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-C2p
AC CVCL_DH03
DR GEO; GSM1001415
DR GEO; GSM1001452
DR GEO; GSM1001462
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 8,13
ST D5S818: 10,12
ST D7S820: 9,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 17,18
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-C3x
AC CVCL_DH04
DR GEO; GSM1001399
DR GEO; GSM1001436
DR GEO; GSM1001459
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-C4p
AC CVCL_DH05
DR GEO; GSM1001397
DR GEO; GSM1001434
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 17
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-C5x
AC CVCL_DH06
DR GEO; GSM1001396
DR GEO; GSM1001433
DR GEO; GSM1001495
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 10,11,12
ST D16S539: 10,11,12
ST D5S818: 10,11
ST D7S820: 8,12
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 18,22
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-CSp
AC CVCL_DH07
DR GEO; GSM1001416
DR GEO; GSM1001453
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-D1p
AC CVCL_DH08
DR GEO; GSM1001408
DR GEO; GSM1001445
DR GEO; GSM1001458
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C8106; Ovarian dysgerminoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-E1p
AC CVCL_DH09
DR GEO; GSM1001400
DR GEO; GSM1001437
DR GEO; GSM1001463
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11,12
ST D7S820: 11,12
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 14,19
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-E2p
AC CVCL_DH10
DR GEO; GSM1001402
DR GEO; GSM1001439
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-E3x
AC CVCL_DH11
DR GEO; GSM1001411
DR GEO; GSM1001448
DR GEO; GSM1001468
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,10
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 8,9
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-EP1p
AC CVCL_DH12
DR GEO; GSM1001407
DR GEO; GSM1001444
DR GEO; GSM1001464
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11,14
ST D16S539: 9,11
ST D5S818: 16,17
ST D7S820: 10,13
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 16,19
DI NCIt; C7979; Ovarian endometrioid adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-Ly1
AC CVCL_1879
SY OCI-LY1; OCI-LY-1; OCI-Ly-1; Oci-Ly-1; OCI-Ly01; OCI Ly1; Ly1; LY1
DR EFO; EFO_0005907
DR Cosmic; 1134602
DR Cosmic; 1295512
DR Cosmic; 1329091
DR Cosmic; 1517641
DR Cosmic; 1541900
DR Cosmic; 1629932
DR Cosmic; 1636682
DR Cosmic; 1945183
DR Cosmic; 2276318
DR DSMZ; ACC-722
DR ENCODE; ENCBS397COL
DR ENCODE; ENCBS729LWO
DR ENCODE; ENCBS899DSB
DR ENCODE; ENCBS945KYE
DR GEO; GSM1957
DR GEO; GSM380130
DR GEO; GSM552450
DR GEO; GSM1059803
DR GEO; GSM1374783
RX PubMed=3567358;
RX PubMed=10676951;
RX PubMed=11807979;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=23292937;
RX PubMed=23699601;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~50-60 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Genome sequenced.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12
ST D16S539: 9
ST D5S818: 11,12
ST D7S820: 11
ST TH01: 9.3
ST TPOX: 8,9
ST vWA: 15,16
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly10
AC CVCL_8795
SY OCI-LY10; OCI-LY-10; OCILY-10; OCI Ly10; OCILY10; Ly10; LY10
DR EFO; EFO_0006708
DR BioSample; SAMN03470849
DR CCLE; OCILY10_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1134604
DR Cosmic; 1329095
DR Cosmic; 1486585
DR Cosmic; 1487547
DR Cosmic; 1517650
DR Cosmic; 1541905
DR Cosmic; 1550338
DR Cosmic; 1945184
DR Cosmic; 2139542
DR Cosmic; 2276333
DR Cosmic; 2437310
DR GEO; GSM1956
DR GEO; GSM2015
DR GEO; GSM2071
DR GEO; GSM552455
DR GEO; GSM1059800
DR GEO; GSM1374784
DR GEO; GSM1890029
DR GEO; GSM1890030
DR GEO; GSM1890031
DR GEO; GSM1890032
DR Lonza; 944
RX PubMed=3567358;
RX PubMed=10676951;
RX PubMed=23292937;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 13
ST D18S51: 14,18
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 13,14
ST FGA: 20
ST Penta D: 9
ST Penta E: 14,17
ST TH01: 6,7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly11
AC CVCL_M071
SY OCI-LY11
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly12
AC CVCL_8796
SY OCI-LY12; OCI-LY-12; OCI Ly12; Ly12
DR GEO; GSM1990
RX PubMed=3567358;
RX PubMed=10676951;
RX PubMed=11807979;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Transcriptome analysis.
DI NCIt; C27810; Malignant non-Hodgkin's lymphoma, cleaved cell
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly13.1
AC CVCL_M072
SY OCI-LY13.1
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8797 ! OCI-Ly13.2
SX Female
CA Cancer cell line
//
ID OCI-Ly13.2
AC CVCL_8797
SY OCI-LY13.2; OCI-LY-13.2; OCI Ly13.2; Ly13.2
DR GEO; GSM1989
RX PubMed=3567358;
RX PubMed=10676951;
RX PubMed=11807979;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_M072 ! OCI-Ly13.1
SX Female
CA Cancer cell line
//
ID OCI-Ly14
AC CVCL_M073
SY OCI-LY14
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly15
AC CVCL_M074
SY OCI-LY15
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C7873; Adult immunoblastic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly16
AC CVCL_M076
SY OCI-LY16
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Miscellaneous: Cell line has been lost (PubMed=3567358).
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly17
AC CVCL_8798
SY OCI-LY17; OCI-LY-17; OCI-Ly 17; OCI Ly17; Ly17
RX PubMed=1493476;
RX PubMed=11807979;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3466; T-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly18
AC CVCL_1880
SY OCI-LY18; OCI-LY-18; Ly18; LY18
DR BioSample; SAMN03473448
DR Cosmic; 1517651
DR Cosmic; 1541906
DR Cosmic; 1636683
DR Cosmic; 2276334
DR DSMZ; ACC-699
DR GEO; GSM380131
DR GEO; GSM552456
DR GEO; GSM1374785
RX PubMed=1311715;
RX PubMed=11807979;
RX PubMed=19278952;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~30-40 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
CC Misspelling: 'OCI-LZ18' in BioSample SAMN03473448.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 11,13
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 15,19
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly19
AC CVCL_1878
SY OCI-LY19; OCI-LY-19; OCI Ly19; OCILY-19; OCILY19; Ly19; LY19
DR EFO; EFO_0006709
DR BioSample; SAMN03471654
DR CCLE; OCILY19_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1079258
DR Cosmic; 1086340
DR Cosmic; 1295509
DR Cosmic; 1329093
DR Cosmic; 1629933
DR Cosmic; 1945185
DR Cosmic; 2276335
DR Cosmic-CLP; 1330984
DR DSMZ; ACC-528
DR GDSC; 1330984
DR GEO; GSM380132
DR GEO; GSM552460
DR GEO; GSM887471
DR GEO; GSM888551
DR GEO; GSM1374786
DR GEO; GSM1670298
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 12
ST D18S51: 14
ST D21S11: 30
ST D3S1358: 15,16
ST D5S818: 9,11
ST D7S820: 12
ST D8S1179: 14,15
ST FGA: 20,23
ST Penta D: 12,13
ST Penta E: 12,15
ST TH01: 6,7
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-Ly2
AC CVCL_8799
SY OCI-LY2; OCI-LY-2; OCI-Ly-2; OCI-Ly02; Ly2; LY2
DR Cosmic; 1176630
DR GEO; GSM1059810
RX PubMed=3567358;
RX PubMed=11807979;
RX PubMed=19358282;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly3
AC CVCL_8800
SY OCI-LY3; OCI-LY-3; Oci-Ly-3; OCILY-3; OCI-Ly03; OCI Ly3; OCILY3; Ly3; LY3
DR EFO; EFO_0006710
DR CCLE; OCILY3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 1290019
DR Cosmic; 1329094
DR Cosmic; 1486584
DR Cosmic; 1487544
DR Cosmic; 1517647
DR Cosmic; 1541901
DR Cosmic; 1548654
DR Cosmic; 1550337
DR Cosmic; 1945198
DR Cosmic; 2276329
DR Cosmic; 2437309
DR DSMZ; ACC-761
DR ENCODE; ENCBS018GXW
DR ENCODE; ENCBS757GPD
DR GEO; GSM2023
DR GEO; GSM1963
DR GEO; GSM380133
DR GEO; GSM552451
DR GEO; GSM887472
DR GEO; GSM888552
DR GEO; GSM1059799
DR GEO; GSM1374787
DR GEO; GSM1890025
DR GEO; GSM1890026
DR GEO; GSM1890027
DR GEO; GSM1890028
DR Lonza; 945
RX PubMed=3567358;
RX PubMed=10676951;
RX PubMed=11807979;
RX PubMed=19278952;
RX PubMed=22460905;
RX PubMed=23292937;
RX PubMed=23699601;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~24 hours (DSMZ).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Caution: A cell line, now termed GNE-587170 (CVCL_AT69), was mistakenly distributed by OCI to a number of groups under the designation OCI-Ly-3, the origin of that cell line is now known.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 7,9.3
ST TPOX: 8,12
ST vWA: 17
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly4
AC CVCL_8801
SY OCI-LY4; OCI-LY-4; Ly4; LY4
DR Cosmic; 1517648
DR Cosmic; 1541902
DR Cosmic; 1636684
DR Cosmic; 2276330
DR GEO; GSM380134
DR GEO; GSM552452
DR GEO; GSM1374788
RX PubMed=3567358;
RX PubMed=11807979;
RX PubMed=19278952;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly5
AC CVCL_M075
SY OCI-LY5
RX PubMed=3567358;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C7540; Small lymphocytic lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly6
AC CVCL_8802
SY OCI-LY6; OCI-LY-6; Ly6
RX PubMed=3567358;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-Ly7
AC CVCL_1881
SY OCI-LY7; OCI-LY-7; OCI-Ly-7; Oci-Ly-7; OCI-Ly07; OCILY7; Ly7; LY7
DR EFO; EFO_0006711
DR BioSample; SAMN03473439
DR Cosmic; 1329092
DR Cosmic; 1517649
DR Cosmic; 1541903
DR Cosmic; 1629934
DR Cosmic; 1945199
DR Cosmic; 2276331
DR Cosmic-CLP; 1659819
DR DSMZ; ACC-688
DR ENCODE; ENCBS006VZG
DR ENCODE; ENCBS040MJM
DR ENCODE; ENCBS121JKZ
DR ENCODE; ENCBS141AMI
DR ENCODE; ENCBS304FAI
DR ENCODE; ENCBS581USS
DR ENCODE; ENCBS699NWP
DR ENCODE; ENCBS865AAA
DR ENCODE; ENCBS866AAA
DR ENCODE; ENCBS886BJZ
DR GDSC; 1659819
DR GEO; GSM380135
DR GEO; GSM552453
DR GEO; GSM1059809
DR GEO; GSM1374789
RX PubMed=3567358;
RX PubMed=11807979;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=23292937;
RX PubMed=23699601;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.innovationbridge.com/uhn/diffuse-large-b-cell-lymphoma-cell-lines?categories=32&communities=5&forums=&organizations=&tags=
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~20-24 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Genome sequenced.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,9.3
ST TPOX: 8,12
ST vWA: 15,18
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCI-Ly8
AC CVCL_8803
SY OCI-LY8; OCI-LY-8; OCI-Ly-8; OCLY8; Ly8; LY8
DR Cosmic; 1134603
DR Cosmic; 1517603
DR Cosmic; 1541904
DR Cosmic; 1945186
DR Cosmic; 2276332
DR Cosmic; 2297007
DR GEO; GSM116023
DR GEO; GSM380136
DR GEO; GSM552454
DR GEO; GSM1374790
RX PubMed=3567358;
RX PubMed=7849311;
RX PubMed=11807979;
RX PubMed=16960149;
RX PubMed=19278952;
RX PubMed=19358282;
RX PubMed=23292937;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Array-based CGH.
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-M1
AC CVCL_2149
SY OCI M1; OCIM1
DR BTO; BTO:0004622
DR EFO; EFO_0006712
DR BioSample; SAMN03473108
DR CCLE; OCIM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 787471
DR Cosmic; 924043
DR Cosmic; 975293
DR Cosmic; 1281348
DR Cosmic; 2131554
DR Cosmic; 2306235
DR Cosmic-CLP; 1330985
DR DSMZ; ACC-529
DR GDSC; 1330985
DR GEO; GSM887473
DR GEO; GSM888553
DR GEO; GSM1374791
DR GEO; GSM1670299
RX PubMed=3166384;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12,14
ST D13S317: 11,12
ST D16S539: 9
ST D18S51: 16
ST D21S11: 31.2,33.2
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 13
ST FGA: 18,24
ST Penta D: 6,11
ST Penta E: 10,11
ST TH01: 9
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-M1p
AC CVCL_DH13
DR GEO; GSM1001395
DR GEO; GSM1001432
DR GEO; GSM1001465
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 11
ST D5S818: 16,17
ST D7S820: 11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 18
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-M2
AC CVCL_2150
SY OCI M2; OCIM2
DR BTO; BTO:0004623
DR EFO; EFO_0006713
DR BioSample; SAMN03473109
DR Cosmic; 787472
DR Cosmic; 924044
DR Cosmic; 975294
DR Cosmic; 1012112
DR Cosmic; 1245830
DR Cosmic; 1281349
DR Cosmic; 1465962
DR Cosmic; 2306236
DR DSMZ; ACC-619
DR GEO; GSM1374792
RX PubMed=3166384;
RX PubMed=16408098;
RX PubMed=25485619;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Doubling time: ~36 hours (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,14
ST D16S539: 11
ST D18S51: 16,20
ST D21S11: 29
ST D3S1358: 15
ST D5S818: 11,12
ST D7S820: 8,11
ST D8S1179: 10,13
ST FGA: 21
ST Penta D: 9
ST Penta E: 10,12
ST TH01: 8,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My1
AC CVCL_E338
SY OCI-MY1; OCI-My 1; OCIMy1
DR Cosmic; 2081400
DR Cosmic; 2367265
DR GEO; GSM1374793
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My2
AC CVCL_E337
SY OCI-MY2; OCI-My 2; OCIMy2
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My3
AC CVCL_E336
SY OCI-MY3; OCI-My 3; OCIMy3
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My4
AC CVCL_E334
SY OCI-MY4; OCI-My 4; OCIMy4
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My5
AC CVCL_E332
SY OCI-MY5; OCI-My 5; OCIMy5; MY5
DR Cosmic; 720791
DR Cosmic; 2081401
DR Cosmic; 2302416
DR Cosmic; 2367261
DR GEO; GSM1374794
RX PubMed=1912582;
RX PubMed=8943038;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
CC Omics: Transcriptome analysis.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My6
AC CVCL_E335
SY OCI-MY6; OCI-My 6; OCIMy6
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-My7
AC CVCL_E333
SY OCI-MY7; OCI-My 7; OCIMy7
DR Cosmic; 2081402
DR Cosmic; 2367266
RX PubMed=1912582;
RX PubMed=10936422;
CC From: Ontario Cancer Institute (OCI); Toronto; Canada.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCI-P1a
AC CVCL_DH14
DR GEO; GSM1001410
DR GEO; GSM1001447
DR GEO; GSM1001470
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,13
ST D16S539: 12,14
ST D5S818: 11,13
ST D7S820: 11,12
ST TH01: 9.3
ST TPOX: 11,12
ST vWA: 16,20
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P2a
AC CVCL_DH15
DR GEO; GSM1001401
DR GEO; GSM1001438
DR GEO; GSM1001466
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 9,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P3a
AC CVCL_DH16
DR GEO; GSM1001413
DR GEO; GSM1001450
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P4p
AC CVCL_DH17
DR GEO; GSM1001405
DR GEO; GSM1001442
DR GEO; GSM1001469
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P5x
AC CVCL_DH18
DR GEO; GSM1001414
DR GEO; GSM1001451
DR GEO; GSM1001457
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 10,12
ST D7S820: 12
ST TH01: 6
ST TPOX: 9,11
ST vWA: 14,17
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P6p
AC CVCL_DH19
DR GEO; GSM1001412
DR GEO; GSM1001449
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P7a
AC CVCL_DH20
DR GEO; GSM1001409
DR GEO; GSM1001446
DR GEO; GSM1001460
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 8,14
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 6,10
ST TPOX: 9,11
ST vWA: 15,18
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P8p
AC CVCL_DH21
DR GEO; GSM1001431
DR GEO; GSM1001456
RX PubMed=26080861;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 11,12
ST D16S539: 9
ST D5S818: 11,13
ST D7S820: 9,10
ST TH01: 7,9.3
ST TPOX: 9,11
ST vWA: 15,17
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCI-P9a1
AC CVCL_DH22
DR GEO; GSM1001403
DR GEO; GSM1001440
DR GEO; GSM1001461
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,13
ST D16S539: 9
ST D5S818: 11
ST D7S820: 9,14
ST TH01: 9.3
ST TPOX: 8
ST vWA: 17,19
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DH23 ! OCI-P9a2
SX Female
CA Cancer cell line
//
ID OCI-P9a2
AC CVCL_DH23
DR GEO; GSM1001418
DR GEO; GSM1001455
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Derived from metastatic site: Ascites.
DI NCIt; C7550; Ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DH22 ! OCI-P9a1
SX Female
CA Cancer cell line
//
ID OCI-U1a
AC CVCL_DH24
DR GEO; GSM1001404
DR GEO; GSM1001441
DR GEO; GSM1001494
RX PubMed=26080861;
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): PubMed=26080861
ST Amelogenin: X
ST CSF1PO: 10,14
ST D13S317: 8,10
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCL-1
AC CVCL_6701
DR BTO; BTO:0004802
RX PubMed=6420051;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCL-3
AC CVCL_6702
DR BTO; BTO:0004840
RX PubMed=19501511;
CC Miscellaneous: Not listed anywhere else than in the paper listed by BTO (PubMed=19501511).
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCM-1
AC CVCL_6934
SY OCM1; Ocm1; Ocular Choroidal Melanoma-1
DR BTO; BTO:0002736
DR Cosmic; 848327
DR Cosmic; 899892
DR Cosmic; 916139
DR Cosmic; 986617
DR Cosmic; 1320368
DR Cosmic; 1628408
DR GEO; GSM276733
RX PubMed=2722439;
RX PubMed=8621261;
RX PubMed=9154388;
RX PubMed=15714118;
RX PubMed=16772116;
RX PubMed=17487557;
RX PubMed=18689700;
RX PubMed=22236444;
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=18689700;
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9
ST D18S51: 13,18
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13
ST FGA: 21
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_3448 ! MuM-2C
SX Female
CA Cancer cell line
//
ID OCM-1A
AC CVCL_6935
SY OCM1A; OCM1a
DR CCRID; 3111C0001CCC000234
DR Cosmic; 1247863
DR GEO; GSM1082693
RX PubMed=15299072;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6934 ! OCM-1
SX Female
CA Cancer cell line
//
ID OCM-2
AC CVCL_6936
SY OCM2; Ocular Choroidal Melanoma-2
RX PubMed=2722439;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCM-3
AC CVCL_6937
SY OCM3; Ocm3; ocm-3
DR Cosmic; 916142
DR Cosmic; 1320369
DR Cosmic; 1628409
DR Cosmic; 2163831
DR ESTDAB; ESTDAB-129
RX PubMed=16772116;
RX PubMed=18689700;
RX PubMed=22236444;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Was originally thought to originate from an uveal melanoma.
CC From: Kan-Mitchell J.; Wayne State University; Detroit; USA.
ST Source(s): ESTDAB; PubMed=18689700;
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,16
ST D21S11: 28,29
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13
ST FGA: 19
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,19
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID OCM-8
AC CVCL_6938
SY OCM8; Ocm8; ocm-8
DR Cosmic; 1320370
DR Cosmic; 1628410
DR ESTDAB; ESTDAB-130
RX PubMed=16772116;
RX PubMed=18689700;
RX PubMed=22236444;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a SK-MEL-28 derivative (PubMed=22236444 and STR profile from PubMed=18689700). Was originally thought to originate from an uveal melanoma.
CC From: Kan-Mitchell J.; Wayne State University; Detroit; USA.
ST Source(s): ESTDAB; PubMed=18689700;
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11,12
ST D16S539: 9,12
ST D18S51: 12,16
ST D21S11: 28,29
ST D3S1358: 16,18
ST D5S818: 11,13
ST D7S820: 10
ST D8S1179: 13
ST FGA: 19
ST TH01: 7
ST TPOX: 8,12
ST vWA: 16,19
DI NCIt; C3510; Cutaneous melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0526 ! SK-MEL-28
SX Male
CA Cancer cell line
//
ID OCPC-2-VGH
AC CVCL_GT40
SY VGH-OCPC-2
DR BCRC; 60603
RX CelloPub=CLPUB00351;
RX PubMed=10592434;
DI NCIt; C7278; Ovarian papillary cystadenoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCRG9
AC CVCL_C395
DR RCB; AES0152
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID OCUB-1
AC CVCL_L114
RX PubMed=7873497;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUB-F
AC CVCL_3352
SY OCUB-1F; OCUBF
DR CLO; CLO_0051610
DR BioSample; SAMN03472189
DR Cosmic; 997934
DR Cosmic; 1046937
DR Cosmic; 1289404
DR GEO; GSM217593
DR GEO; GSM459705
DR GEO; GSM1661986
DR RCB; RCB0882
RX PubMed=7873497;
RX PubMed=15677628;
RX PubMed=23601657;
CC Microsatellite instability: Instable (MSI) (PubMed=15677628).
CC Omics: miRNA expression profiling.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10
ST D7S820: 9,13
ST TH01: 9
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L114 ! OCUB-1
SX Female
CA Cancer cell line
//
ID OCUB-M
AC CVCL_1621
SY OCUB-1M
DR CLO; CLO_0051609
DR BioSample; SAMN03472188
DR ChEMBL-Cells; CHEMBL3308245
DR ChEMBL-Targets; CHEMBL2366121
DR Cosmic; 909256
DR Cosmic-CLP; 909256
DR GDSC; 909256
DR GEO; GSM217594
DR GEO; GSM1661987
DR GEO; GSM1670300
DR RCB; RCB0881
RX PubMed=7873497;
RX PubMed=15677628;
RX PubMed=27397505;
CC Microsatellite instability: Instable (MSI-low) (PubMed=15677628; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10
ST D7S820: 9,13
ST TH01: 9
ST TPOX: 7,8
ST vWA: 18
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L114 ! OCUB-1
SX Female
CA Cancer cell line
//
ID OCUCh-LM1
AC CVCL_L091
SY Osaka City University Cholangiocarcinoma-Liver Metastasis 1
RX CelloPub=CLPUB00275;
RX PubMed=7880737;
CC Doubling time: 31 hours (PubMed=7880737).
CC Derived from metastatic site: Liver.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUCh-LM1-H1
AC CVCL_L092
RX PubMed=7880737;
CC Derived from metastatic site: Liver.
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L091 ! OCUCh-LM1
SX Male
CA Cancer cell line
//
ID OCUG-1
AC CVCL_3083
SY Osaka City University Gallblader-1
DR BioSample; SAMN03471651
DR GEO; GSM827176
DR JCRB; JCRB0191
RX PubMed=21533512;
CC Doubling time: 47.1 hours (PubMed=21533512).
CC Derived from metastatic site: Peritoneal effusion.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,11
ST D16S539: 9,13
ST D5S818: 10,12
ST D7S820: 10,11
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUM-1
AC CVCL_3084
SY OCUM1
DR BTO; BTO:0005918
DR EFO; EFO_0006714
DR BioSample; SAMN03471652
DR BioSample; SAMN03473049
DR CCLE; OCUM1_STOMACH
DR CGH-DB; 131-1
DR Cosmic; 1889265
DR Cosmic; 2009531
DR Cosmic; 2443794
DR Cosmic; 2484967
DR Cosmic-CLP; 1298358
DR GDSC; 1298358
DR GEO; GSM827576
DR GEO; GSM887474
DR GEO; GSM888554
DR GEO; GSM1374795
DR GEO; GSM1670301
DR JCRB; JCRB0192
RX PubMed=1961183;
RX PubMed=15723654;
RX PubMed=21115893;
RX PubMed=22460905;
RX PubMed=24807215;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 33.2 hours (PubMed=1961183).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 11
ST D18S51: 12,13
ST D21S11: 30
ST D3S1358: 17
ST D5S818: 9,10
ST D7S820: 12
ST D8S1179: 11,12
ST FGA: 19,23
ST Penta D: 12,13
ST Penta E: 12,19
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,17 (Cosmic-CLP; PubMed=25877200)
ST vWA: 14,16,17 (JCRB)
DI NCIt; C5250; Signet ring cell gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUM-11
AC CVCL_8379
RX PubMed=15546507;
CC Doubling time: 11.3 hours (PubMed=15546507).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUM-12
AC CVCL_8380
DR Cosmic; 2009532
RX PubMed=20145613;
RX PubMed=21115893;
CC Doubling time: 13.4 hours, at 190th passage (PubMed=20145613).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUM-12/Hypo
AC CVCL_8381
RX PubMed=20145613;
RX PubMed=21965748;
CC Characteristics: Hypoxia-resistant.
CC Doubling time: 24.9 hours, at 10th passage (PubMed=20145613).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8380 ! OCUM-12
SX Male
CA Cancer cell line
//
ID OCUM-2D
AC CVCL_8382
RX PubMed=7577468;
RX PubMed=21115893;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M
AC CVCL_8383
DR Cosmic; 2009533
RX PubMed=7577468;
RX PubMed=11221876;
RX PubMed=21115893;
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_8382 ! OCUM-2D
SX Female
CA Cancer cell line
//
ID OCUM-2M/5-FU
AC CVCL_IV67
SY OCUM-2M/5FU
RX PubMed=20393015;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M/DDP
AC CVCL_8384
RX PubMed=9137537;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M/GEM
AC CVCL_IV68
RX PubMed=20393015;
CC Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M/OXA
AC CVCL_IV69
RX PubMed=20393015;
RX PubMed=27157913;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M/PTX
AC CVCL_IV70
RX PubMed=20393015;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2M/SN38
AC CVCL_IV71
RX PubMed=20393015;
RX PubMed=21997136;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2MD3
AC CVCL_8385
SY OCUM-2 MD3; OCUM2-MD3
RX PubMed=8912536;
RX PubMed=11221876;
RX PubMed=21115893;
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-2MLN
AC CVCL_8386
SY OCUM-2M LN
RX PubMed=9626818;
RX PubMed=11221876;
RX PubMed=21115893;
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8383 ! OCUM-2M
SX Female
CA Cancer cell line
//
ID OCUM-6
AC CVCL_8387
DR BioSample; SAMN03151875
RX PubMed=11605005;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCUM-11 derivative (PubMed=20143388).
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8379 ! OCUM-11
SX Female
CA Cancer cell line
//
ID OCUM-7
AC CVCL_8388
RX PubMed=15254696;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 23 hours, at 25th passage (PubMed=15254696).
CC Microsatellite instability: Instable (MSI-high) (PubMed=15254696).
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUM-8
AC CVCL_8389
RX PubMed=15546507;
CC Doubling time: 13.4 hours (PubMed=15546507).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUM-8/5-FU
AC CVCL_IG91
RX PubMed=21997136;
CC Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8389 ! OCUM-8
SX Female
CA Cancer cell line
//
ID OCUM-8/GEM
AC CVCL_II63
RX PubMed=21997136;
CC Selected for resistance to: ChEBI; CHEBI:175901; Gemcitabine (Gemzar).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8389 ! OCUM-8
SX Female
CA Cancer cell line
//
ID OCUM-8/OXA
AC CVCL_IL00
RX PubMed=21997136;
RX PubMed=27157913;
CC Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8389 ! OCUM-8
SX Female
CA Cancer cell line
//
ID OCUM-8/PTX
AC CVCL_IP78
RX PubMed=21997136;
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8389 ! OCUM-8
SX Female
CA Cancer cell line
//
ID OCUM-8/SN38
AC CVCL_IV66
RX PubMed=21997136;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC Derived from metastatic site: Ascites.
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8389 ! OCUM-8
SX Female
CA Cancer cell line
//
ID OCUM-9
AC CVCL_8390
RX PubMed=21115893;
DI NCIt; C9159; Diffuse gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUP-A1
AC CVCL_CW20
RX PubMed=27067801;
CC Doubling time: 20.6 +- 1.2 hours (PubMed=27067801).
DI NCIt; C5722; Undifferentiated pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUP-A2
AC CVCL_CW21
RX PubMed=27067801;
CC Doubling time: 20.6 +- 1.4 hours (PubMed=27067801).
DI NCIt; C5722; Undifferentiated pancreatic carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OCUT-1
AC CVCL_6017
SY Ocut-1; OCUT1
DR BTO; BTO:0004846
DR Cosmic; 1152123
DR Cosmic; 1239960
DR Cosmic; 1280045
DR Cosmic; 1507372
DR Cosmic; 1533548
DR Cosmic; 1536125
DR Cosmic; 1889003
DR Cosmic; 2054107
DR Cosmic; 2319852
RX PubMed=12210034;
RX PubMed=23833040;
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUT-2
AC CVCL_9814
SY OCUT2
DR BTO; BTO:0005143
DR Cosmic; 1507373
DR Cosmic; 1533549
DR Cosmic; 1536126
DR Cosmic; 1889004
RX PubMed=15785737;
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OCUT-2C
AC CVCL_W915
SY OCUT2C
DR Cosmic; 2054108
RX PubMed=23833040;
DI NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9814 ! OCUT-2
SX Female
CA Cancer cell line
//
ID OCUU-1
AC CVCL_HF21
SY OCUU1; Osaka City University Urology-1
RX PubMed=14534724;
RX PubMed=15604581;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUU-2
AC CVCL_HF22
SY Osaka City University Urology-2
RX PubMed=14534724;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUU-3
AC CVCL_HF23
SY OCUU3; Osaka City University Urology-3
RX PubMed=15604581;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUU-4
AC CVCL_HF24
SY OCUU4; Osaka City University Urology-4
RX PubMed=14534724;
RX PubMed=15604581;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUU-5
AC CVCL_HF25
SY OCUU5; Osaka City University Urology-5
RX PubMed=14534724;
RX PubMed=15604581;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OCUU-6
AC CVCL_M615
SY Osaka City University Urology-6
RX PubMed=15859154;
CC Doubling time: 26 hours (PubMed=15859154).
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OD-3
AC CVCL_G237
SY OD3
DR CLO; CLO_0008237
DR ATCC; HB-10204
RX Patent=US5604107;
CC Monoclonal antibody target: UniProtKB; P04626; Human ERBB2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ODA
AC CVCL_0G09
SY Oda
RX PubMed=9738977;
RX PubMed=10557056;
RX PubMed=11429052;
RX PubMed=12886255;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Odense-3
AC CVCL_B019
SY Odense3; OD3; SDUe001-A
DR hPSCreg; SDUe001-A
DR ISCR; 1773
RX PubMed=18393673;
CC From: University of Southern Denmark; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Odense-4
AC CVCL_B018
SY Odense4; SDUe006-A
DR hPSCreg; SDUe006-A
CC From: University of Southern Denmark; Denmark.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Odf2-deficient F9 cells
AC CVCL_T374
DR CLO; CLO_0050540
DR RCB; RCB2808
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0259 ! F9
SX Male
CA Cancer cell line
//
ID Odour
AC CVCL_W935
DR Cosmic; 931130
RX PubMed=170370;
RX PubMed=9473234;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OE
AC CVCL_J350
SY Okayama Endometrium
DR BioSample; SAMN03151749
RX PubMed=1246601;
RX PubMed=4946504;
RX PubMed=5169552;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID OE-E6/E7
AC CVCL_F597
DR BTO; BTO:0003067
RX PubMed=11468776;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OE19
AC CVCL_1622
SY OE-19; JROECL19; JROECL 19; OEC19
DR CLO; CLO_0008238
DR EFO; EFO_0002308
DR CLDB; cl3761
DR BioSample; SAMN03471032
DR CCLE; OE19_OESOPHAGUS
DR ChEMBL-Cells; CHEMBL3308462
DR ChEMBL-Targets; CHEMBL1075555
DR Cosmic; 871232
DR Cosmic; 910079
DR Cosmic; 978854
DR Cosmic; 997860
DR Cosmic; 1175878
DR Cosmic; 1599342
DR Cosmic; 1618819
DR Cosmic; 1995600
DR Cosmic-CLP; 910079
DR DSMZ; ACC-700
DR ECACC; 96071721
DR GDSC; 910079
DR GEO; GSM827301
DR GEO; GSM887475
DR GEO; GSM888555
DR GEO; GSM1264050
DR GEO; GSM1264051
DR GEO; GSM1264052
DR GEO; GSM1264053
DR GEO; GSM1264054
DR GEO; GSM1264092
DR GEO; GSM1264093
DR GEO; GSM1264094
DR GEO; GSM1264095
DR GEO; GSM1264096
DR GEO; GSM1670302
DR IGRhCellID; OE19
RX PubMed=9010035;
RX PubMed=16364037;
RX PubMed=20075370;
RX PubMed=22460905;
RX PubMed=23795680;
RX PubMed=24083764;
RX PubMed=25070024;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 9,11
ST D16S539: 12,13
ST D18S51: 12
ST D19S433: 13
ST D21S11: 30
ST D2S1338: 18,19
ST D3S1358: 15,18
ST D5S818: 11,14
ST D7S820: 8
ST D8S1179: 13,15
ST FGA: 23,26
ST Penta D: 9
ST Penta E: 5,8
ST TH01: 8,9
ST TPOX: 8
ST vWA: 16,17 (Cosmic-CLP; ECACC)
ST vWA: 16,17,18 (DSMZ; PubMed=25877200)
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OE21
AC CVCL_2661
SY OE-21; JROECL21
DR BTO; BTO:0004489
DR CLO; CLO_0008239
DR EFO; EFO_0002309
DR CLDB; cl5089
DR BioSample; SAMN03472891
DR CCLE; OE21_OESOPHAGUS
DR Cosmic; 1339912
DR Cosmic; 1995601
DR Cosmic; 2009522
DR Cosmic-CLP; 1298359
DR ECACC; 96062201
DR GDSC; 1298359
DR GEO; GSM827300
DR GEO; GSM888556
DR GEO; GSM1374796
DR GEO; GSM1374797
DR GEO; GSM1670303
DR IGRhCellID; OE21
RX PubMed=9010035;
RX PubMed=16364037;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X (Cosmic-CLP)
ST Amelogenin: X,Y (ECACC; PubMed=25877200)
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12,13 (Cosmic-CLP; PubMed=25877200)
ST D16S539: 13 (ECACC)
ST D18S51: 19
ST D19S433: 15.2
ST D21S11: 30,31
ST D2S1338: 17,19
ST D3S1358: 17
ST D5S818: 13 (Cosmic-CLP)
ST D5S818: 12,13 (ECACC; PubMed=25877200)
ST D7S820: 11,12
ST D8S1179: 12
ST FGA: 20
ST Penta D: 11,12
ST Penta E: 12
ST TH01: 7,8 (Cosmic-CLP)
ST TH01: 8 (ECACC; PubMed=25877200)
ST TPOX: 8,11
ST vWA: 15,16 (Cosmic-CLP)
ST vWA: 16,17 (ECACC; PubMed=25877200)
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OE33
AC CVCL_0471
SY OE-33; JROECL33; JROECL 33; OEC33
DR BTO; BTO:0003541
DR CLO; CLO_0008240
DR EFO; EFO_0002310
DR MCCL; MCC:0000369
DR CLDB; cl3762
DR BioSample; SAMN03472890
DR BioSample; SAMN03473392
DR CCLE; OE33_OESOPHAGUS
DR ChEMBL-Cells; CHEMBL3308776
DR ChEMBL-Targets; CHEMBL1075556
DR Cosmic; 871233
DR Cosmic; 910549
DR Cosmic; 978855
DR Cosmic; 997861
DR Cosmic; 1175877
DR Cosmic; 1599343
DR Cosmic; 1618820
DR Cosmic-CLP; 910549
DR DSMZ; ACC-706
DR ECACC; 96070808
DR GDSC; 910549
DR GEO; GSM827306
DR GEO; GSM887476
DR GEO; GSM888557
DR GEO; GSM1670304
DR IGRhCellID; OE33
RX PubMed=9010035;
RX PubMed=20075370;
RX PubMed=22460905;
RX PubMed=23795680;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.addexbio.com/productdetail?pid=115
WW http://www.addexbio.com/productdetail?pid=121
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 33 hours (PubMed=25984343); ~30 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,11 (Cosmic-CLP; DSMZ)
ST CSF1PO: 10 (ECACC; PubMed=25877200)
ST D13S317: 14
ST D16S539: 12
ST D18S51: 12
ST D19S433: 12,15,16
ST D21S11: 29,31.2
ST D2S1338: 17,19,20
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 9,10
ST D8S1179: 10,12
ST FGA: 23
ST Penta D: 9,11
ST Penta E: 12,18
ST TH01: 7,8 (Cosmic-CLP; ECACC; PubMed=25877200)
ST TH01: 7 (DSMZ)
ST TPOX: 8,11
ST vWA: 17 (Cosmic-CLP; DSMZ; ECACC)
ST vWA: 14,17 (PubMed=25877200)
DI NCIt; C7027; Barrett adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OE47
AC CVCL_4627
SY OE-47; JROECL47
DR CLO; CLO_0008241
DR CLDB; cl3763
DR Cosmic; 997862
DR ECACC; 96061336
RX PubMed=9010035;
RX PubMed=23795680;
CC Discontinued: ECACC; 96061336; probable.
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OE50
AC CVCL_4628
SY OE-50; JROECL50
DR CLO; CLO_0008242
DR CLDB; cl3764
DR Cosmic; 997863
DR ECACC; 96061337
RX PubMed=9010035;
RX PubMed=23795680;
CC Discontinued: ECACC; 96061337; probable.
DI NCIt; C4025; Esophageal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OECM-1
AC CVCL_6782
SY OECM1; OEC-M1
DR BTO; BTO:0003964
RX PubMed=8083436;
RX PubMed=9877329;
RX PubMed=15466821;
RX PubMed=24825747;
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24825747; obtained by personal communication of Yuan T-.C.
ST Source(s): PubMed=24825747
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 10,12
ST D18S51: 16
ST D19S433: 13,14
ST D21S11: 29,32.2
ST D2S1338: 18,23
ST D3S1358: 15,18
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 15
ST FGA: 22,28
ST TH01: 9
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OEE-III
AC CVCL_A764
DR Cosmic; 1590844
RX PubMed=12089864;
RX PubMed=22038905;
CC Derived from metastatic site: Lymph node.
DI NCIt; C46099; Hereditary thyroid gland medullary carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OELE
AC CVCL_IW56
DR CCLE; OELE_OVARY
RX PubMed=25984343;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 48 hours (PubMed=25984343).
CC Omics: shRNA library screening.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Oex2054SV.4
AC CVCL_DQ96
RX PubMed=27346197;
DI NCIt; C34864; Hereditary optic atrophy
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID OF
AC CVCL_M621
DR BioSample; SAMN03151750
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID OF4374
AC CVCL_6F49
RX PubMed=12441130;
OX NCBI_TaxID=9888; ! Muntiacus muntjak
HI CVCL_6F46 ! F4374
SX Female
CA Finite cell line
//
ID OFCOL II
AC CVCL_HA27
DR BCRJ; 0192
RX PubMed=18754721;
RX PubMed=23146572;
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Finite cell line
//
ID OFP8
AC CVCL_L234
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L235 ! OKP8
SX Sex undetermined
CA Finite cell line
//
ID Ogg1 KO MEF
AC CVCL_6E74
DR Ximbio; 151846
RX PubMed=10557315;
CC Knockout cell: Method=KO mouse; MGI; MGI:1097693; Ogg1.
OX NCBI_TaxID=10090; ! Mus musculus
CA Spontaneously immortalized cell line
//
ID OGU1
AC CVCL_4664
DR CLO; CLO_0050008
DR BioSample; SAMN03471968
DR RCB; RCB2351
RX PubMed=25846106;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 12,13
ST D5S818: 12
ST D7S820: 10
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ogun
AC CVCL_V742
SY OGUN; P4-Ogun
DR CGH-DB; 9203-4
RX PubMed=4321974;
RX PubMed=5786183;
RX PubMed=6018567;
RX PubMed=6060209;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OH-1
AC CVCL_A765
SY OH1; O-H-1
DR Cosmic; 953984
RX PubMed=6108156;
RX PubMed=6120760;
RX PubMed=6264474;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OH-2 [Human lung carcinoma]
AC CVCL_X427
DR Cosmic; 953986
RX PubMed=6304739;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OH-2 [Human plasma cell myeloma]
AC CVCL_5442
RX PubMed=8062895;
RX PubMed=10936422;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=OH-2
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OH-3
AC CVCL_A766
SY OH3
DR Cosmic; 953982
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OH931
AC CVCL_M833
RX PubMed=9109944;
DI NCIt; C4247; Unclassified pleomorphic sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OHH1.K
AC CVCL_4546
DR CLO; CLO_0008243
DR CLDB; cl3765
DR ATCC; CRL-6193
DR BCRC; 60281
DR IZSLER; BS CL 123
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9872; ! Odocoileus hemionus
OI CVCL_4547 ! OHH1.Li
OI CVCL_4548 ! OHH1.Lu
OI CVCL_S205 ! OHH1.Sp
SX Male
CA Finite cell line
//
ID OHH1.Li
AC CVCL_4547
DR CLO; CLO_0008244
DR ATCC; CRL-6194
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9872; ! Odocoileus hemionus
OI CVCL_4546 ! OHH1.K
OI CVCL_4548 ! OHH1.Lu
OI CVCL_S205 ! OHH1.Sp
SX Male
CA Finite cell line
//
ID OHH1.Lu
AC CVCL_4548
SY OHH1.LU
DR CLO; CLO_0008245
DR ATCC; CRL-6195
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6195; true.
OX NCBI_TaxID=9872; ! Odocoileus hemionus
OI CVCL_4546 ! OHH1.K
OI CVCL_4547 ! OHH1.Li
OI CVCL_S205 ! OHH1.Sp
SX Male
CA Finite cell line
//
ID OHH1.Sp
AC CVCL_S205
DR ATCC; CRL-6196
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6196; true.
OX NCBI_TaxID=9872; ! Odocoileus hemionus
OI CVCL_4546 ! OHH1.K
OI CVCL_4547 ! OHH1.Li
OI CVCL_4548 ! OHH1.Lu
SX Male
CA Finite cell line
//
ID OHK [Human primary effusion lymphoma]
AC CVCL_W730
RX PubMed=11841405;
DI NCIt; C6915; Primary effusion lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OHK [Human ovarian tumor]
AC CVCL_W731
RX CelloPub=CLPUB00136;
CC Doubling time: 38.4 hours (CelloPub=CLPUB00136).
DI NCIt; C4270; Malignant ovarian Brenner tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OHN-GM
AC CVCL_A662
DR Cosmic; 787473
DR Cosmic; 975295
DR Cosmic; 1281350
RX PubMed=9266938;
DI NCIt; C8252; Therapy-related acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OHP101.B11.1
AC CVCL_J481
SY OHP 101.B11.1
DR JCRB; JCRB1316.2
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHP138.H8.1
AC CVCL_J482
SY OHP 138.H8.1
DR JCRB; JCRB1316.3
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHP1E9.3.1
AC CVCL_J483
SY OHP 1E9.3.1; 1E9
DR JCRB; JCRB1316.4
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHP4B2.2.3
AC CVCL_J484
SY OHP 4B2.2.3; 4B2
DR JCRB; JCRB1316.5
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHP57.G6.1
AC CVCL_J485
SY OHP 57.G6.1
DR JCRB; JCRB1316.1
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHP7D7.2.3
AC CVCL_J486
SY OHP 7D7.2.3; 7D7
DR JCRB; JCRB1316.6
RX PubMed=3312820;
CC Monoclonal antibody target: ChEBI; CHEBI:17252; 17alpha-hydroxyprogesterone.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OHR
AC CVCL_F503
DR Cosmic; 1358200
RX DOI=10.14930/jsma1939.51.429;
RX PubMed=2562091;
DI NCIt; C3728; Hepatoblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OHS
AC CVCL_B450
SY OHSX; OHS-50
DR Cosmic; 1529909
DR GEO; GSM879220
DR GEO; GSM1676308
DR GEO; GSM1701642
RX PubMed=3459716;
RX PubMed=8198963;
RX PubMed=19787792;
RX PubMed=21519327;
RX PubMed=26351324;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OHS-4
AC CVCL_R724
SY OHS4
RX PubMed=1860886;
CC Doubling time: 39 hours (PubMed=1860886).
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_B450 ! OHS
SX Male
CA Cancer cell line
//
ID OHSTMAM-4
AC CVCL_D244
RX DOI=10.1016/0165-4608(96)85254-X;
RX PubMed=21556597;
CC Derived from metastatic site: Submandibular mass.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OHTA
AC CVCL_4665
DR RCB; RCB0545
CC Breed/subspecies: ICR.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID OIH-1
AC CVCL_4872
DR CLO; CLO_0050990
DR BioSample; SAMN03472124
DR RCB; RCB1290
RX PubMed=9631582;
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10,12
ST D5S818: 13
ST D7S820: 11
ST TH01: 6
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C3247; Myelodysplastic syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OK
AC CVCL_0472
SY Opossum Kidney; OK-WT
DR BTO; BTO:0003069
DR CLO; CLO_0008246
DR MCCL; MCC:0000370
DR CLDB; cl3766
DR ATCC; CRL-1840
DR CCRID; 3131C0001000400020
DR CLS; 606465/p702_OK
DR ECACC; 91021202
DR KCB; KCB 200824YJ
DR TOKU-E; 2794
DR Wikidata; Q25326634
RX PubMed=566717;
RX PubMed=1802405;
WW https://en.wikipedia.org/wiki/OK_cells
WW http://fluoview.magnet.fsu.edu/gallery/cells/ok/okcells.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-497.html
CC Doubling time: 18 hours (PubMed=566717).
OX NCBI_TaxID=9267; ! Didelphis virginiana
SX Female
CA Spontaneously immortalized cell line
//
ID OK [Sheep]
AC CVCL_X339
SY Ovine Kidney
DR ATCC; CRL-6551
RX PubMed=5587551;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6551; true.
OX NCBI_TaxID=9940; ! Ovis aries
SX Male
CA Finite cell line
//
ID OK-92
AC CVCL_A767
SY OK92
DR Cosmic; 1118795
RX PubMed=15069686;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OK7A
AC CVCL_W411
SY OK7a; OK-7A
RX PubMed=7503230;
RX PubMed=7681260;
OX NCBI_TaxID=9267; ! Didelphis virginiana
HI CVCL_0472 ! OK
SX Female
CA Spontaneously immortalized cell line
//
ID OKa-C-1
AC CVCL_3085
DR JCRB; JCRB1343
DR JCRB; NIHS0544
RX PubMed=8641981;
CC Doubling time: 95 hours (PubMed=8641981).
CC Discontinued: JCRB; NIHS0544; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 11,13
ST D7S820: 10,11
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 14,18
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Okajima
AC CVCL_9815
SY OKAJIMA
DR EFO; EFO_0006715
DR BioSample; SAMN03470905
DR CGH-DB; 123-1
DR CGH-DB; 9025-4
DR Cosmic; 926117
DR Cosmic; 1001656
DR Cosmic; 1518258
DR Cosmic; 2443795
RX PubMed=3962675;
RX PubMed=15723654;
RX PubMed=24807215;
RX PubMed=25485619;
CC Doubling time: 36-40 hours (PubMed=3962675).
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 9,11
ST D18S51: 15,18
ST D19S433: 14.2
ST D21S11: 29,30
ST D2S1338: 17,24
ST D3S1358: 17,18
ST D5S818: 11
ST D7S820: 8,12
ST D8S1179: 14,15
ST FGA: 19,25
ST Penta D: 9,12
ST Penta E: 17,21
ST TH01: 8
ST TPOX: 8
ST vWA: 14
DI NCIt; C4004; Gastric adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OKB
AC CVCL_D041
SY OK/B; Opossum Kidney clone B
RX PubMed=2539748;
OX NCBI_TaxID=9267; ! Didelphis virginiana
HI CVCL_0472 ! OK
SX Female
CA Spontaneously immortalized cell line
//
ID OKB2
AC CVCL_L219
SY OK-B2
RX PubMed=1708735;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L220 ! OKF4
OI CVCL_L221 ! OKP4
SX Male
CA Finite cell line
//
ID OKB3
AC CVCL_L239
SY OK-B3
RX PubMed=1708735;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID OKB4
AC CVCL_L240
SY OK-B4
RX PubMed=1708735;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID OKB8
AC CVCL_L228
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID OKF4
AC CVCL_L220
SY OK-F4
DR GEO; GSM1431137
RX PubMed=1708735;
RX PubMed=10648628;
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L219 ! OKB2
OI CVCL_L221 ! OKP4
SX Male
CA Finite cell line
//
ID OKF4/E6E7
AC CVCL_L226
SY OKF4 E6E7
DR GEO; GSM1431132
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L220 ! OKF4
SX Male
CA Transformed cell line
//
ID OKF4/TERT-1
AC CVCL_L227
SY OKF4 TERT
DR GEO; GSM1431131
RX PubMed=10648628;
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L220 ! OKF4
SX Male
CA Telomerase immortalized cell line
//
ID OKF6
AC CVCL_L222
SY OK-F6; OKF-6; OKF/6
DR BTO; BTO:0005374
RX PubMed=10648628;
RX PubMed=22546478;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID OKF6/E6E7
AC CVCL_L223
SY OKF6 E6E7
DR GEO; GSM1431133
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L222 ! OKF6
SX Male
CA Transformed cell line
//
ID OKF6/TERT-1
AC CVCL_L224
SY OKF6 Tert 1; OKF6 TERT1
DR GEO; GSM1431135
RX PubMed=10648628;
RX PubMed=21868764;
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L222 ! OKF6
SX Male
CA Telomerase immortalized cell line
//
ID OKF6/TERT-2
AC CVCL_L225
SY OKF6 Tert 2; OKF6 TERT2
DR GEO; GSM1431130
RX PubMed=10648628;
RX PubMed=21868764;
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 12,13
ST D7S820: 8,10
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 14,15
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L222 ! OKF6
SX Male
CA Telomerase immortalized cell line
//
ID OKG12
AC CVCL_L231
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L241 ! GingF12
SX Male
CA Finite cell line
//
ID OKG4
AC CVCL_L229
SY OK-G4
RX PubMed=1708735;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L230 ! OKHP1
SX Sex undetermined
CA Finite cell line
//
ID OKH
AC CVCL_D042
SY OK/H; Opossum Kidney clone H
RX PubMed=2539748;
OX NCBI_TaxID=9267; ! Didelphis virginiana
HI CVCL_0472 ! OK
SX Female
CA Spontaneously immortalized cell line
//
ID OKHP1
AC CVCL_L230
SY OK-HP1
RX PubMed=1708735;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L229 ! OKG4
SX Sex undetermined
CA Finite cell line
//
ID OKIBA
AC CVCL_L499
RX PubMed=15767549;
CC Part of: JFCR45 cancer cell line panel.
CC From: Kawaguchi T.; Department of Pathology; Cancer Institute, Japanese Foundation for Cancer Research; Tokyo; Japan.
DI NCIt; C4911; Gastric carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OKM-2T
AC CVCL_5849
DR BTO; BTO:0004184
RX PubMed=9802061;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OKM-4
AC CVCL_C396
DR RCB; AES0050
DR RCB; RCB2199
CC Discontinued: RCB; RCB2199; true.
CC Breed/subspecies: ICR.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID OKM1
AC CVCL_G132
SY OKM 1
DR CLO; CLO_0008247
DR ATCC; CRL-8026
DR BCRC; 60271
DR ECACC; 88012702
DR KCLB; 28026
DR TKG; TKG 0432
DR Wikidata; Q27554393
RX Patent=US4364936;
RX PubMed=6342816;
CC Monoclonal antibody target: UniProtKB; P11215; Human ITGAM/CD11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKM10
AC CVCL_2G58
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OKM3
AC CVCL_2E68
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OKM5
AC CVCL_2G54
RX PubMed=3900210;
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OKM6
AC CVCL_2G55
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OKM8
AC CVCL_2G56
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OKM9
AC CVCL_2G57
RX PubMed=6342816;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Oko
AC CVCL_R798
RX PubMed=1690682;
RX PubMed=8891732;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Transformed cell line
//
ID OKO160
AC CVCL_W461
SY OKO 160
RX PubMed=10612458;
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3987 ! CGR8
SX Male
CA Embryonic stem cell
//
ID OKP
AC CVCL_D040
SY OK/P; OK-P; Opossum Kidney clone P
DR TOKU-E; 4061
RX PubMed=2539748;
OX NCBI_TaxID=9267; ! Didelphis virginiana
HI CVCL_0472 ! OK
CA Spontaneously immortalized cell line
//
ID OKP-GS
AC CVCL_L980
DR CLO; CLO_0008248
DR CLDB; cl3767
WW http://www.rccc.cytspb.rssi.ru/ecellbank/human/hokp-gs.htm
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OKP4
AC CVCL_L221
SY OK-P4
RX PubMed=1708735;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L219 ! OKB2
OI CVCL_L220 ! OKF4
SX Male
CA Finite cell line
//
ID OKP7
AC CVCL_L232
DR GEO; GSM1431136
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID OKP7/bmi1/TERT
AC CVCL_L233
SY OKP7 bmi1 TERT; OKP7 bmi Tert
DR GEO; GSM1431128
RX PubMed=25169794;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC Transfected with: HGNC; 1066; BMI1.
CC Transfected with: HGNC; 11730; TERT.
CC Omics: CNV analysis.
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L232 ! OKP7
SX Male
CA Telomerase immortalized cell line
//
ID OKP8
AC CVCL_L235
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L234 ! OFP8
SX Sex undetermined
CA Finite cell line
//
ID OKT 1
AC CVCL_2662
SY OKT1
DR CLO; CLO_0008249
DR ATCC; CRL-8000
DR ECACC; 86022705
DR NCBI_Iran; H164
DR TKG; TKG 0459
RX Patent=US4363799;
CC Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 10
AC CVCL_2663
SY OKT10
DR CLO; CLO_0008250
DR ATCC; CRL-8022
DR ECACC; 87021903
DR NCBI_Iran; H103
RX Patent=US4364935;
CC Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 11
AC CVCL_2664
SY OKT11
DR CLO; CLO_0008251
DR ATCC; CRL-8027
DR CCRID; 3131C0001000600056
DR ECACC; 86050802
DR KCLB; 28027
DR NCBI_Iran; H105
RX Patent=US4364937;
CC Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 3
AC CVCL_2665
SY OKT3
DR CLO; CLO_0008252
DR CLDB; cl5239
DR ATCC; CRL-8001
DR BCRC; 60154
DR CCRID; 3131C0001001200019
DR ECACC; 86022706
DR IZSLER; BS Hy 12
DR NCBI_Iran; H104
RX Patent=US4361549;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 4
AC CVCL_2666
SY OKT4
DR CLO; CLO_0008253
DR CLDB; cl5240
DR ATCC; CRL-8002
DR BCRC; 60235
DR ECACC; 87012602
DR IZSLER; BS Hy 13
DR KCLB; 28002
DR NCBI_Iran; H101
RX Patent=US4381295;
CC Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 5
AC CVCL_2667
SY OKT5
DR CLO; CLO_0008254
DR CLO; CLO_0008255
DR ATCC; CRL-8013
DR ATCC; CRL-8016
DR ECACC; 88070705
RX Patent=US4364932;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 6
AC CVCL_2668
SY OKT6
DR CLO; CLO_0008256
DR ATCC; CRL-8020
DR ECACC; 87091001
DR NCBI_Iran; H111
RX Patent=US4364933;
CC Monoclonal antibody target: UniProtKB; P06126; Human CD1A.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 8
AC CVCL_2669
SY OKT8
DR CLO; CLO_0008257
DR CLDB; cl5241
DR ATCC; CRL-8014
DR BCRC; 60257
DR ECACC; 85112802
DR IZSLER; BS Hy 16
DR NCBI_Iran; H102
RX Patent=US4361550;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT 9
AC CVCL_2670
SY OKT9
DR CLO; CLO_0008258
DR ATCC; CRL-8021
DR ECACC; 86022707
DR NCBI_Iran; H125
RX Patent=US4364934;
CC Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OKT1
AC CVCL_E233
RX PubMed=9826457;
DI NCIt; C7982; Cervical small cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OKT4
AC CVCL_L236
SY OK-T4
RX PubMed=1708735;
WW http://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Finite cell line
//
ID OKTr-1
AC CVCL_9U40
RX PubMed=7724618;
CC Group: Crustacean cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=29019; ! Litopenaeus stylirostris
CA Transformed cell line
//
ID OKTr-23
AC CVCL_9U41
RX PubMed=7724618;
CC Group: Crustacean cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=29019; ! Litopenaeus stylirostris
CA Transformed cell line
//
ID Oku-BL
AC CVCL_7206
RX PubMed=12219084;
RX PubMed=16051863;
RX PubMed=21088132;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OL-1
AC CVCL_U377
RX PubMed=17306496;
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Finite cell line
//
ID OL-17
AC CVCL_M762
SY Oryzias Latipes-17
RX DOI=10.1007/BF02628830;
CC Group: Fish cell line.
CC Breed/subspecies: Orange-red.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Male
CA Spontaneously immortalized cell line
//
ID OL-32
AC CVCL_M755
SY OL32; Oryzias Latipes-32
RX DOI=10.1007/BF02628830;
RX PubMed=7881826;
RX PubMed=16341864;
CC Group: Fish cell line.
CC Breed/subspecies: HB32.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Male
CA Spontaneously immortalized cell line
//
ID Olare
AC CVCL_IU25
RX PubMed=178913;
RX PubMed=4122458;
RX PubMed=4364259;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OLC2-1
AC CVCL_U897
DR RCB; AES0154
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID OLCAB-2
AC CVCL_M756
RX PubMed=16341864;
CC Group: Fish cell line.
CC Breed/subspecies: CAB.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLCAB-e1
AC CVCL_M757
SY OLCAB-e31
DR CLO; CLO_0051614
DR RCB; RCB2944
RX PubMed=16341864;
CC Group: Fish cell line.
CC Breed/subspecies: CAB.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLCAB-e21
AC CVCL_6D98
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: CAB.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLCAB-e3
AC CVCL_M758
DR CLO; CLO_0051615
DR RCB; RCB2946
RX PubMed=16341864;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: CAB.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLCAB-e31
AC CVCL_6D99
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: CAB.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLD1612
AC CVCL_F504
DR Cosmic; 1522777
DR GEO; GSM726281
RX PubMed=21642991;
CC Omics: SNP array analysis.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OLES1
AC CVCL_6F85
SY Oryzias Latipes Embryonic Stem cells 1
RX PubMed=8000476;
WW https://kaken.nii.ac.jp/d/p/06680717.ja.html
CC Group: Fish cell line.
CC Breed/subspecies: HNI.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Embryonic stem cell
//
ID OLF-124
AC CVCL_R980
SY Oryzias Latipes Fin-124
RX CelloPub=CLPUB00092;
CC Group: Fish cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLF-136
AC CVCL_3766
SY Oryzias Latipes Fin-136
DR CLO; CLO_0051619
DR RCB; RCB0184
RX CelloPub=CLPUB00092;
RX PubMed=20624282;
CC Group: Fish cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLF10.1.8
AC CVCL_6F60
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF3.3
AC CVCL_M961
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF3.6
AC CVCL_M962
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.1
AC CVCL_M963
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.3
AC CVCL_M964
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.4.1
AC CVCL_M965
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.4.2
AC CVCL_M966
SY OLF442
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.5.1
AC CVCL_M967
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.6.1
AC CVCL_M968
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.6.2
AC CVCL_M969
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.6.3
AC CVCL_M970
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLF4.7.8
AC CVCL_M971
RX PubMed=8841984;
CC Transfected with: MGI; MGI:97357; Mycn.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OLGA
AC CVCL_E797
SY Olga; OLL; TER175; TER215; TER346; TER363
DR dbMHC; 48991
DR dbMHC; 48992
DR ECACC; 88052071
DR IHW; IHW9071
DR IHW; IHW9100
DR IMGT/HLA; 11212
DR IMGT/HLA; 11213
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl71.html
WW http://bioinformatics.hsanmartino.it/ecbr/cl100.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OLGA-PH-J/92
AC CVCL_U272
SY OLGA PH J/92; OL-J/92
DR ATCC; CRL-2576
DR BioSample; SAMN03152023
RX CelloPub=CLPUB00251;
RX PubMed=11125551;
RX PubMed=21938590;
WW http://www.atcc.org/Global/FAQs/2/7/OLGAPHJ92%20OLJ92%20ATCC%20CRL2576-1052.aspx
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified. Shown not to originate from the crayfish Orconectes limosus. May have been derived from contaminating fresh water amoeba that could have been present in the neural tissue of the originating crayfish (PubMed=21938590).
CC Discontinued: ATCC; CRL-2576; true.
OX NCBI_TaxID=32644; ! Unidentified
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLGS1
AC CVCL_EJ00
DR Cosmic; 1494008
RX PubMed=21381030;
DI NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OLHdrR-e3
AC CVCL_M759
DR CLO; CLO_0051613
DR RCB; RCB2943
RX PubMed=16341864;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: HdrR.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLHE-131
AC CVCL_4873
SY Oryzias Latipes HEpatoma-131
DR CLO; CLO_0051617
DR RCB; RCB0187
RX CelloPub=CLPUB00092;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: H04C.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Cancer cell line
//
ID OLHNI-1
AC CVCL_M754
RX PubMed=16341864;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: HNI.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLHNI-2
AC CVCL_J027
DR CLO; CLO_0051616
DR RCB; RCB2942
RX PubMed=16341864;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: HNI.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLKaga-e1
AC CVCL_6D97
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: Kaga.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLKaga-e2
AC CVCL_M760
RX PubMed=16341864;
CC Group: Fish cell line.
CC Breed/subspecies: Kaga.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLME-104
AC CVCL_3767
SY Oryzias Latipes MElanoma-104
DR CLO; CLO_0051620
DR RCB; RCB0188
RX CelloPub=CLPUB00092;
RX PubMed=20624282;
CC Group: Fish cell line.
CC Breed/subspecies: HB32.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Cancer cell line
//
ID OLN-93
AC CVCL_5850
SY OLN93; OLN 93
DR BTO; BTO:0002400
DR NCBI_Iran; C617
RX PubMed=8843033;
CC Breed/subspecies: Wistar.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Spontaneously immortalized cell line
//
ID OLP6
AC CVCL_U466
DR CLO; CLO_0051390
DR RCB; RCB2864
RX PubMed=16181743;
RX PubMed=17233813;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Conditionally immortalized cell line
//
ID OLSOK-e7
AC CVCL_M761
RX PubMed=16341864;
CC Group: Fish cell line.
CC Breed/subspecies: SOK.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OLV2-1
AC CVCL_U896
DR RCB; AES0153
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID OM 3-1.1
AC CVCL_G238
SY OM3-1.1
DR CLO; CLO_0008261
DR ATCC; HB-134
CC Monoclonal antibody target: UniProtKB; P02771; Human AFP.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OM-1
AC CVCL_W941
SY OM1
DR CGH-DB; 359-2
DR ChEMBL-Cells; CHEMBL3307304
DR ChEMBL-Targets; CHEMBL614136
DR Cosmic; 930342
DR Cosmic; 1046036
DR Cosmic; 1120713
DR Cosmic; 1123044
RX PubMed=17052259;
RX PubMed=17599052;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OM-2
AC CVCL_W942
SY OM2
DR CGH-DB; 362-2
DR Cosmic; 930343
DR Cosmic; 1046037
RX PubMed=17052259;
RX PubMed=17599052;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OM1
AC CVCL_L098
DR ATCC; PTA-5938
RX Patent=US7611707;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OM10.1
AC CVCL_D567
SY OM-10.1
DR NIH-ARP; 1319-337
RX PubMed=1678437;
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0002 ! HL-60
SX Female
CA Cancer cell line
//
ID OM2
AC CVCL_L099
DR ATCC; PTA-5939
RX Patent=US7611707;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OM3
AC CVCL_L097
DR ATCC; PTA-5940
RX Patent=US7611707;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID Om37
AC CVCL_N327
SY OM37
DR ATCC; HB-8233
RX Patent=US4643971;
CC Discontinued: ATCC; HB-8233; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OM4
AC CVCL_L100
DR ATCC; PTA-5941
RX Patent=US7611707;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3412 ! P3X63Ag8U.1
CA Hybridoma
//
ID OM421
AC CVCL_X145
RX PubMed=6386741;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OM431
AC CVCL_J308
SY OM-431
RX PubMed=1531323;
RX PubMed=6386741;
RX PubMed=7641843;
RX PubMed=7573309;
RX PubMed=16772116;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OM439
AC CVCL_X146
RX PubMed=6386741;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OM443
AC CVCL_X147
RX PubMed=6386741;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OM449
AC CVCL_X148
RX PubMed=6386741;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OM464
AC CVCL_J309
RX PubMed=1531323;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OM467
AC CVCL_J310
RX PubMed=1531323;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OM482
AC CVCL_J311
RX PubMed=1531323;
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Om5
AC CVCL_N328
SY OM5
DR ATCC; HB-8270
RX Patent=US4643971;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID OM9;22
AC CVCL_A663
SY OM9:22; OM9-22; OM 9;22; OM 9:22
DR Cosmic; 996293
DR Cosmic; 998696
DR Cosmic; 999743
DR Cosmic; 1037735
DR Cosmic; 2491089
RX PubMed=9067587;
DI NCIt; C9143; Adult B acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OMA-AML-1
AC CVCL_A110
DR Cosmic; 787474
DR Cosmic; 975296
DR Cosmic; 1281351
RX PubMed=1379848;
DI NCIt; C7463; Acute myelomonocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OMA-BL-1
AC CVCL_M553
SY OMA BL-1; OMA-BL1; Oma
RX PubMed=1848532;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Omaka cells
AC CVCL_6F86
RX PubMed=810810;
CC Group: Fish cell line.
OX NCBI_TaxID=197572; ! Atule mate
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OMB3
AC CVCL_U136
RX PubMed=9185613;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID OMB4
AC CVCL_U137
DR CLO; CLO_0050330
DR RCB; RCB2048
RX PubMed=9185613;
CC Monoclonal antibody target: N-linked neutral oligosaccharides of glycoproteins.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID OMC-1 [Human cervical carcinoma]
AC CVCL_1623
DR CLO; CLO_0050939
DR BioSample; SAMN03472225
DR ChEMBL-Cells; CHEMBL3308213
DR ChEMBL-Targets; CHEMBL2366339
DR Cosmic; 949154
DR Cosmic; 1152541
DR Cosmic; 1995602
DR Cosmic-CLP; 949154
DR GDSC; 949154
DR GEO; GSM1670305
DR RCB; RCB0753
RX DOI=10.1267/ahc.26.515;
RX PubMed=2486664;
RX PubMed=2531191;
RX PubMed=3746026;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Virchow's lymph node.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 11,12
ST D5S818: 10,11
ST D7S820: 11,12
ST TH01: 6
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C4028; Cervical squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-1 [Human ovarian carcinoma]
AC CVCL_9T73
DR Cosmic; 2429302
RX CelloPub=CLPUB00307;
RX PubMed=19154404;
RX PubMed=22246397;
CC Doubling time: 24 hours (CelloPub=CLPUB00307).
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-2
AC CVCL_3353
DR CLO; CLO_0050887
DR BioSample; SAMN03471931
DR Cosmic; 1152551
DR RCB; RCB2830
RX PubMed=2624581;
CC Doubling time: 55-139 hours (PubMed=2624581).
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 8,10
ST TH01: 7
ST TPOX: 9,12
ST vWA: 15
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-3
AC CVCL_3354
SY OMC3
DR CLO; CLO_0051448
DR BioSample; SAMN03472226
DR Cosmic; 1152555
DR RCB; RCB0755
RX DOI=10.1267/ahc.26.515;
RX PubMed=2010102;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11
ST D13S317: 8
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 8
ST TH01: 7
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-4
AC CVCL_A108
SY OMC4
DR Cosmic; 877474
DR Cosmic; 1152547
RX DOI=10.1267/ahc.26.515;
RX PubMed=2531191;
RX PubMed=3598280;
CC Doubling time: 63 hours (PubMed=3598280).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-5
AC CVCL_9U42
RX DOI=10.11437/sanpunosinpo1949.40.17;
CC Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).
CC Breed/subspecies: ICR.
DI NCIt; C24077; Mouse cervical squamous cell carcinoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID OMC-6
AC CVCL_A109
DR Cosmic; 1152554
RX DOI=10.1267/ahc.26.515;
RX PubMed=3225484;
DI NCIt; C8973; Endometrioid stromal sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMC-9
AC CVCL_3355
DR CLO; CLO_0050888
DR BioSample; SAMN03471932
DR RCB; RCB2832
RX PubMed=18397474;
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,10
ST D16S539: 9,12
ST D5S818: 13
ST D7S820: 8,12
ST TH01: 8,9
ST TPOX: 8,11
ST vWA: 19,20
DI NCIt; C8973; Endometrioid stromal sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OME/CTVM21
AC CVCL_Z172
DR TCB; 3136
RX PubMed=19252822;
RX PubMed=21955214;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OME/CTVM22
AC CVCL_Z173
DR TCB; 3141
RX PubMed=19252822;
RX PubMed=21955214;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OME/CTVM24
AC CVCL_Z174
DR TCB; 3146
RX PubMed=19252822;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OME/CTVM25
AC CVCL_Z175
RX PubMed=19252822;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OME/CTVM26
AC CVCL_Z176
RX PubMed=19252822;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OME/CTVM27
AC CVCL_Z177
RX PubMed=19252822;
RX PubMed=22743047;
CC Group: Tick cell line.
OX NCBI_TaxID=6938; ! Ornithodoros moubata
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID OMEGA-E
AC CVCL_2151
SY Omega E
DR CLO; CLO_0008264
DR CLDB; cl3772
DR DSMZ; ACC-253
DR Ximbio; 151463
RX PubMed=2194165;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/o/cell-lines-detail-237.html
CC Group: Retrovirus packaging cell line.
CC Doubling time: ~20-30 hours (DSMZ).
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID OMEGA-Z
AC CVCL_DC35
RX PubMed=7153601;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMK-210
AC CVCL_L983
SY OMK210; Owl Monkey Kidney-210
RX CelloPub=CLPUB00093;
RX PubMed=76312;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9505; ! Aotus trivirgatus
SX Female
CA Spontaneously immortalized cell line
//
ID OMK-637
AC CVCL_4264
SY OMK637; OMK (637-69); OMK(637-69); Owl Monkey Kidney-637
DR CLO; CLO_0008265
DR CLO; CLO_0008266
DR CLDB; cl3773
DR ATCC; CRL-1556
DR ECACC; 90110510
RX PubMed=76312;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9505; ! Aotus trivirgatus
SX Female
CA Finite cell line
//
ID OML clone 13C
AC CVCL_6427
SY OML, clone 13C; Owl monkey 13C; Owl Monkey Lymphoblast clone 13C
DR CLO; CLO_0008267
DR ATCC; CRL-2312
RX PubMed=9081215;
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9505; ! Aotus trivirgatus
SX Female
CA Transformed cell line
//
ID OMM-1
AC CVCL_6939
SY OMM1; Omm1
DR Cosmic; 848331
DR Cosmic; 899895
DR Cosmic; 916147
DR Cosmic; 1628402
DR Cosmic; 1669126
DR Cosmic; 2036704
RX PubMed=8621261;
RX PubMed=16772116;
RX PubMed=22236444;
RX PubMed=24994677;
CC Doubling time: 34 hours (PubMed=24994677).
CC Derived from metastatic site: Hypodermis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OMM-2
AC CVCL_6940
SY OMM2
DR Cosmic; 848332
DR Cosmic; 899896
RX PubMed=8621261;
CC Derived from metastatic site: Hypodermis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OMM-3
AC CVCL_6941
SY OMM3
DR Cosmic; 848333
DR Cosmic; 899897
RX PubMed=8621261;
CC Derived from metastatic site: Hypodermis.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OMM2.2
AC CVCL_C305
SY OMM2_2; OMM 2-2
DR Cosmic; 899899
RX PubMed=9247253;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C302 ! Mel270
OI CVCL_C306 ! OMM2.3
OI CVCL_C307 ! OMM2.5
OI CVCL_C308 ! OMM2.6
SX Male
CA Cancer cell line
//
ID OMM2.3
AC CVCL_C306
SY Omm2.3; OMM2_3; OMM-2.3; OMM 2-3; OMM1.3; Omm1_3; OMM1_3
DR Cosmic; 899900
DR Cosmic; 916145
DR Cosmic; 1628397
DR Cosmic; 1669127
DR Cosmic; 2036705
RX PubMed=9247253;
RX PubMed=16772116;
RX PubMed=22236444;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
CC Derived from metastatic site: Liver.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C302 ! Mel270
OI CVCL_C305 ! OMM2.2
OI CVCL_C307 ! OMM2.5
OI CVCL_C308 ! OMM2.6
SX Male
CA Cancer cell line
//
ID OMM2.5
AC CVCL_C307
SY Omm2.5; OMM2_5; OMM1.5; Omm1_5
DR Cosmic; 916146
DR Cosmic; 1628398
RX PubMed=9247253;
RX PubMed=22236444;
RX PubMed=24994677;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
CC Doubling time: 50 hours (PubMed=24994677).
CC Derived from metastatic site: Liver.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C302 ! Mel270
OI CVCL_C305 ! OMM2.2
OI CVCL_C306 ! OMM2.3
OI CVCL_C308 ! OMM2.6
SX Male
CA Cancer cell line
//
ID OMM2.6
AC CVCL_C308
SY OMM2_6; OMM 2-6
DR Cosmic; 899901
RX PubMed=9247253;
CC From: Ksander B.; Schepens Eye Research Institute; Boston; USA.
DI NCIt; C7712; Uveal melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C302 ! Mel270
OI CVCL_C305 ! OMM2.2
OI CVCL_C306 ! OMM2.3
OI CVCL_C307 ! OMM2.5
SX Male
CA Cancer cell line
//
ID OMMT-ARK-1
AC CVCL_IW23
RX PubMed=22498937;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMMT-ARK-2
AC CVCL_IW24
RX PubMed=22498937;
DI NCIt; C9192; Ovarian carcinosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OMR5
AC CVCL_U138
DR CLO; CLO_0050331
DR RCB; RCB2049
RX PubMed=9185613;
CC Monoclonal antibody target: F1-linked neutral oligosaccharides of glycoproteins.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID OMR6
AC CVCL_U139
DR CLO; CLO_0050332
DR RCB; RCB2050
RX PubMed=9185613;
CC Monoclonal antibody target: M1-linked neutral oligosaccharides of glycoproteins.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J288 ! PAI
CA Hybridoma
//
ID OMT-1
AC CVCL_0G03
DR CGH-DB; 9027-4
RX PubMed=10570904;
DI NCIt; C9142; Adult T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OMW
AC CVCL_E798
DR dbMHC; 48993
DR ECACC; 98092903
DR IHW; IHW9058
DR IMGT/HLA; 11215
WW http://bioinformatics.hsanmartino.it/ecbr/cl58.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID On Ser
AC CVCL_U693
SY OnSer
DR ATCC; CRL-1112
CC Discontinued: ATCC; CRL-1112; true.
DI NCIt; C61255; Lesch-Nyhan syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Onc-M10
AC CVCL_0U30
DR ATCC; HB-9244
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9244; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M11
AC CVCL_0U31
DR ATCC; HB-9245
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9245; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M12
AC CVCL_0U32
DR ATCC; HB-9246
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9246; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M15
AC CVCL_0U33
DR ATCC; HB-9247
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9247; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M16
AC CVCL_0U34
DR ATCC; HB-9216
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9216; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M21
AC CVCL_0U35
SY ONC M21
DR ATCC; HB-9248
RX Patent=US5849876;
RX Patent=US6004761;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M22
AC CVCL_0U36
DR ATCC; HB-9249
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9249; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M23
AC CVCL_0U37
DR ATCC; HB-9250
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9250; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M25
AC CVCL_0U38
DR ATCC; HB-9217
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9217; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M26
AC CVCL_0U39
DR ATCC; HB-9212
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9212; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M27
AC CVCL_0U40
DR ATCC; HB-9229
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9229; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M29
AC CVCL_0U41
DR ATCC; HB-9210
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9210; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M29.41
AC CVCL_0U42
SY ONC M29.41
DR ATCC; HB-9243
RX Patent=US5849876;
RX Patent=US6004761;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0U41 ! Onc-M29
CA Hybridoma
//
ID Onc-M30
AC CVCL_0U43
DR ATCC; HB-9211
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9211; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M38
AC CVCL_0U44
SY ONC M38
DR ATCC; HB-9365
RX Patent=US5849876;
RX Patent=US6004761;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID Onc-M8
AC CVCL_0U45
DR ATCC; HB-9209
RX Patent=US5849876;
RX Patent=US6004761;
CC Discontinued: ATCC; HB-9209; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID ONCO-DG-1
AC CVCL_1882
SY ONCO-DG 1; ONCO-DG1; ONCODG1
DR BTO; BTO:0004847
DR BioSample; SAMN03151879
DR CCLE; ONCODG1_OVARY
DR DSMZ; ACC-507
RX PubMed=1381131;
RX PubMed=20143388;
RX PubMed=23839242;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OVCAR-3 derivative (PubMed=20143388). Originally thought to originate from a thyroid gland papillary carcinoma.
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~30 hours (DSMZ).
CC Derived from metastatic site: Ascites.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 17
DI NCIt; C105555; High grade ovarian serous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0465 ! OVCAR-3
SX Female
CA Cancer cell line
//
ID Onda 10
AC CVCL_3075
SY no.10; no-10; Case 6
DR BioSample; SAMN03472789
DR CGH-DB; 151-1
DR ChEMBL-Cells; CHEMBL3308838
DR ChEMBL-Targets; CHEMBL2366071
DR Cosmic; 687579
DR Cosmic; 908452
DR Cosmic; 2367541
DR Cosmic-CLP; 908452
DR GDSC; 908452
DR GEO; GSM1670281
DR IFO; IFO50368
DR JCRB; JCRB1606
DR RCB; RCB4499
RX CelloPub=CLPUB00089;
RX PubMed=3188836;
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=16232199;
RX PubMed=18415661;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 12
ST D16S539: 11
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 7,9
ST TPOX: 9
ST vWA: 17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Onda 11
AC CVCL_3076
SY no.11; no-11; Case 3
DR BioSample; SAMN03481112
DR CGH-DB; 152-1
DR ChEMBL-Cells; CHEMBL3308224
DR ChEMBL-Targets; CHEMBL2366326
DR Cosmic; 687580
DR Cosmic; 908450
DR Cosmic; 2367542
DR Cosmic-CLP; 908450
DR GDSC; 908450
DR GEO; GSM1670282
DR IFO; IFO50369
DR JCRB; JCRB1605
DR RCB; RCB4500
RX CelloPub=CLPUB00089;
RX PubMed=3188836;
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=16232199;
RX PubMed=18415661;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; JCRB
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8
ST D16S539: 11
ST D5S818: 10,11
ST D7S820: 11
ST TH01: 8
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Onda 7
AC CVCL_4W67
SY Case 9
DR JCRB; JCRB1575
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 9,13
ST D5S818: 10,12
ST D7S820: 9,10
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Onda 8
AC CVCL_4W68
SY Case 8
DR JCRB; JCRB1578
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11,12
ST D5S818: 10,12
ST D7S820: 10,12
ST TH01: 6
ST TPOX: 9
ST vWA: 18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Onda 9
AC CVCL_1R14
SY no.9; Case 10
DR JCRB; JCRB1576
RX PubMed=3188836;
RX PubMed=8878451;
RX PubMed=10551321;
RX PubMed=18415661;
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 9,12
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4W69 ! Onda 9R
SX Male
CA Cancer cell line
//
ID Onda 9R
AC CVCL_4W69
DR JCRB; JCRB1583
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 9,12
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1R14 ! Onda 9
SX Male
CA Cancer cell line
//
ID Onda 9R-B12
AC CVCL_4W70
DR JCRB; JCRB1607
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 11
ST D16S539: 11,13
ST D5S818: 9,12
ST D7S820: 12
ST TH01: 9
ST TPOX: 8,9
ST vWA: 14,18
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4W69 ! Onda 9R
SX Male
CA Cancer cell line
//
ID ONE58
AC CVCL_2671
DR CBA; CBA-0143
DR Cosmic; 1522773
DR Cosmic; 1963332
DR ECACC; 10092313
DR GEO; GSM726282
RX PubMed=1703129;
RX PubMed=21642991;
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Onesmas
AC CVCL_IU26
RX PubMed=4122458;
RX PubMed=4364259;
RX PubMed=4932228;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ONS-12
AC CVCL_S732
SY ONS12
RX PubMed=9310141;
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ONS-21
AC CVCL_5G58
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2395860;
DI NCIt; C4326; Anaplastic oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ONS-21-C2
AC CVCL_5G59
RX PubMed=2395860;
DI NCIt; C4326; Anaplastic oligodendroglioma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5G58 ! ONS-21
SX Male
CA Cancer cell line
//
ID ONS-75
AC CVCL_S733
RX PubMed=9310141;
DI NCIt; C9477; Anaplastic astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ONS-76
AC CVCL_1624
SY ONS76
DR BCRJ; 0294
DR BioSample; SAMN03470886
DR CCLE; ONS76_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308540
DR ChEMBL-Targets; CHEMBL2366068
DR Cosmic; 909248
DR Cosmic; 1995603
DR Cosmic-CLP; 909248
DR GDSC; 909248
DR GEO; GSM887477
DR GEO; GSM888558
DR GEO; GSM919364
DR GEO; GSM1670306
DR IFO; IFO50355
RX CelloPub=CLPUB00094;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2818910;
RX PubMed=22460905;
RX PubMed=22951319;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 8,13
ST D16S539: 9,10
ST D18S51: 14,21
ST D19S433: 14,15.2
ST D21S11: 29,30.3
ST D2S1338: 17,19
ST D3S1358: 15
ST D5S818: 9,10
ST D7S820: 11,12
ST D8S1179: 10
ST FGA: 24
ST Penta D: 12,13
ST Penta E: 15,16
ST TH01: 9
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ONS-81
AC CVCL_M702
RX CelloPub=CLPUB00094;
RX DOI=10.1016/B978-0-12-333530-2.50005-8;
RX PubMed=2818910;
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ONS-B11
AC CVCL_S734
RX PubMed=22951319;
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1624 ! ONS-76
SX Female
CA Cancer cell line
//
ID ONS-F11
AC CVCL_S735
RX PubMed=22951319;
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1624 ! ONS-76
SX Female
CA Cancer cell line
//
ID ONS-F8
AC CVCL_S736
RX PubMed=22951319;
CC Transformant: NCIt; C129643; Cesium-137 gamma radiation.
DI NCIt; C3222; Medulloblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1624 ! ONS-76
SX Female
CA Cancer cell line
//
ID ONSA-8
AC CVCL_M601
SY ONSA 8; ONcology SArcoma, line 8
RX PubMed=4471180;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OnyCap-1
AC CVCL_IQ33
SY Onycap-1; ONYCAP-1; ONYCAP1
RX Patent=US7303911;
CC From: Onyvax, Ltd; UK.
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032802.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4889 ! PNT2-C2
SX Male
CA Transformed cell line
//
ID OnyCap-23
AC CVCL_IQ34
SY Onycap-23; ONYCAP-23; Onycap23; ONYCAP23; Ony-Cap 23
RX Patent=US7303911;
CC From: Onyvax, Ltd; UK.
CC Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 00032801.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Caution: Was originally thought to arise from the ascitic fluid of a prostate carcinoma patient and described as such in patent application GB008032.5 from Jan. 4, 2000.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4889 ! PNT2-C2
SX Male
CA Transformed cell line
//
ID OOS [Dog osteosarcoma]
AC CVCL_L369
RX PubMed=9673952;
CC Doubling time: 45.0 +- 0.5 hours (PubMed=9673952).
CC Breed/subspecies: Maltese.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OOS [Human B-cell IHW]
AC CVCL_1M75
SY GM06827
DR CLO; CLO_0036521
DR Coriell; GM06827
RX PubMed=6417008;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID OP-1
AC CVCL_DG77
SY OP1
DR Cosmic; 1524811
DR GEO; GSM236800
DR GEO; GSM236836
RX PubMed=8142640;
RX PubMed=9446662;
DI NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OP-9S
AC CVCL_HC57
DR ATCC; PTA-10785
RX Patent=US9121008;
RX PubMed=15650053;
CC Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC Doubling time: 58-72 hours; slow-growing derivative of OP9.
CC Discontinued: ATCC; PTA-10785; probable.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4398 ! OP9
CA Stromal cell line
//
ID OP-9S/LMJSN
AC CVCL_HC58
RX Patent=US9121008;
RX PubMed=15650053;
CC Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC Doubling time: 58-72 hours; slow-growing derivative of OP9.
CC Transfected with: MGI; MGI:1098270; Jag2.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HC57 ! OP-9S
CA Stromal cell line
//
ID OP42
AC CVCL_D676
DR BCRJ; 0193
RX PubMed=7561035;
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID OP9
AC CVCL_4398
SY OP-9
DR BTO; BTO:0003295
DR CLO; CLO_0008268
DR ATCC; CRL-2749
DR BCRC; 60566
DR BCRJ; 0309
DR CCRID; 3131C0001000300017
DR RCB; RCB1124
RX PubMed=8066449;
RX PubMed=8990620;
RX PubMed=23469264;
RX PubMed=28176856;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=op9
CC Characteristics: Does not produce Csf1 (M-CSF) due to a mutation in the gene.
CC Characteristics: Used as feeder cells for the differentiation of ES cells and iPS cells into hematopoietic cells.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
CA Stromal cell line
//
ID OP9/G
AC CVCL_B217
DR CLO; CLO_0050190
DR RCB; RCB2121
DR RCB; RCB2924
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Discontinued: RCB; RCB2121; true.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4398 ! OP9
CA Stromal cell line
//
ID OP9/G-DLL1
AC CVCL_B218
DR CLO; CLO_0050191
DR RCB; RCB2122
DR RCB; RCB2925
CC Transfected with: MGI; MGI:104659; Dll1.
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Discontinued: RCB; RCB2122; true.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4398 ! OP9
CA Stromal cell line
//
ID OP9/N
AC CVCL_B219
DR CLO; CLO_0050189
DR RCB; RCB2123
DR RCB; RCB2926
CC Transfected with: HGNC; 7809; NGFR.
CC Discontinued: RCB; RCB2123; true.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4398 ! OP9
CA Stromal cell line
//
ID OP9/N-DLL1
AC CVCL_B220
DR CLO; CLO_0050188
DR RCB; RCB2124
DR RCB; RCB2927
CC Transfected with: HGNC; 7809; NGFR.
CC Transfected with: MGI; MGI:104659; Dll1.
CC Discontinued: RCB; RCB2124; true.
CC Breed/subspecies: (C57BL/6 x C3H) F2-op/op.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4398 ! OP9
CA Stromal cell line
//
ID OPA1-null MEFs
AC CVCL_L694
DR ATCC; CRL-2995
CC Knockout cell: Method=KO mouse; MGI:1921393; Opa1.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OpC-109
AC CVCL_T723
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=8597; ! Heterodon platirhinos
CA Spontaneously immortalized cell line
//
ID OpC-115
AC CVCL_T722
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=35024; ! Crotalus horridus
OI CVCL_T718 ! OpC-89
OI CVCL_T719 ! OpC-90
OI CVCL_T720 ! OpC-91
OI CVCL_T721 ! OpC-94
SX Male
CA Spontaneously immortalized cell line
//
ID OpC-80
AC CVCL_T717
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=165023; ! Lampropeltis getula nigrita
CA Spontaneously immortalized cell line
//
ID OpC-89
AC CVCL_T718
SY C-89
RX PubMed=4347028;
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=35024; ! Crotalus horridus
OI CVCL_T719 ! OpC-90
OI CVCL_T720 ! OpC-91
OI CVCL_T721 ! OpC-94
OI CVCL_T722 ! OpC-115
SX Male
CA Cancer cell line
//
ID OpC-90
AC CVCL_T719
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=35024; ! Crotalus horridus
OI CVCL_T718 ! OpC-89
OI CVCL_T720 ! OpC-91
OI CVCL_T721 ! OpC-94
OI CVCL_T722 ! OpC-115
SX Male
CA Spontaneously immortalized cell line
//
ID OpC-91
AC CVCL_T720
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=35024; ! Crotalus horridus
OI CVCL_T718 ! OpC-89
OI CVCL_T719 ! OpC-90
OI CVCL_T721 ! OpC-94
OI CVCL_T722 ! OpC-115
SX Male
CA Spontaneously immortalized cell line
//
ID OpC-94
AC CVCL_T721
RX PubMed=4795513;
CC Group: Reptilian cell line.
OX NCBI_TaxID=35024; ! Crotalus horridus
OI CVCL_T718 ! OpC-89
OI CVCL_T719 ! OpC-90
OI CVCL_T720 ! OpC-91
OI CVCL_T722 ! OpC-115
SX Male
CA Spontaneously immortalized cell line
//
ID OPC1
AC CVCL_HP89
SY Osteoblastic Precursor Cell line 1
RX PubMed=10491220;
WW https://www.abmgood.com/Immortalized-Osteoprecursor-Cells-(OPC1)-T0230.html
CC Doubling time: 1.8 days (PubMed=10491220).
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pMx-1-SV40T].
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID OPCA-iPSC1
AC CVCL_L661
SY OPCA-iPS1
DR ISCR; 1985
RX PubMed=22301348;
CC From: Guangzhou Medical College; China.
DI NCIt; C82341; Spinocerebellar ataxia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L662 ! OPCA-iPSC2
OI CVCL_L663 ! OPCA-iPSC3
SX Female
CA Induced pluripotent stem cell
//
ID OPCA-iPSC2
AC CVCL_L662
SY OPCA-iPS2
DR ISCR; 1986
RX PubMed=22301348;
CC From: Guangzhou Medical College; China.
DI NCIt; C82341; Spinocerebellar ataxia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L661 ! OPCA-iPSC1
OI CVCL_L663 ! OPCA-iPSC3
SX Female
CA Induced pluripotent stem cell
//
ID OPCA-iPSC3
AC CVCL_L663
SY OPCA-iPS3
DR ISCR; 1987
RX PubMed=22301348;
CC From: Guangzhou Medical College; China.
DI NCIt; C82341; Spinocerebellar ataxia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_L661 ! OPCA-iPSC1
OI CVCL_L662 ! OPCA-iPSC2
SX Female
CA Induced pluripotent stem cell
//
ID OPCN-1
AC CVCL_5566
SY OPCN 1; OPCN1
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5569 ! OPCT-1
SX Male
CA Transformed cell line
//
ID OPCN-2
AC CVCL_5567
SY OPCN 2; OPCN2
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5570 ! OPCT-2
SX Male
CA Transformed cell line
//
ID OPCN-3
AC CVCL_5568
SY OPCN 3; OPCN3
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5571 ! OPCT-3
SX Male
CA Transformed cell line
//
ID OPCT-1
AC CVCL_5569
SY OPCT 1; OPCT1
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5566 ! OPCN-1
SX Male
CA Transformed cell line
//
ID OPCT-2
AC CVCL_5570
SY OPCT 2; OPCT2
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5567 ! OPCN-2
SX Male
CA Transformed cell line
//
ID OPCT-3
AC CVCL_5571
SY OPCT 3; OPCT3
RX CelloPub=CLPUB00242;
WW http://www.asterandbio.com/biospecimens/human-tissue-derived-products/cell-lines/
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5568 ! OPCN-3
SX Male
CA Transformed cell line
//
ID OPL-1
AC CVCL_X743
RX PubMed=8690530;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OPL-2
AC CVCL_X744
RX PubMed=8690530;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OPL-3
AC CVCL_X745
RX PubMed=14556658;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OPL-4
AC CVCL_X746
RX PubMed=14556658;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OPL-5
AC CVCL_X747
RX PubMed=14556658;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OPL-7
AC CVCL_X748
RX PubMed=14556658;
RX PubMed=17488335;
RX PubMed=18079737;
DI NCIt; C45691; Pyothorax-associated lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OPM-1
AC CVCL_5210
SY OPM1
DR Cosmic; 720768
DR Cosmic; 2081431
DR Cosmic; 2367299
RX PubMed=3926660;
RX PubMed=10087940;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1625 ! OPM-2
SX Female
CA Cancer cell line
//
ID OPM-2
AC CVCL_1625
SY OPM2
DR BTO; BTO:0005919
DR CLO; CLO_0008269
DR EFO; EFO_0006716
DR CLDB; cl3774
DR BioSample; SAMN03473240
DR CCLE; OPM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CGH-DB; 36-1
DR CGH-DB; 9158-4
DR ChEMBL-Cells; CHEMBL3308883
DR ChEMBL-Targets; CHEMBL2366353
DR Cosmic; 720767
DR Cosmic; 735529
DR Cosmic; 759901
DR Cosmic; 759907
DR Cosmic; 760390
DR Cosmic; 760403
DR Cosmic; 909249
DR Cosmic; 1889515
DR Cosmic; 2081432
DR Cosmic; 2302417
DR Cosmic; 2367300
DR Cosmic; 2391792
DR Cosmic-CLP; 909249
DR DSMZ; ACC-50
DR GDSC; 909249
DR GEO; GSM143336
DR GEO; GSM290303
DR GEO; GSM887478
DR GEO; GSM888559
DR GEO; GSM1374799
DR GEO; GSM1670307
RX PubMed=3926660;
RX PubMed=8943038;
RX PubMed=10087940;
RX PubMed=10583232;
RX PubMed=10936422;
RX PubMed=15215163;
RX PubMed=16956823;
RX PubMed=17171682;
RX PubMed=18700954;
RX PubMed=19306352;
RX PubMed=21173094;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 50 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 13,14
ST D21S11: 30,33.2
ST D3S1358: 15,18
ST D5S818: 13
ST D7S820: 12
ST D8S1179: 10,13
ST FGA: 20,21
ST Penta D: 9
ST Penta E: 12,21
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_5210 ! OPM-1
SX Female
CA Cancer cell line
//
ID OPM-2/BTZ
AC CVCL_4V72
SY OPM2/BTZ
RX PubMed=20555361;
CC Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1625 ! OPM-2
SX Female
CA Cancer cell line
//
ID OPM-3
AC CVCL_M529
RX PubMed=9858236;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OPMDCl2
AC CVCL_6B29
RX PubMed=22040608;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C84942; Oculopharyngeal muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID Or De
AC CVCL_3322
DR CLO; CLO_0008270
DR CLDB; cl3775
DR ATCC; CRL-1366
DR BioSample; SAMN03471358
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 11,12
ST D16S539: 9,12
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,7
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C125698; Ehlers-Danlos syndrome, type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID ORL-115
AC CVCL_S690
RX PubMed=17273794;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ORL-136
AC CVCL_S691
RX PubMed=17273794;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ORL-48
AC CVCL_S692
DR Cosmic; 2296300
RX PubMed=17273794;
RX PubMed=25275298;
CC Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC Omics: Deep exome analysis.
ST Source(s): PubMed=25275298
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 11,13
ST D18S51: 14
ST D21S11: 29,32.2
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 11
ST D8S1179: 12,15
ST FGA: 24,25
ST Penta D: 9,11
ST Penta E: 7,18
ST TH01: 6,9
ST TPOX: 11
ST vWA: 19
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ORMES-1
AC CVCL_2U86
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-10
AC CVCL_2U95
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-11
AC CVCL_2U96
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-12
AC CVCL_2U97
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-13
AC CVCL_2U98
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-14
AC CVCL_2U99
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-15
AC CVCL_2V00
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-16
AC CVCL_2V01
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-17
AC CVCL_2V02
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-18
AC CVCL_2V03
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-2
AC CVCL_2U87
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-3
AC CVCL_2U88
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-4
AC CVCL_2U89
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-5
AC CVCL_2U90
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-6
AC CVCL_2U91
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-7
AC CVCL_2U92
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Male
CA Embryonic stem cell
//
ID ORMES-8
AC CVCL_2U93
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORMES-9
AC CVCL_2U94
RX PubMed=16741224;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9544; ! Macaca mulatta
SX Female
CA Embryonic stem cell
//
ID ORS [Goat]
AC CVCL_IR22
SY Outer Root Sheath
RX PubMed=22105552;
CC Doubling time: ~52 hours (PubMed=22105552).
CC Breed/subspecies: Jining Grey.
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Finite cell line
//
ID ORS [Human Ewing sarcoma]
AC CVCL_U565
DR Cosmic; 2250465
RX PubMed=25223734;
CC From: Delattre O.; Institut Curie; Paris; France.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID ORS-Pop-93
AC CVCL_Z460
SY Pop 1
RX PubMed=8826086;
RX PubMed=22358547;
CC Group: Insect cell line.
CC Doubling time: 40 hours, at 50th passage (PubMed=8826086).
OX NCBI_TaxID=192464; ! Phthorimaea operculella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-93 Pop 2
AC CVCL_Z461
SY Pop 2; ORS-Pop-2
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
HI CVCL_Z460 ! ORS-Pop-93
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-93 Pop 3
AC CVCL_Z462
SY Pop 3; ORS-Pop-3
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
HI CVCL_Z460 ! ORS-Pop-93
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-93 Pop 4
AC CVCL_Z463
SY Pop 4; ORS-Pop-4
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
HI CVCL_Z460 ! ORS-Pop-93
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-93 Pop cl 1A
AC CVCL_Z464
SY Pop cl 1A
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
HI CVCL_Z460 ! ORS-Pop-93
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-93 Pop cl 2B
AC CVCL_Z465
SY Pop cl 2B
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
HI CVCL_Z460 ! ORS-Pop-93
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-94A
AC CVCL_Z466
SY Pop A
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
OI CVCL_Z467 ! ORS-Pop-94B
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-94B
AC CVCL_Z467
SY Pop B
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
OI CVCL_Z466 ! ORS-Pop-94A
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORS-Pop-95
AC CVCL_Z468
SY Pop 95
RX PubMed=9338147;
RX PubMed=22358547;
CC Group: Insect cell line.
OX NCBI_TaxID=192464; ! Phthorimaea operculella
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ORT
AC CVCL_N815
DR Cosmic; 1656045
RX PubMed=15274292;
RX PubMed=22426987;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS 179
AC CVCL_FA10
SY OS-179
RX PubMed=15026342;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS 187
AC CVCL_1R50
SY OS-187; OS187
DR BioSample; SAMN03151646
RX PubMed=15026342;
RX PubMed=18483362;
RX PubMed=24046071;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HCT 15 derivative (PubMed=24046071). Was originally thought to originate from an osteosarcoma.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0292 ! HCT 15
SX Male
CA Cancer cell line
//
ID OS 99-1
AC CVCL_F502
SY OS99-1
RX PubMed=18247100;
RX PubMed=20309879;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Os Te
AC CVCL_3323
DR CLO; CLO_0008272
DR ATCC; CRL-1262
DI NCIt; C26837; Osteogenesis imperfecta
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID OS-1
AC CVCL_S988
RX PubMed=16035505;
DI NCIt; C40439; Ovarian small cell carcinoma, hypercalcemic type
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS-A
AC CVCL_0C23
DR Cosmic; 2239090
RX PubMed=7736387;
RX PubMed=9559344;
RX PubMed=9815546;
CC Derived from metastatic site: Subcutaneous.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS-P2/HTLV-I
AC CVCL_1T58
SY OS-P2
DR NIH-ARP; 1393-338
CC Characteristics: HTLV-1 producing cell line.
CC Doubling time: ~6 days (NIH-ARP).
CC Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID OS-RC-2
AC CVCL_1626
SY RC-2
DR BTO; BTO:0002403
DR CLO; CLO_0050889
DR BioSample; SAMN03472222
DR CCLE; OSRC2_KIDNEY
DR CCRID; 3111C0001CCC000292
DR CCRID; 3131C0001000700040
DR ChEMBL-Cells; CHEMBL3308274
DR ChEMBL-Targets; CHEMBL2366188
DR Cosmic; 909250
DR Cosmic-CLP; 909250
DR GDSC; 909250
DR GEO; GSM1670310
DR KCB; KCB 200779YJ
DR RCB; RCB0735
RX PubMed=4008433;
RX PubMed=14534724;
RX PubMed=15604581;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 8,12
ST D16S539: 11
ST D5S818: 11,12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OS1 [Human lung carcinoma]
AC CVCL_Z602
RX PubMed=1325431;
RX PubMed=2161815;
RX PubMed=8075973;
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OS1 [Human osteosarcoma]
AC CVCL_F864
RX PubMed=2823272;
RX PubMed=19746444;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS1-CLS
AC CVCL_5851
DR CLS; 500369/p620_OS1-CLS
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Sex undetermined
CA Cancer cell line
//
ID OS10
AC CVCL_Z611
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS15
AC CVCL_Z612
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS17
AC CVCL_Z613
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS18A
AC CVCL_Z614
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS2 [Human lung carcinoma]
AC CVCL_Z603
RX PubMed=1325431;
RX PubMed=2161815;
RX PubMed=8075973;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z604 ! OS2-RA
SX Female
CA Cancer cell line
//
ID OS2 [Human osteosarcoma]
AC CVCL_F865
RX PubMed=2823272;
RX PubMed=19746444;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS2-RA
AC CVCL_Z604
SY OS2RA; OS2-R
RX PubMed=1325431;
RX PubMed=8075973;
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z603 ! OS2 [Human lung carcinoma]
SX Female
CA Cancer cell line
//
ID OS2.4
AC CVCL_L370
SY OS2_4
DR GEO; GSM1974796
RX PubMed=9585065;
RX PubMed=21801068;
RX PubMed=27197945;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Cancer cell line
//
ID OS2.4/Doxo
AC CVCL_L371
RX PubMed=17916018;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_L370 ! OS2.4
CA Cancer cell line
//
ID OS2000
AC CVCL_D881
RX PubMed=12898310;
RX PubMed=19818766;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS3 [Human lung carcinoma]
AC CVCL_Z605
RX PubMed=1325431;
RX PubMed=2161815;
RX PubMed=8075973;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z606 ! OS3-R5
CA Cancer cell line
//
ID OS3 [Human osteosarcoma]
AC CVCL_F866
DR Cosmic; 1077282
RX PubMed=2823272;
RX PubMed=19746444;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OS3 [Mouse adrenocortical tumor]
AC CVCL_5F73
RX PubMed=4311571;
RX PubMed=6270152;
RX PubMed=7588376;
RX PubMed=15541570;
WW http://www.flintbox.com/public/project/2353
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0585 ! Y1
SX Male
CA Cancer cell line
//
ID OS3 [Mouse brain]
AC CVCL_U177
DR CLO; CLO_0050904
DR RCB; RCB1593
CC Breed/subspecies: C3H/HeN.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID OS3-HGPRT-
AC CVCL_5G25
RX PubMed=198663;
RX PubMed=6270152;
CC Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC Breed/subspecies: LAF1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5F73 ! OS3 [Mouse adrenocortical tumor]
SX Male
CA Cancer cell line
//
ID OS3-R5
AC CVCL_Z606
SY OS3R5
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z605 ! OS3 [Human lung carcinoma]
CA Cancer cell line
//
ID OSA-80
AC CVCL_EQ73
SY OSA 80
DR GDSC; 1298361
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSA344
AC CVCL_6264
SY OSA-344
DR BTO; BTO:0004885
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS4
AC CVCL_Z607
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS5
AC CVCL_Z608
RX PubMed=8075973;
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS6
AC CVCL_Z609
RX PubMed=1325431;
RX PubMed=12569360;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OS7
AC CVCL_Z610
RX PubMed=1325431;
RX PubMed=8075973;
RX PubMed=12569360;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSC-1 [Human esophageal squamous cell carcinoma]
AC CVCL_E312
SY OSC1
RX PubMed=9216685;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSC-1 [Human tongue squamous cell carcinoma]
AC CVCL_HF91
RX PubMed=7703799;
CC Doubling time: 38.6 hours (PubMed=7703799).
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-19
AC CVCL_3086
SY OSC19; Osc19
DR BioSample; SAMN03471655
DR Cosmic; 1120701
DR Cosmic-CLP; 1298362
DR GDSC; 1298362
DR GEO; GSM1670308
DR JCRB; JCRB0198
RX CelloPub=CLPUB00244;
RX CelloPub=CLPUB00295;
RX CelloPub=CLPUB00296;
RX PubMed=19123955;
RX PubMed=21868764;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): Cosmic-CLP; JCRB; PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9,12
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14 (Cosmic-CLP; JCRB)
ST vWA: 14,18 (PubMed=21868764)
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-19LN1
AC CVCL_AT74
SY OSC19LN1
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3086 ! OSC-19
SX Male
CA Cancer cell line
//
ID OSC-19LN2
AC CVCL_AT75
SY OSC19LN2
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AT74 ! OSC-19LN1
SX Male
CA Cancer cell line
//
ID OSC-19LN3
AC CVCL_AT76
SY OSC19LN3
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AT75 ! OSC-19LN2
SX Male
CA Cancer cell line
//
ID OSC-19LN4
AC CVCL_AT77
SY OSC19LN4
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AT76 ! OSC-19LN3
SX Male
CA Cancer cell line
//
ID OSC-19LN5
AC CVCL_AT78
SY OSC19LN5
RX PubMed=21868764;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): PubMed=21868764
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D5S818: 10,13
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 11
ST vWA: 14,18
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_AT77 ! OSC-19LN4
SX Male
CA Cancer cell line
//
ID OSC-2 [Human esophageal squamous cell carcinoma]
AC CVCL_E313
SY OSC2
RX PubMed=9216685;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSC-2 [Human gingival squamous cell carcinoma]
AC CVCL_HF92
RX PubMed=7703799;
CC Doubling time: 22.9 hours (PubMed=7703799).
CC Derived from metastatic site: Submandibular lymph node.
DI NCIt; C129857; Gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OSC-20
AC CVCL_3087
SY OSC20
DR Cosmic; 1120702
DR Cosmic; 1995604
DR Cosmic-CLP; 1240196
DR GDSC; 1240196
DR GEO; GSM827220
DR GEO; GSM1670309
DR JCRB; JCRB0197
RX CelloPub=CLPUB00095;
RX CelloPub=CLPUB00244;
RX PubMed=19123955;
RX PubMed=27397505;
CC Doubling time: 27.4 hours, at 35th passage (CelloPub=CLPUB00095).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Derived from metastatic site: Cervical lymph node.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 8
ST D16S539: 9,13
ST D5S818: 13
ST D7S820: 10
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 18
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OSC-3
AC CVCL_HF93
RX PubMed=7703799;
CC Doubling time: 31.3 hours (PubMed=7703799).
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C129857; Gingival squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-30
AC CVCL_A399
SY OSC30
DR Cosmic; 1120703
RX CelloPub=CLPUB00244;
RX PubMed=19123955;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSC-4
AC CVCL_HF94
SY OSC4
DR Cosmic; 2546838
RX PubMed=7703799;
RX PubMed=17325662;
CC Doubling time: 21.2 hours (PubMed=7703799).
CC Derived from metastatic site: Submandibular lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-40
AC CVCL_A400
SY OSC40
RX CelloPub=CLPUB00244;
RX PubMed=19123955;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSC-5
AC CVCL_HF95
SY OSC5
DR Cosmic; 2546839
RX PubMed=7703799;
RX PubMed=17325662;
CC Doubling time: 32.5 hours (PubMed=7703799).
CC Derived from metastatic site: Submandibular lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OSC-6
AC CVCL_HF96
SY OSC6
DR Cosmic; 2546840
RX PubMed=7703799;
RX PubMed=17325662;
CC Doubling time: 39.4 hours (PubMed=7703799).
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-7
AC CVCL_HF97
RX PubMed=7703799;
CC Doubling time: 54.7 hours (PubMed=7703799).
CC Derived from metastatic site: Cervical lymph node.
DI NCIt; C102872; Pharyngeal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSC-70
AC CVCL_A401
SY OSC70
DR Cosmic; 1120704
RX CelloPub=CLPUB00244;
RX PubMed=19123955;
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSCA-00
AC CVCL_0A73
SY OSCA-0
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-01
AC CVCL_L372
SY OSCA-1
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-02
AC CVCL_0A74
SY OSCA-2
RX PubMed=21621658;
RX PubMed=23365669;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-03
AC CVCL_0A75
SY OSCA-3
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-04
AC CVCL_L388
SY OSCA-4
RX PubMed=21621658;
RX PubMed=23311495;
CC Caution: Indicated as being from a male dog in PubMed=21621658 and a female dog in PubMed=23311495.
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-05
AC CVCL_0A76
SY OSCA-5
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-06M
AC CVCL_L397
SY ACCR-6; OSCA-6
RX PubMed=21621658;
RX PubMed=23311495;
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Rhodesian Ridgeback.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-07
AC CVCL_0A77
SY OSCA-7
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-08
AC CVCL_L405
SY OSCA-8; OSA8
DR GEO; GSM1974797
RX PubMed=20594083;
RX PubMed=21621658;
RX PubMed=23311495;
RX PubMed=23365669;
RX PubMed=27197945;
RX PubMed=27257868;
WW https://www.kerafast.com/product/2246/canine-osteosarcoma-cell-line-osca-8
CC Part of: FACC canine tumor cell line panel.
CC Doubling time: ~22 hours (Kerafast).
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-09
AC CVCL_0A78
SY OSCA-9
RX PubMed=21621658;
CC Breed/subspecies: Irish Setter.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-10
AC CVCL_0A79
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-109
AC CVCL_L373
RX PubMed=23311495;
CC Breed/subspecies: Irish Setter.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-11M
AC CVCL_L374
SY OSCA-11
RX PubMed=21621658;
RX PubMed=23311495;
CC Caution: Indicated as being from a female dog in PubMed=21621658 and a male dog in PubMed=23311495.
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-12
AC CVCL_L375
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-13
AC CVCL_0A80
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-14
AC CVCL_0A81
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-15
AC CVCL_0A82
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-16
AC CVCL_L376
SY OSCA-16M; OSA16
RX PubMed=20594083;
RX PubMed=21621658;
RX PubMed=23311495;
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-17
AC CVCL_L377
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-18
AC CVCL_0A83
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-19
AC CVCL_L378
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-20
AC CVCL_L379
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-21
AC CVCL_L380
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-22
AC CVCL_L381
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-23
AC CVCL_L382
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-24
AC CVCL_0A84
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-25
AC CVCL_L383
SY OSCA 25
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-26
AC CVCL_0A85
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-27
AC CVCL_0A86
RX PubMed=21621658;
CC Breed/subspecies: Irish Setter.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-28
AC CVCL_0A87
RX PubMed=21621658;
CC Breed/subspecies: Greyhound.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-29
AC CVCL_L384
RX PubMed=21621658;
RX PubMed=23311495;
RX PubMed=23365669;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-30
AC CVCL_L385
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: German Shepherd.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-31
AC CVCL_0A88
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-32
AC CVCL_L386
SY OSCA 32; OSA32
RX PubMed=20594083;
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Pyrenean mountain dog.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-33
AC CVCL_L387
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-35
AC CVCL_0A89
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-36
AC CVCL_0A90
SY OSA36
RX PubMed=20594083;
RX PubMed=21621658;
CC Breed/subspecies: Doberman Pinscher.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-37
AC CVCL_0A91
RX PubMed=21621658;
CC Breed/subspecies: Greyhound.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-38
AC CVCL_0A92
RX PubMed=21621658;
CC Breed/subspecies: Pyrenean mountain dog.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-39
AC CVCL_0A93
RX PubMed=21621658;
CC Breed/subspecies: Great Dane.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-40
AC CVCL_L389
RX PubMed=21621658;
RX PubMed=23311495;
RX PubMed=23365669;
WW https://www.kerafast.com/product/2248/canine-osteosarcoma-cell-line-osca-40
CC Doubling time: ~22 hours (Kerafast).
CC Breed/subspecies: Saint Bernard.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-41
AC CVCL_L390
SY OSCA 41
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Alaskan Malamute.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-42
AC CVCL_0A94
RX PubMed=21621658;
CC Breed/subspecies: Pyrenean mountain dog.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-43
AC CVCL_0A95
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-44
AC CVCL_0A96
RX PubMed=21621658;
CC Breed/subspecies: Leonberger.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-45
AC CVCL_L391
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Irish Setter.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-46
AC CVCL_0A97
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-47
AC CVCL_0A98
RX PubMed=21621658;
CC Breed/subspecies: Irish Setter.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-48
AC CVCL_0A99
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-49
AC CVCL_0B00
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-50
AC CVCL_L392
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-51
AC CVCL_0B01
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-52
AC CVCL_0B02
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-53M
AC CVCL_0B03
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-54
AC CVCL_0B04
RX PubMed=21621658;
CC Breed/subspecies: Boxer.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-55
AC CVCL_L393
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Borzoi.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-56
AC CVCL_L394
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-57
AC CVCL_L395
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-58
AC CVCL_0B05
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-59
AC CVCL_L396
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-60
AC CVCL_L398
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Mastiff.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-61
AC CVCL_0B06
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-62
AC CVCL_0B17
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-63
AC CVCL_0B07
RX PubMed=21621658;
CC Breed/subspecies: Scottish Deerhound.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-64M
AC CVCL_0B08
RX PubMed=21621658;
CC Derived from metastatic site: Not specified.
CC Breed/subspecies: Rhodesian Ridgeback.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-65
AC CVCL_0B09
RX PubMed=21621658;
CC Breed/subspecies: American Bulldog.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-66
AC CVCL_0B10
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-67
AC CVCL_L399
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Mastiff.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-68
AC CVCL_0B11
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-69
AC CVCL_0B12
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-70
AC CVCL_0B13
RX PubMed=21621658;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-71
AC CVCL_L400
RX PubMed=21621658;
RX PubMed=23311495;
RX PubMed=23365669;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-72
AC CVCL_0B14
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-73
AC CVCL_L401
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-74
AC CVCL_0B15
RX PubMed=21621658;
CC Breed/subspecies: Doberman Pinscher.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-75
AC CVCL_L402
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Golden Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-76
AC CVCL_0B16
RX PubMed=21621658;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-77
AC CVCL_L403
RX PubMed=21621658;
RX PubMed=23311495;
CC Breed/subspecies: Malinois.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-78
AC CVCL_L404
RX PubMed=21621658;
RX PubMed=23311495;
RX PubMed=23365669;
WW https://www.kerafast.com/product/2249/canine-osteosarcoma-cell-line-osca-78
CC Doubling time: ~22 hours (Kerafast).
CC Breed/subspecies: German Shepherd.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-84
AC CVCL_L406
RX PubMed=23311495;
CC Breed/subspecies: Rottweiler.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-96
AC CVCL_L407
RX PubMed=23311495;
CC Breed/subspecies: Mastiff.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCA-98
AC CVCL_L408
RX PubMed=23311495;
CC Breed/subspecies: Labrador Retriever.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OSCA-99
AC CVCL_L409
RX PubMed=23311495;
CC Breed/subspecies: Labrador Retriever mix.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID OSCAR
AC CVCL_B020
SY INSERMe001-A; INSRMe001-A
DR hPSCreg; INSRMe001-A
WW http://www.agence-biomedecine.fr/IMG/pdf/inserm_oscar.pdf
CC From: INSERM; France.
CC Registration: French Agence de la Biomedecine; FE08-088-L1.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Embryonic stem cell
//
ID OSCC-3
AC CVCL_L894
SY OSCC3
DR Cosmic; 2550366
RX PubMed=8686749;
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSCC-BD
AC CVCL_2H27
RX PubMed=26234610;
CC Omics: Proteome analysis.
DI NCIt; C129863; Oral dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1180 ! DOK
SX Male
CA Cancer cell line
//
ID OSE10 sv
AC CVCL_6703
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OSE2a sv
AC CVCL_6704
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6705 ! OSE2b sv
SX Female
CA Transformed cell line
//
ID OSE2b sv
AC CVCL_6705
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_6704 ! OSE2a sv
SX Female
CA Transformed cell line
//
ID OSE2b-2 sv
AC CVCL_6706
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6705 ! OSE2b sv
SX Female
CA Transformed cell line
//
ID OSE4 sv
AC CVCL_6707
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OSE6 sv
AC CVCL_6708
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OSE7 sv
AC CVCL_6709
RX PubMed=11277643;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSVori-8-16].
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID OSHU-1
AC CVCL_M604
RX PubMed=6931250;
DI NCIt; C2946; Chondrosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID OSQ1
AC CVCL_Z081
RX PubMed=12569360;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSrb/N-M
AC CVCL_IP67
RX PubMed=10077219;
CC Doubling time: 84.7 hours (PubMed=10077219).
CC Miscellaneous: Patient suffered from bilateral retinoblastoma at infancy.
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID OSRGa
AC CVCL_4459
SY OSRGA
DR BTO; BTO:0003967
RX PubMed=15894525;
CC Transformant: NCIt; C129639; Cerium-144 beta radiation.
CC Breed/subspecies: Sprague-Dawley.
DI NCIt; C60487; Rat osteosarcoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Cancer cell line
//
ID OSS
AC CVCL_1B46
SY Ovarian Somatic Sheath
DR EFO; EFO_0005835
DR DGRC; 190
DR ENCODE; ENCBS977DNJ
RX PubMed=17056713;
RX PubMed=24434506;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_1B45 ! fGS/OSS
SX Female
CA Spontaneously immortalized cell line
//
ID OST
AC CVCL_8399
DR BioSample; SAMN03151751
DR ChEMBL-Cells; CHEMBL3307563
DR ChEMBL-Targets; CHEMBL614210
DR RCB; RCB0454
RX PubMed=12645653;
RX PubMed=15150091;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC Discontinued: RCB; RCB0454; true.
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID OST 10 PT
AC CVCL_W923
SY OST10T
DR Cosmic; 2053615
RX PubMed=24190505;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OST 7 PT
AC CVCL_W924
SY OST7T
DR Cosmic; 2053621
RX PubMed=24190505;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OST 8 PT
AC CVCL_W925
SY OST8T
DR Cosmic; 2053622
RX PubMed=24190505;
DI NCIt; C9145; Osteosarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID OSU-CLL
AC CVCL_Y382
RX PubMed=24130782;
CC Doubling time: ~50 hours (PubMed=24130782).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
DI NCIt; C3163; Chronic lymphocytic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_IV04 ! OSU-NB
SX Male
CA Transformed cell line
//
ID OSU-NB
AC CVCL_IV04
RX PubMed=24130782;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Transcriptome analysis.
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Y382 ! OSU-CLL
SX Male
CA Transformed cell line
//
ID OSU1
AC CVCL_6428
SY 57.Thy
DR CLO; CLO_0008273
DR ATCC; CRL-6178
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6178; true.
OX NCBI_TaxID=9685; ! Felis catus
SX Sex undetermined
CA Finite cell line
//
ID OSW
AC CVCL_0B19
SY Oswald
DR ATCC; PTA-9116
DR GEO; GSM1974798
RX Patent=US7897150;
RX PubMed=17532464;
RX PubMed=21908323;
RX PubMed=23365669;
RX PubMed=26842912;
RX PubMed=27197945;
RX PubMed=27257868;
CC Part of: FACC canine tumor cell line panel.
CC Omics: Transcriptome analysis.
CC Breed/subspecies: Airedale Terrier.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID OT11
AC CVCL_T370
SY OT-11
DR CLO; CLO_0050531
DR RCB; RCB1926
RX PubMed=9374409;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OT13
AC CVCL_T371
SY OT-13
DR CLO; CLO_0050532
DR RCB; RCB1927
RX PubMed=9374409;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID OT145
AC CVCL_CW44
DR NCBI_Iran; H155
RX PubMed=3464003;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID OTCD1TKB
AC CVCL_L557
DR CLO; CLO_0050656
DR BioSample; SAMN03472272
DR RCB; RCB0492
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 10,11
ST D5S818: 12,13
ST D7S820: 11,12
ST TH01: 9
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C84957; Ornithine carbamoyltransferase deficiency disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID OTH-74D4
AC CVCL_2152
SY OTH74D4
DR CLO; CLO_0008275
DR DSMZ; ACC-478
CC Doubling time: ~40-50 hours (DSMZ).
CC Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID OTT1
AC CVCL_5345
RX PubMed=1883955;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=OTT1
CC Characteristics: CFS2, IL3 or IL5 dependent.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Factor-dependent cell line
//
ID OTT6050
AC CVCL_5572
SY OTT 6050; OTT-6050
DR JCRB; JCRB0720
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0E97 ! OC15
SX Male
CA Cancer cell line
//
ID OTT6050(A)
AC CVCL_4U63
SY OTT6050 (A); OTT6050-A
DR TKG; TKG 0329
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID OTT6050(B)
AC CVCL_4U64
SY OTT6050 (B); OTT6050-B
DR TKG; TKG 0330
CC Breed/subspecies: 129/Sv.
DI NCIt; C129859; Mouse teratocarcinoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5572 ! OTT6050
SX Male
CA Cancer cell line
//
ID OU-AML-1
AC CVCL_8391
DR BioSample; SAMN03151867
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
//
ID OU-AML-2
AC CVCL_8392
DR BioSample; SAMN03151868
RX PubMed=10027306;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a OCI-AML2 derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1619 ! OCI-AML2
SX Male
CA Cancer cell line
- 公告/新闻
免费订购电话: 400-800-2947